Query psy3329
Match_columns 694
No_of_seqs 647 out of 4115
Neff 10.3
Searched_HMMs 46136
Date Fri Aug 16 22:10:08 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy3329.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/3329hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PLN00113 leucine-rich repeat r 100.0 5.6E-54 1.2E-58 504.6 35.9 498 11-536 87-589 (968)
2 PLN00113 leucine-rich repeat r 100.0 1.3E-47 2.9E-52 450.7 34.5 491 12-533 113-609 (968)
3 KOG4194|consensus 100.0 1.9E-49 4.2E-54 393.2 9.9 445 69-608 83-529 (873)
4 KOG4194|consensus 100.0 1.3E-40 2.9E-45 330.6 7.9 392 18-451 53-447 (873)
5 KOG0472|consensus 100.0 1.4E-38 3E-43 303.0 -9.9 476 9-531 37-541 (565)
6 KOG0472|consensus 100.0 2E-37 4.2E-42 295.1 -13.7 440 11-512 62-545 (565)
7 KOG0618|consensus 100.0 1E-34 2.2E-39 304.3 -5.5 444 19-530 23-488 (1081)
8 KOG0618|consensus 100.0 1E-31 2.2E-36 281.9 -5.1 460 21-531 2-465 (1081)
9 KOG0444|consensus 100.0 3.2E-31 7E-36 265.8 -2.1 371 14-435 4-380 (1255)
10 KOG4237|consensus 100.0 3.5E-30 7.5E-35 245.6 3.9 330 238-578 67-406 (498)
11 KOG4237|consensus 100.0 4.4E-31 9.6E-36 251.7 -2.7 308 20-346 49-358 (498)
12 KOG0444|consensus 100.0 1.1E-30 2.4E-35 261.9 -1.4 370 63-511 6-379 (1255)
13 PRK15387 E3 ubiquitin-protein 99.9 2.1E-21 4.5E-26 211.8 19.8 257 190-532 203-459 (788)
14 PRK15387 E3 ubiquitin-protein 99.9 1.6E-21 3.6E-26 212.6 18.9 265 138-514 201-465 (788)
15 PLN03210 Resistant to P. syrin 99.9 5.6E-20 1.2E-24 216.7 30.8 311 34-370 552-878 (1153)
16 PLN03210 Resistant to P. syrin 99.9 4.4E-20 9.6E-25 217.6 28.1 338 9-372 550-904 (1153)
17 PRK15370 E3 ubiquitin-protein 99.8 1.4E-18 3E-23 191.2 15.2 249 213-532 178-429 (754)
18 PRK15370 E3 ubiquitin-protein 99.8 3.3E-18 7.1E-23 188.3 14.2 162 164-350 180-341 (754)
19 cd00116 LRR_RI Leucine-rich re 99.7 1.8E-18 3.9E-23 177.6 3.3 286 192-530 2-319 (319)
20 cd00116 LRR_RI Leucine-rich re 99.7 2.4E-17 5.2E-22 169.3 6.2 207 21-227 2-235 (319)
21 KOG0617|consensus 99.5 2.8E-16 6E-21 133.6 -5.8 157 13-175 29-186 (264)
22 KOG0617|consensus 99.5 4.7E-16 1E-20 132.3 -4.8 111 416-533 101-214 (264)
23 KOG3207|consensus 99.3 5.6E-13 1.2E-17 130.5 1.8 169 134-302 117-287 (505)
24 KOG3207|consensus 99.3 1.2E-12 2.7E-17 128.1 2.4 187 86-274 119-313 (505)
25 PF14580 LRR_9: Leucine-rich r 99.2 4.5E-12 9.7E-17 113.9 4.3 123 24-152 4-127 (175)
26 KOG1909|consensus 99.2 4.3E-12 9.2E-17 121.1 4.1 160 186-346 118-310 (382)
27 KOG1909|consensus 99.2 2.3E-12 4.9E-17 123.0 1.7 197 305-531 87-311 (382)
28 PF14580 LRR_9: Leucine-rich r 99.2 4.8E-11 1E-15 107.2 7.7 113 416-536 18-131 (175)
29 PLN03150 hypothetical protein; 99.1 1.2E-10 2.6E-15 128.6 8.7 113 418-535 419-532 (623)
30 KOG1259|consensus 99.1 2.4E-11 5.1E-16 113.2 1.7 135 236-378 282-416 (490)
31 KOG1259|consensus 99.1 2.2E-11 4.7E-16 113.5 -0.7 134 16-155 283-416 (490)
32 KOG0532|consensus 99.0 1.4E-11 3.1E-16 124.6 -3.6 197 15-248 73-270 (722)
33 COG4886 Leucine-rich repeat (L 99.0 6E-10 1.3E-14 117.7 7.9 86 418-512 210-295 (394)
34 KOG0531|consensus 99.0 9.4E-11 2E-15 123.8 -0.3 241 239-532 73-319 (414)
35 PF13855 LRR_8: Leucine rich r 99.0 5.4E-10 1.2E-14 82.5 3.9 59 444-505 2-60 (61)
36 PF13855 LRR_8: Leucine rich r 98.9 7.2E-10 1.6E-14 81.8 4.0 61 417-479 1-61 (61)
37 KOG0531|consensus 98.9 1.1E-10 2.4E-15 123.3 -1.1 246 37-302 69-321 (414)
38 COG4886 Leucine-rich repeat (L 98.9 1.2E-09 2.7E-14 115.3 6.0 198 21-231 97-295 (394)
39 KOG4658|consensus 98.9 1E-09 2.2E-14 123.7 4.7 321 13-344 519-856 (889)
40 KOG4658|consensus 98.9 1.1E-09 2.4E-14 123.4 4.8 333 27-371 511-856 (889)
41 KOG0532|consensus 98.9 1.7E-10 3.6E-15 117.0 -2.1 177 14-199 95-271 (722)
42 PLN03150 hypothetical protein; 98.7 3.9E-08 8.5E-13 108.8 9.8 107 42-150 420-527 (623)
43 KOG2120|consensus 98.6 2.6E-09 5.6E-14 99.9 -2.5 178 139-321 186-374 (419)
44 KOG2982|consensus 98.6 1.6E-08 3.5E-13 94.6 1.0 81 212-292 198-285 (418)
45 KOG2120|consensus 98.6 3.5E-09 7.6E-14 99.0 -3.7 185 88-274 185-375 (419)
46 KOG2982|consensus 98.5 7.9E-08 1.7E-12 90.1 2.6 86 90-175 47-134 (418)
47 KOG1859|consensus 98.5 1.9E-09 4.2E-14 112.3 -8.8 126 66-200 166-291 (1096)
48 KOG4341|consensus 98.4 4E-08 8.6E-13 96.5 -0.5 61 212-272 293-356 (483)
49 KOG4341|consensus 98.4 2.9E-08 6.2E-13 97.5 -2.4 230 41-274 139-384 (483)
50 KOG1859|consensus 98.3 1.2E-08 2.7E-13 106.5 -6.5 132 17-154 164-295 (1096)
51 PF13306 LRR_5: Leucine rich r 98.3 2E-06 4.3E-11 74.9 6.7 122 35-164 7-128 (129)
52 COG5238 RNA1 Ran GTPase-activa 98.2 7.9E-07 1.7E-11 82.5 3.7 87 16-102 29-134 (388)
53 COG5238 RNA1 Ran GTPase-activa 98.2 2.5E-06 5.3E-11 79.3 6.1 90 211-300 155-256 (388)
54 PF13306 LRR_5: Leucine rich r 98.2 4.5E-06 9.7E-11 72.6 7.2 126 8-141 3-129 (129)
55 KOG1644|consensus 98.1 5.8E-06 1.3E-10 73.7 6.2 107 42-152 21-127 (233)
56 KOG1644|consensus 98.1 7E-06 1.5E-10 73.2 5.9 105 418-528 43-150 (233)
57 KOG4579|consensus 98.0 5.4E-07 1.2E-11 74.7 -1.9 106 17-124 27-135 (177)
58 KOG1187|consensus 97.9 8.2E-07 1.8E-11 91.1 -2.7 48 625-672 61-112 (361)
59 PF12799 LRR_4: Leucine Rich r 97.9 8.7E-06 1.9E-10 54.7 2.9 37 444-481 2-38 (44)
60 KOG4579|consensus 97.9 1.2E-06 2.6E-11 72.8 -1.8 113 240-354 29-143 (177)
61 PF12799 LRR_4: Leucine Rich r 97.9 1.8E-05 3.8E-10 53.2 3.9 38 18-55 2-39 (44)
62 KOG3665|consensus 97.9 1.3E-05 2.9E-10 88.6 5.0 155 88-246 122-283 (699)
63 KOG3665|consensus 97.7 3.2E-05 6.9E-10 85.6 4.4 108 163-273 123-231 (699)
64 PRK15386 type III secretion pr 97.6 0.00036 7.9E-09 71.1 9.8 138 37-198 49-187 (426)
65 TIGR00864 PCC polycystin catio 97.6 6.6E-05 1.4E-09 91.4 5.1 67 500-566 1-70 (2740)
66 PRK15386 type III secretion pr 97.6 0.00058 1.3E-08 69.6 11.0 54 260-320 50-104 (426)
67 KOG1947|consensus 97.4 8.4E-05 1.8E-09 81.1 2.2 64 186-249 241-306 (482)
68 KOG2123|consensus 97.3 1.5E-05 3.2E-10 74.5 -4.0 82 39-124 18-100 (388)
69 KOG2739|consensus 97.2 0.00015 3.3E-09 67.8 1.8 103 236-340 41-149 (260)
70 KOG2739|consensus 97.2 0.00022 4.8E-09 66.7 2.5 88 62-152 41-130 (260)
71 KOG2123|consensus 97.2 2.9E-05 6.4E-10 72.6 -3.3 101 111-218 18-122 (388)
72 KOG1947|consensus 97.0 0.00021 4.5E-09 78.0 1.0 237 38-297 186-438 (482)
73 KOG3653|consensus 96.9 0.0002 4.3E-09 72.3 -0.8 52 633-687 208-259 (534)
74 PF00560 LRR_1: Leucine Rich R 95.4 0.0074 1.6E-07 33.5 1.0 16 445-460 2-17 (22)
75 smart00082 LRRCT Leucine rich 94.7 0.015 3.1E-07 40.7 1.2 18 528-545 1-18 (51)
76 KOG0193|consensus 94.3 0.0066 1.4E-07 63.7 -1.8 36 641-678 398-433 (678)
77 KOG4236|consensus 94.2 0.011 2.3E-07 60.9 -0.5 53 631-683 560-613 (888)
78 PF13504 LRR_7: Leucine rich r 94.0 0.037 8E-07 28.4 1.4 14 444-457 2-15 (17)
79 PF00560 LRR_1: Leucine Rich R 93.6 0.027 5.8E-07 31.3 0.5 9 68-76 4-12 (22)
80 PF03109 ABC1: ABC1 family; I 93.5 0.027 5.9E-07 47.6 0.7 40 638-677 14-53 (119)
81 smart00370 LRR Leucine-rich re 93.3 0.061 1.3E-06 31.2 1.8 21 443-463 2-22 (26)
82 smart00369 LRR_TYP Leucine-ric 93.3 0.061 1.3E-06 31.2 1.8 21 443-463 2-22 (26)
83 PLN03224 probable serine/threo 93.2 0.016 3.6E-07 62.2 -1.4 32 638-669 148-196 (507)
84 cd05102 PTKc_VEGFR3 Catalytic 92.9 0.028 6.1E-07 58.0 -0.2 30 641-670 13-48 (338)
85 KOG0473|consensus 92.7 0.002 4.4E-08 59.0 -7.6 98 25-125 26-124 (326)
86 KOG4308|consensus 91.8 0.0047 1E-07 65.7 -7.5 91 285-375 203-304 (478)
87 PRK09188 serine/threonine prot 91.5 0.03 6.6E-07 57.4 -1.8 29 640-668 23-53 (365)
88 PF13504 LRR_7: Leucine rich r 91.5 0.12 2.5E-06 26.5 1.2 16 18-33 2-17 (17)
89 cd05064 PTKc_EphR_A10 Catalyti 91.4 0.029 6.3E-07 55.5 -2.1 32 641-672 11-46 (266)
90 smart00369 LRR_TYP Leucine-ric 91.4 0.19 4.1E-06 29.1 2.2 21 494-514 2-22 (26)
91 smart00370 LRR Leucine-rich re 91.4 0.19 4.1E-06 29.1 2.2 21 494-514 2-22 (26)
92 cd05104 PTKc_Kit Catalytic dom 91.2 0.032 7E-07 58.4 -2.0 31 640-670 40-76 (375)
93 KOG2052|consensus 91.2 0.034 7.4E-07 56.3 -1.7 29 641-670 217-245 (513)
94 KOG4308|consensus 90.8 0.0069 1.5E-07 64.4 -7.5 183 19-201 89-303 (478)
95 cd05108 PTKc_EGFR Catalytic do 90.7 0.044 9.6E-07 55.9 -1.6 31 640-670 12-47 (316)
96 cd05103 PTKc_VEGFR2 Catalytic 90.5 0.045 9.8E-07 56.6 -1.8 29 641-669 13-47 (343)
97 KOG4250|consensus 90.2 0.1 2.2E-06 56.2 0.6 33 640-672 18-51 (732)
98 cd05054 PTKc_VEGFR Catalytic d 90.0 0.067 1.5E-06 55.1 -1.0 29 641-669 13-47 (337)
99 cd05033 PTKc_EphR Catalytic do 90.0 0.048 1E-06 53.9 -2.0 35 639-673 8-46 (266)
100 cd05144 RIO2_C RIO kinase fami 90.0 0.05 1.1E-06 51.1 -1.8 27 641-667 21-47 (198)
101 cd05109 PTKc_HER2 Catalytic do 89.8 0.05 1.1E-06 54.2 -2.1 37 641-677 13-54 (279)
102 PLN00034 mitogen-activated pro 89.6 0.047 1E-06 56.7 -2.5 30 641-670 80-110 (353)
103 cd05106 PTKc_CSF-1R Catalytic 89.5 0.062 1.4E-06 56.2 -1.7 31 641-671 44-80 (374)
104 TIGR01982 UbiB 2-polyprenylphe 89.5 0.06 1.3E-06 57.2 -1.8 33 638-670 120-152 (437)
105 KOG0597|consensus 89.4 0.056 1.2E-06 56.5 -2.0 34 641-674 8-42 (808)
106 cd05049 PTKc_Trk Catalytic dom 89.4 0.062 1.4E-06 53.5 -1.8 33 641-673 11-49 (280)
107 cd05096 PTKc_DDR1 Catalytic do 89.3 0.058 1.3E-06 54.6 -2.1 31 641-671 11-58 (304)
108 KOG1026|consensus 89.3 0.11 2.3E-06 57.2 -0.1 42 641-682 492-539 (774)
109 KOG0192|consensus 89.2 0.043 9.4E-07 56.3 -3.1 32 640-671 46-77 (362)
110 KOG3864|consensus 89.1 0.082 1.8E-06 47.9 -1.0 82 140-221 103-184 (221)
111 cd05105 PTKc_PDGFR_alpha Catal 88.7 0.069 1.5E-06 56.3 -2.1 30 641-670 43-78 (400)
112 cd06624 STKc_ASK Catalytic dom 88.5 0.09 1.9E-06 52.0 -1.3 35 639-673 12-47 (268)
113 PTZ00283 serine/threonine prot 88.4 0.066 1.4E-06 58.3 -2.5 30 641-670 38-68 (496)
114 cd05067 PTKc_Lck_Blk Catalytic 88.3 0.069 1.5E-06 52.6 -2.2 30 641-670 12-41 (260)
115 KOG3864|consensus 88.1 0.13 2.8E-06 46.7 -0.4 84 88-171 101-185 (221)
116 KOG0575|consensus 88.1 0.087 1.9E-06 55.7 -1.7 36 640-675 23-59 (592)
117 cd06641 STKc_MST3 Catalytic do 88.0 0.087 1.9E-06 52.5 -1.8 30 641-670 10-40 (277)
118 KOG0658|consensus 87.9 0.1 2.2E-06 51.6 -1.2 28 638-665 27-55 (364)
119 KOG0580|consensus 87.9 0.11 2.4E-06 48.4 -1.0 42 641-682 28-72 (281)
120 cd05090 PTKc_Ror1 Catalytic do 87.9 0.085 1.8E-06 52.7 -1.9 31 641-671 11-46 (283)
121 cd05043 PTK_Ryk Pseudokinase d 87.7 0.078 1.7E-06 52.9 -2.3 31 640-670 11-46 (280)
122 KOG0473|consensus 87.6 0.021 4.5E-07 52.6 -5.7 87 14-102 39-125 (326)
123 cd05091 PTKc_Ror2 Catalytic do 87.5 0.075 1.6E-06 53.1 -2.6 32 641-672 11-48 (283)
124 cd07871 STKc_PCTAIRE3 Catalyti 87.4 0.076 1.7E-06 53.3 -2.6 30 641-670 11-41 (288)
125 cd07869 STKc_PFTAIRE1 Catalyti 87.4 0.08 1.7E-06 53.6 -2.5 31 641-671 11-42 (303)
126 PHA02882 putative serine/threo 87.0 0.1 2.2E-06 52.5 -1.9 26 641-666 18-47 (294)
127 cd05107 PTKc_PDGFR_beta Cataly 86.9 0.096 2.1E-06 55.3 -2.3 31 641-671 43-79 (401)
128 KOG0595|consensus 86.6 0.15 3.2E-06 51.3 -1.0 29 643-671 18-47 (429)
129 cd05597 STKc_DMPK_like Catalyt 86.5 0.12 2.7E-06 53.0 -1.7 29 641-669 7-36 (331)
130 PTZ00284 protein kinase; Provi 86.4 0.13 2.8E-06 55.8 -1.7 28 641-668 135-163 (467)
131 KOG1027|consensus 86.1 0.33 7.1E-06 53.5 1.2 42 638-680 512-554 (903)
132 cd05624 STKc_MRCK_beta Catalyt 86.0 0.15 3.2E-06 52.4 -1.4 29 641-669 7-36 (331)
133 PLN03225 Serine/threonine-prot 85.8 0.15 3.2E-06 56.3 -1.6 29 640-668 137-170 (566)
134 cd05600 STKc_Sid2p_Dbf2p Catal 85.8 0.16 3.4E-06 52.2 -1.4 32 641-672 7-39 (333)
135 smart00090 RIO RIO-like kinase 85.7 0.14 2.9E-06 49.6 -1.7 29 641-669 34-64 (237)
136 cd05599 STKc_NDR_like Catalyti 85.5 0.16 3.5E-06 53.0 -1.5 30 641-670 7-37 (364)
137 cd05148 PTKc_Srm_Brk Catalytic 85.1 0.16 3.5E-06 49.9 -1.6 32 641-672 12-43 (261)
138 cd06619 PKc_MKK5 Catalytic dom 85.0 0.13 2.8E-06 51.3 -2.3 32 641-672 7-39 (279)
139 cd07872 STKc_PCTAIRE2 Catalyti 84.8 0.12 2.6E-06 52.5 -2.8 30 641-670 12-42 (309)
140 cd05072 PTKc_Lyn Catalytic dom 84.8 0.16 3.4E-06 50.1 -1.9 29 641-669 12-40 (261)
141 cd05056 PTKc_FAK Catalytic dom 84.7 0.17 3.7E-06 50.1 -1.7 32 640-671 11-46 (270)
142 cd05038 PTKc_Jak_rpt2 Catalyti 84.5 0.17 3.6E-06 50.5 -1.9 32 641-672 10-46 (284)
143 cd05073 PTKc_Hck Catalytic dom 84.4 0.2 4.4E-06 49.3 -1.3 29 641-669 12-40 (260)
144 KOG0591|consensus 84.3 0.31 6.8E-06 46.6 0.0 26 641-666 25-51 (375)
145 cd05626 STKc_LATS2 Catalytic d 84.2 0.21 4.5E-06 52.5 -1.4 30 641-670 7-37 (381)
146 KOG4257|consensus 84.1 0.21 4.5E-06 53.0 -1.3 32 638-669 392-428 (974)
147 cd05097 PTKc_DDR_like Catalyti 83.9 0.22 4.9E-06 50.0 -1.2 34 641-674 11-59 (295)
148 cd06617 PKc_MKK3_6 Catalytic d 83.5 0.15 3.3E-06 50.8 -2.6 30 641-670 7-37 (283)
149 cd05061 PTKc_InsR Catalytic do 83.5 0.18 4E-06 50.5 -2.1 28 641-668 12-45 (288)
150 cd05068 PTKc_Frk_like Catalyti 83.4 0.18 3.8E-06 49.7 -2.2 29 641-669 12-40 (261)
151 cd05065 PTKc_EphR_B Catalytic 83.3 0.19 4E-06 49.8 -2.1 31 640-670 9-43 (269)
152 cd07878 STKc_p38beta_MAPK11 Ca 83.3 0.17 3.7E-06 52.2 -2.4 30 641-670 21-51 (343)
153 cd05601 STKc_CRIK Catalytic do 83.1 0.23 5E-06 50.9 -1.5 32 641-672 7-39 (330)
154 cd05625 STKc_LATS1 Catalytic d 83.0 0.25 5.5E-06 51.9 -1.3 30 641-670 7-37 (382)
155 PTZ00036 glycogen synthase kin 83.0 0.23 5E-06 53.2 -1.6 28 641-668 72-100 (440)
156 cd05573 STKc_ROCK_NDR_like Cat 82.8 0.23 5E-06 51.4 -1.7 31 641-671 7-38 (350)
157 cd08224 STKc_Nek6_Nek7 Catalyt 82.4 0.2 4.4E-06 49.3 -2.2 29 640-668 7-36 (267)
158 cd05623 STKc_MRCK_alpha Cataly 82.4 0.27 5.8E-06 50.5 -1.4 29 641-669 7-36 (332)
159 cd05034 PTKc_Src_like Catalyti 82.3 0.22 4.7E-06 49.0 -2.0 29 641-669 12-40 (261)
160 cd06642 STKc_STK25-YSK1 Cataly 82.1 0.19 4.1E-06 50.0 -2.6 29 641-669 10-39 (277)
161 cd05114 PTKc_Tec_Rlk Catalytic 82.1 0.23 5E-06 48.7 -1.9 28 641-668 10-37 (256)
162 KOG0661|consensus 82.0 0.51 1.1E-05 48.6 0.5 37 641-677 16-53 (538)
163 PF13516 LRR_6: Leucine Rich r 82.0 0.5 1.1E-05 26.7 0.3 14 495-508 3-16 (24)
164 cd07849 STKc_ERK1_2_like Catal 81.5 0.25 5.5E-06 50.8 -2.0 29 641-669 11-40 (336)
165 cd05612 STKc_PRKX_like Catalyt 81.4 0.25 5.4E-06 49.6 -2.0 29 641-669 7-36 (291)
166 cd06620 PKc_MAPKK_Byr1_like Ca 81.4 0.18 4E-06 50.3 -3.0 30 641-670 11-41 (284)
167 cd05628 STKc_NDR1 Catalytic do 81.2 0.31 6.6E-06 50.8 -1.4 30 641-670 7-37 (363)
168 KOG1095|consensus 81.2 0.27 5.8E-06 56.4 -2.0 39 640-678 697-741 (1025)
169 cd05057 PTKc_EGFR_like Catalyt 81.2 0.24 5.3E-06 49.3 -2.1 34 641-674 13-51 (279)
170 cd05629 STKc_NDR_like_fungal C 81.2 0.31 6.7E-06 51.1 -1.4 30 641-670 7-37 (377)
171 cd05036 PTKc_ALK_LTK Catalytic 81.1 0.23 5E-06 49.4 -2.3 36 641-676 12-53 (277)
172 cd06649 PKc_MEK2 Catalytic dom 81.0 0.26 5.6E-06 50.6 -2.1 30 641-670 11-41 (331)
173 cd05046 PTK_CCK4 Pseudokinase 81.0 0.31 6.6E-06 48.4 -1.5 32 641-672 11-48 (275)
174 cd05598 STKc_LATS Catalytic do 81.0 0.34 7.3E-06 50.8 -1.3 30 641-670 7-37 (376)
175 KOG0667|consensus 80.9 0.32 7E-06 52.0 -1.4 40 641-680 192-232 (586)
176 cd05048 PTKc_Ror Catalytic Dom 80.8 0.27 5.8E-06 49.0 -2.0 31 641-671 11-47 (283)
177 cd07862 STKc_CDK6 Catalytic do 80.8 0.19 4E-06 50.4 -3.2 29 641-669 7-37 (290)
178 cd05050 PTKc_Musk Catalytic do 80.6 0.28 6.1E-06 49.1 -1.9 30 641-670 11-46 (288)
179 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 80.6 0.3 6.4E-06 48.8 -1.7 30 641-670 10-44 (284)
180 cd05071 PTKc_Src Catalytic dom 80.5 0.27 5.9E-06 48.4 -2.0 29 641-669 12-40 (262)
181 cd05039 PTKc_Csk_like Catalyti 80.4 0.32 7E-06 47.6 -1.6 32 640-672 11-42 (256)
182 cd07844 STKc_PCTAIRE_like Cata 80.4 0.23 5E-06 49.8 -2.7 31 641-671 11-42 (291)
183 cd05063 PTKc_EphR_A2 Catalytic 80.3 0.27 5.9E-06 48.5 -2.1 32 639-670 9-44 (268)
184 cd05101 PTKc_FGFR2 Catalytic d 80.3 0.36 7.8E-06 48.8 -1.3 29 641-669 21-57 (304)
185 cd06650 PKc_MEK1 Catalytic dom 80.3 0.27 5.8E-06 50.5 -2.2 30 641-670 11-41 (333)
186 PTZ00263 protein kinase A cata 80.2 0.34 7.5E-06 49.6 -1.4 30 641-670 24-54 (329)
187 cd05062 PTKc_IGF-1R Catalytic 80.2 0.29 6.3E-06 48.6 -2.0 30 640-669 11-46 (277)
188 cd05080 PTKc_Tyk2_rpt2 Catalyt 80.1 0.32 6.9E-06 48.5 -1.7 30 641-670 10-44 (283)
189 KOG0659|consensus 80.1 0.3 6.5E-06 46.4 -1.7 31 640-670 7-38 (318)
190 cd05095 PTKc_DDR2 Catalytic do 79.9 0.33 7.2E-06 48.8 -1.7 31 641-671 11-58 (296)
191 cd05112 PTKc_Itk Catalytic dom 79.9 0.25 5.5E-06 48.3 -2.5 30 641-670 10-39 (256)
192 cd05070 PTKc_Fyn_Yrk Catalytic 79.8 0.31 6.6E-06 47.9 -2.0 29 641-669 12-40 (260)
193 cd06917 STKc_NAK1_like Catalyt 79.8 0.27 5.8E-06 48.9 -2.4 29 641-669 7-36 (277)
194 KOG0577|consensus 79.7 0.37 8.1E-06 50.9 -1.3 35 641-678 32-67 (948)
195 cd06622 PKc_MAPKK_PBS2_like Ca 79.6 0.28 6.1E-06 49.0 -2.3 29 641-669 7-36 (286)
196 cd06629 STKc_MAPKKK_Bck1_like 79.6 0.42 9.2E-06 47.3 -1.0 29 640-668 6-35 (272)
197 cd06618 PKc_MKK7 Catalytic dom 79.6 0.27 5.9E-06 49.5 -2.5 31 640-670 20-51 (296)
198 cd05088 PTKc_Tie2 Catalytic do 79.5 0.31 6.7E-06 49.3 -2.0 29 641-669 13-44 (303)
199 cd05055 PTKc_PDGFR Catalytic d 79.4 0.33 7.2E-06 49.0 -1.9 31 640-670 40-76 (302)
200 KOG0201|consensus 79.3 0.35 7.5E-06 49.2 -1.7 30 641-670 19-49 (467)
201 KOG0032|consensus 79.1 0.3 6.5E-06 50.7 -2.3 36 641-676 41-77 (382)
202 cd07846 STKc_CDKL2_3 Catalytic 79.0 0.33 7.3E-06 48.4 -2.0 31 641-671 7-38 (286)
203 cd06610 STKc_OSR1_SPAK Catalyt 79.0 0.31 6.7E-06 48.0 -2.2 29 641-669 7-36 (267)
204 cd05051 PTKc_DDR Catalytic dom 78.8 0.33 7.2E-06 48.7 -2.1 31 641-671 11-58 (296)
205 KOG1166|consensus 78.8 0.4 8.7E-06 54.9 -1.6 33 641-673 704-736 (974)
206 cd05581 STKc_PDK1 Catalytic do 78.4 0.41 9E-06 47.5 -1.5 29 641-669 7-36 (280)
207 cd05110 PTKc_HER4 Catalytic do 78.3 0.36 7.9E-06 48.7 -2.0 32 641-672 13-49 (303)
208 cd06616 PKc_MKK4 Catalytic dom 78.3 0.36 7.7E-06 48.3 -2.0 34 640-673 9-43 (288)
209 cd05079 PTKc_Jak1_rpt2 Catalyt 78.3 0.38 8.2E-06 48.0 -1.9 29 641-669 10-43 (284)
210 KOG1035|consensus 78.2 0.85 1.8E-05 52.7 0.7 26 641-666 485-511 (1351)
211 cd07870 STKc_PFTAIRE2 Catalyti 78.2 0.31 6.7E-06 48.9 -2.5 31 641-671 11-42 (291)
212 cd07837 STKc_CdkB_plant Cataly 78.2 0.33 7.2E-06 48.7 -2.3 31 640-670 6-37 (295)
213 PRK04750 ubiB putative ubiquin 78.1 0.41 8.9E-06 51.9 -1.7 31 640-670 124-155 (537)
214 KOG0194|consensus 78.1 0.39 8.5E-06 50.6 -1.8 29 641-669 163-196 (474)
215 KOG0600|consensus 78.0 0.39 8.5E-06 49.8 -1.8 25 641-665 123-148 (560)
216 cd07848 STKc_CDKL5 Catalytic d 78.0 0.27 5.8E-06 49.2 -3.0 29 641-669 7-36 (287)
217 cd06646 STKc_MAP4K5 Catalytic 77.9 0.35 7.5E-06 47.7 -2.2 29 641-669 15-44 (267)
218 KOG0598|consensus 77.9 0.85 1.8E-05 45.5 0.5 35 641-675 31-66 (357)
219 cd07867 STKc_CDC2L6 Catalytic 77.6 0.37 8.1E-06 49.0 -2.1 29 641-669 7-38 (317)
220 smart00365 LRR_SD22 Leucine-ri 77.5 2 4.2E-05 24.9 1.7 15 443-457 2-16 (26)
221 cd07877 STKc_p38alpha_MAPK14 C 77.3 0.42 9E-06 49.4 -1.9 30 641-670 23-53 (345)
222 cd07868 STKc_CDK8 Catalytic do 77.2 0.43 9.4E-06 48.5 -1.8 29 641-669 7-38 (317)
223 cd05066 PTKc_EphR_A Catalytic 77.2 0.36 7.8E-06 47.7 -2.4 31 640-670 9-43 (267)
224 cd05627 STKc_NDR2 Catalytic do 77.0 0.5 1.1E-05 49.2 -1.4 30 641-670 7-37 (360)
225 cd07876 STKc_JNK2 Catalytic do 77.0 0.32 7E-06 50.6 -2.9 30 641-670 27-57 (359)
226 PHA02988 hypothetical protein; 76.7 0.43 9.4E-06 47.7 -1.9 29 641-670 26-54 (283)
227 cd07873 STKc_PCTAIRE1 Catalyti 76.6 0.34 7.3E-06 48.9 -2.8 30 641-670 12-42 (301)
228 cd08229 STKc_Nek7 Catalytic do 76.3 0.47 1E-05 46.8 -1.8 30 640-669 7-37 (267)
229 PTZ00024 cyclin-dependent prot 76.3 0.37 8.1E-06 49.5 -2.6 30 641-670 15-45 (335)
230 cd06636 STKc_MAP4K4_6 Catalyti 76.3 0.42 9.1E-06 47.6 -2.1 30 641-670 22-52 (282)
231 cd05111 PTK_HER3 Pseudokinase 76.0 0.5 1.1E-05 47.0 -1.7 28 641-668 13-45 (279)
232 KOG1025|consensus 76.0 0.44 9.4E-06 52.5 -2.2 36 640-675 701-741 (1177)
233 cd06657 STKc_PAK4 Catalytic do 75.8 0.42 9.2E-06 48.0 -2.3 28 641-668 26-54 (292)
234 cd05053 PTKc_FGFR Catalytic do 75.7 0.44 9.6E-06 47.8 -2.2 30 641-670 18-53 (293)
235 KOG0198|consensus 75.7 0.65 1.4E-05 46.4 -0.9 31 640-670 22-53 (313)
236 cd06638 STKc_myosinIIIA Cataly 75.6 0.56 1.2E-05 46.8 -1.5 29 641-669 24-53 (286)
237 cd07875 STKc_JNK1 Catalytic do 75.6 0.43 9.2E-06 49.8 -2.4 30 641-670 30-60 (364)
238 PTZ00426 cAMP-dependent protei 75.6 0.53 1.1E-05 48.5 -1.7 31 641-671 36-68 (340)
239 cd06605 PKc_MAPKK Catalytic do 75.5 0.38 8.3E-06 47.3 -2.7 34 641-674 7-41 (265)
240 cd06640 STKc_MST4 Catalytic do 75.5 0.4 8.7E-06 47.6 -2.6 30 641-670 10-40 (277)
241 cd05596 STKc_ROCK Catalytic do 75.2 0.57 1.2E-05 48.9 -1.6 30 641-670 49-79 (370)
242 cd05621 STKc_ROCK2 Catalytic d 75.2 0.45 9.7E-06 49.7 -2.4 29 641-669 49-78 (370)
243 cd05113 PTKc_Btk_Bmx Catalytic 75.0 0.6 1.3E-05 45.7 -1.4 29 641-669 10-38 (256)
244 cd06609 STKc_MST3_like Catalyt 74.9 0.4 8.8E-06 47.5 -2.7 31 641-671 7-38 (274)
245 cd05059 PTKc_Tec_like Catalyti 74.8 0.46 1E-05 46.5 -2.3 30 640-669 9-38 (256)
246 cd05098 PTKc_FGFR1 Catalytic d 74.5 0.57 1.2E-05 47.4 -1.8 30 641-670 24-61 (307)
247 cd06623 PKc_MAPKK_plant_like C 74.3 0.54 1.2E-05 46.2 -2.0 31 641-671 7-38 (264)
248 cd05032 PTKc_InsR_like Catalyt 74.3 0.56 1.2E-05 46.5 -1.9 31 641-671 12-48 (277)
249 PRK13184 pknD serine/threonine 73.7 0.57 1.2E-05 53.9 -2.1 29 641-669 8-37 (932)
250 cd06615 PKc_MEK Catalytic doma 73.7 0.55 1.2E-05 47.6 -2.1 30 641-670 7-37 (308)
251 cd05089 PTKc_Tie1 Catalytic do 73.7 0.62 1.4E-05 46.9 -1.7 28 641-668 8-38 (297)
252 cd06639 STKc_myosinIIIB Cataly 73.5 0.66 1.4E-05 46.4 -1.5 29 641-669 28-57 (291)
253 KOG1163|consensus 73.5 0.47 1E-05 44.4 -2.3 30 641-670 21-51 (341)
254 cd06656 STKc_PAK3 Catalytic do 73.4 0.52 1.1E-05 47.5 -2.4 30 641-670 25-55 (297)
255 smart00364 LRR_BAC Leucine-ric 73.3 2.4 5.3E-05 24.5 1.4 16 444-459 3-18 (26)
256 cd07874 STKc_JNK3 Catalytic do 73.1 0.57 1.2E-05 48.6 -2.2 30 641-670 23-53 (355)
257 cd05052 PTKc_Abl Catalytic dom 73.1 0.6 1.3E-05 45.9 -2.0 31 640-670 11-42 (263)
258 KOG3763|consensus 72.6 1.8 3.9E-05 45.7 1.3 66 416-481 217-284 (585)
259 KOG4242|consensus 72.5 28 0.00062 36.4 9.6 114 417-530 354-480 (553)
260 KOG0583|consensus 72.4 0.63 1.4E-05 48.2 -2.0 30 641-670 23-53 (370)
261 cd08228 STKc_Nek6 Catalytic do 72.0 0.6 1.3E-05 46.0 -2.3 29 640-668 7-36 (267)
262 cd05083 PTKc_Chk Catalytic dom 72.0 0.88 1.9E-05 44.4 -1.0 29 640-669 11-39 (254)
263 KOG0197|consensus 71.5 0.94 2E-05 47.3 -1.0 30 641-670 212-241 (468)
264 cd07833 STKc_CDKL Catalytic do 71.4 0.84 1.8E-05 45.5 -1.4 29 641-669 7-36 (288)
265 cd07880 STKc_p38gamma_MAPK12 C 70.8 0.67 1.5E-05 47.8 -2.3 28 641-668 21-49 (343)
266 PLN00009 cyclin-dependent kina 70.7 0.61 1.3E-05 46.8 -2.6 30 641-670 8-38 (294)
267 cd05610 STKc_MASTL Catalytic d 70.5 1 2.2E-05 51.2 -1.1 30 641-670 10-40 (669)
268 cd05574 STKc_phototropin_like 70.1 0.68 1.5E-05 47.0 -2.4 31 641-671 7-38 (316)
269 cd06644 STKc_STK10_LOK Catalyt 70.1 0.83 1.8E-05 45.8 -1.7 30 641-670 18-48 (292)
270 cd07879 STKc_p38delta_MAPK13 C 70.1 0.76 1.6E-05 47.4 -2.1 29 641-669 21-50 (342)
271 KOG1235|consensus 70.0 0.69 1.5E-05 49.7 -2.4 36 638-673 164-199 (538)
272 cd07847 STKc_CDKL1_4 Catalytic 69.9 0.54 1.2E-05 46.9 -3.2 30 641-670 7-37 (286)
273 cd05069 PTKc_Yes Catalytic dom 69.8 0.64 1.4E-05 45.6 -2.6 28 641-668 12-39 (260)
274 cd05092 PTKc_TrkA Catalytic do 69.8 0.89 1.9E-05 45.2 -1.6 31 640-670 10-46 (280)
275 KOG0605|consensus 69.3 1.3 2.7E-05 46.6 -0.6 32 641-672 147-179 (550)
276 cd06607 STKc_TAO Catalytic dom 68.7 0.74 1.6E-05 46.6 -2.5 29 641-669 21-50 (307)
277 COG0661 AarF Predicted unusual 68.5 0.65 1.4E-05 50.0 -3.0 34 638-671 128-161 (517)
278 KOG1006|consensus 68.5 0.65 1.4E-05 44.1 -2.6 42 641-682 70-112 (361)
279 cd05099 PTKc_FGFR4 Catalytic d 67.6 0.93 2E-05 46.0 -2.0 31 640-670 17-55 (314)
280 cd05093 PTKc_TrkB Catalytic do 67.4 1.1 2.4E-05 44.8 -1.5 30 640-669 10-45 (288)
281 cd06612 STKc_MST1_2 Catalytic 67.3 0.91 2E-05 44.3 -2.1 32 640-671 8-40 (256)
282 cd06621 PKc_MAPKK_Pek1_like Ca 67.3 0.82 1.8E-05 45.7 -2.5 31 640-670 6-37 (287)
283 cd06647 STKc_PAK_I Catalytic d 67.2 1 2.2E-05 45.1 -1.7 29 641-669 25-54 (293)
284 cd06652 STKc_MEKK2 Catalytic d 67.0 1.1 2.4E-05 44.0 -1.5 28 640-667 7-35 (265)
285 cd05622 STKc_ROCK1 Catalytic d 67.0 0.91 2E-05 47.4 -2.3 29 641-669 49-78 (371)
286 cd05082 PTKc_Csk Catalytic dom 66.5 1.2 2.5E-05 43.6 -1.6 28 641-669 12-39 (256)
287 PRK09605 bifunctional UGMP fam 66.4 1.1 2.3E-05 49.5 -1.9 21 640-660 338-358 (535)
288 KOG0593|consensus 66.2 1.1 2.4E-05 43.5 -1.6 29 641-669 8-37 (396)
289 cd07864 STKc_CDK12 Catalytic d 66.1 0.72 1.6E-05 46.4 -3.2 31 640-670 12-43 (302)
290 KOG0594|consensus 66.0 1.1 2.3E-05 44.5 -1.8 27 641-667 17-44 (323)
291 cd06637 STKc_TNIK Catalytic do 65.7 1.1 2.4E-05 44.2 -1.9 29 641-669 12-41 (272)
292 cd07850 STKc_JNK Catalytic dom 65.7 0.79 1.7E-05 47.5 -3.0 29 641-669 22-51 (353)
293 cd06659 STKc_PAK6 Catalytic do 65.1 0.92 2E-05 45.6 -2.6 29 641-669 27-56 (297)
294 cd07845 STKc_CDK10 Catalytic d 65.1 0.73 1.6E-05 46.7 -3.4 30 641-670 13-43 (309)
295 cd06635 STKc_TAO1 Catalytic do 64.9 0.96 2.1E-05 46.0 -2.5 31 640-670 30-61 (317)
296 cd06654 STKc_PAK1 Catalytic do 64.6 1 2.2E-05 45.3 -2.4 30 641-670 26-56 (296)
297 cd06648 STKc_PAK_II Catalytic 64.5 1.2 2.5E-05 44.6 -2.0 29 640-668 24-53 (285)
298 KOG0615|consensus 64.4 1.3 2.7E-05 45.0 -1.7 37 641-677 178-215 (475)
299 cd05580 STKc_PKA Catalytic dom 63.9 1.4 3.1E-05 44.0 -1.5 30 641-670 7-37 (290)
300 PHA03211 serine/threonine kina 63.6 1.6 3.4E-05 46.9 -1.2 27 641-667 175-202 (461)
301 cd06651 STKc_MEKK3 Catalytic d 63.1 0.72 1.6E-05 45.4 -3.8 29 640-668 7-36 (266)
302 KOG0574|consensus 62.6 1.5 3.3E-05 42.3 -1.4 26 641-666 39-65 (502)
303 smart00368 LRR_RI Leucine rich 62.5 6.3 0.00014 23.2 1.7 13 468-480 3-15 (28)
304 cd07854 STKc_MAPK4_6 Catalytic 62.4 1.1 2.4E-05 46.1 -2.6 29 641-669 11-40 (342)
305 cd06655 STKc_PAK2 Catalytic do 62.3 1.2 2.7E-05 44.7 -2.3 30 641-670 25-55 (296)
306 PHA03212 serine/threonine kina 62.2 2.1 4.5E-05 45.1 -0.7 29 641-669 98-127 (391)
307 cd05100 PTKc_FGFR3 Catalytic d 61.7 1.6 3.4E-05 44.8 -1.7 29 641-669 18-54 (334)
308 cd06658 STKc_PAK5 Catalytic do 61.4 1.5 3.2E-05 44.0 -1.9 29 641-669 28-57 (292)
309 PHA03209 serine/threonine kina 61.0 1.6 3.4E-05 45.4 -1.9 27 641-667 72-99 (357)
310 KOG0694|consensus 60.9 1.3 2.9E-05 47.9 -2.4 31 641-671 374-405 (694)
311 cd07851 STKc_p38 Catalytic dom 60.8 1.5 3.2E-05 45.3 -2.1 29 641-669 21-50 (343)
312 cd05094 PTKc_TrkC Catalytic do 60.1 1.9 4.1E-05 43.1 -1.3 31 641-671 11-47 (291)
313 KOG3763|consensus 59.8 5.7 0.00012 42.2 2.0 16 186-201 268-283 (585)
314 cd06645 STKc_MAP4K3 Catalytic 59.4 1.3 2.8E-05 43.5 -2.6 29 641-669 15-44 (267)
315 cd06611 STKc_SLK_like Catalyti 59.2 1.4 3E-05 43.8 -2.6 30 641-670 11-41 (280)
316 cd06643 STKc_SLK Catalytic dom 58.9 1.5 3.3E-05 43.5 -2.3 29 641-669 11-40 (282)
317 cd07865 STKc_CDK9 Catalytic do 58.8 1 2.2E-05 45.5 -3.7 30 640-669 17-47 (310)
318 cd07843 STKc_CDC2L1 Catalytic 58.4 1.2 2.5E-05 44.7 -3.2 30 640-669 10-40 (293)
319 PHA03207 serine/threonine kina 58.3 2 4.4E-05 45.2 -1.6 30 641-670 98-130 (392)
320 KOG0662|consensus 58.2 2 4.4E-05 38.1 -1.2 25 641-665 8-33 (292)
321 cd07858 STKc_TEY_MAPK_plant Ca 58.2 1.6 3.4E-05 44.9 -2.4 29 641-669 11-40 (337)
322 cd06614 STKc_PAK Catalytic dom 58.1 1.5 3.2E-05 43.8 -2.6 31 641-671 25-56 (286)
323 cd07852 STKc_MAPK15 Catalytic 57.6 1.5 3.2E-05 45.1 -2.7 28 641-668 13-41 (337)
324 cd06633 STKc_TAO3 Catalytic do 57.5 1.6 3.4E-05 44.3 -2.5 29 641-669 27-56 (313)
325 cd07856 STKc_Sty1_Hog1 Catalyt 55.9 1.6 3.5E-05 44.6 -2.7 28 641-668 16-44 (328)
326 cd06625 STKc_MEKK3_like Cataly 55.4 2.7 5.8E-05 41.2 -1.2 29 640-668 7-36 (263)
327 KOG0663|consensus 55.1 2.7 5.9E-05 41.5 -1.1 26 641-666 82-108 (419)
328 KOG0696|consensus 54.9 11 0.00024 38.4 3.1 44 628-671 339-386 (683)
329 COG2112 Predicted Ser/Thr prot 54.8 1.7 3.7E-05 39.1 -2.3 34 640-674 27-60 (201)
330 cd06653 STKc_MEKK3_like_1 Cata 54.7 2.3 4.9E-05 41.8 -1.8 28 640-667 7-35 (264)
331 cd07855 STKc_ERK5 Catalytic do 54.1 1.9 4.1E-05 44.2 -2.6 30 641-670 11-41 (334)
332 PHA03210 serine/threonine kina 54.0 6.2 0.00013 43.1 1.3 18 641-658 154-171 (501)
333 PHA03390 pk1 serine/threonine- 52.8 2.4 5.2E-05 41.8 -2.0 30 643-672 24-54 (267)
334 KOG1151|consensus 52.7 2.1 4.6E-05 43.7 -2.3 30 641-670 469-499 (775)
335 PRK10359 lipopolysaccharide co 51.7 2.5 5.3E-05 40.4 -2.0 30 641-671 37-66 (232)
336 cd06608 STKc_myosinIII_like Ca 50.3 2.5 5.4E-05 41.6 -2.4 30 641-670 12-42 (275)
337 cd06634 STKc_TAO2 Catalytic do 49.6 2.7 5.9E-05 42.5 -2.3 29 640-668 20-49 (308)
338 cd07866 STKc_BUR1 Catalytic do 49.2 3.1 6.7E-05 41.9 -1.9 28 641-668 14-42 (311)
339 KOG0199|consensus 48.3 3.4 7.3E-05 45.1 -1.8 29 641-669 116-148 (1039)
340 KOG1164|consensus 47.5 3.5 7.5E-05 42.1 -1.9 29 641-669 24-54 (322)
341 KOG0666|consensus 47.0 8.5 0.00018 37.8 0.8 28 641-668 30-62 (438)
342 cd06613 STKc_MAP4K3_like Catal 46.6 3.1 6.8E-05 40.6 -2.3 30 641-670 9-39 (262)
343 KOG0196|consensus 45.8 4.4 9.5E-05 44.9 -1.4 37 641-678 635-675 (996)
344 KOG1989|consensus 44.7 5.3 0.00011 44.6 -1.0 29 640-668 42-71 (738)
345 KOG0581|consensus 44.3 4 8.6E-05 40.9 -1.9 42 641-682 85-127 (364)
346 KOG2345|consensus 44.2 7.8 0.00017 36.8 0.1 31 641-671 27-58 (302)
347 KOG0592|consensus 43.4 9.4 0.0002 40.5 0.6 32 641-672 79-111 (604)
348 KOG0986|consensus 42.8 16 0.00036 37.9 2.1 32 641-672 191-223 (591)
349 KOG0585|consensus 41.6 4.9 0.00011 41.8 -1.7 37 641-677 103-140 (576)
350 cd05609 STKc_MAST Catalytic do 40.2 6.2 0.00014 39.7 -1.3 30 641-670 7-37 (305)
351 PRK10345 hypothetical protein; 39.9 15 0.00032 34.7 1.2 24 636-660 3-26 (210)
352 KOG1165|consensus 39.4 6 0.00013 39.2 -1.4 31 641-671 34-65 (449)
353 cd05120 APH_ChoK_like Aminogly 37.7 4.8 0.0001 35.1 -2.3 30 641-671 4-33 (155)
354 KOG0579|consensus 36.3 11 0.00024 40.7 -0.2 19 642-660 39-57 (1187)
355 PTZ00266 NIMA-related protein 35.7 6.1 0.00013 46.2 -2.4 29 641-669 19-48 (1021)
356 KOG0200|consensus 35.5 6.3 0.00014 44.2 -2.3 37 642-678 303-347 (609)
357 KOG0611|consensus 35.4 13 0.00029 37.8 0.2 38 641-678 59-97 (668)
358 TIGR00864 PCC polycystin catio 35.4 22 0.00047 45.8 2.0 32 423-456 1-32 (2740)
359 KOG0669|consensus 35.3 10 0.00022 36.1 -0.6 25 641-665 23-48 (376)
360 PF09919 DUF2149: Uncharacteri 34.3 9.3 0.0002 30.3 -0.9 21 642-664 69-90 (92)
361 KOG1167|consensus 32.0 15 0.00032 37.7 -0.1 19 640-658 41-59 (418)
362 PTZ00267 NIMA-related protein 30.6 9.8 0.00021 41.3 -1.8 27 641-667 73-101 (478)
363 KOG4278|consensus 29.5 17 0.00036 39.4 -0.2 32 638-669 270-302 (1157)
364 KOG4279|consensus 29.0 11 0.00025 41.2 -1.5 26 641-666 581-607 (1226)
365 smart00367 LRR_CC Leucine-rich 28.2 40 0.00086 19.2 1.3 11 467-477 2-12 (26)
366 KOG1024|consensus 28.1 31 0.00068 35.2 1.4 33 639-671 288-326 (563)
367 cd08216 PK_STRAD Pseudokinase 28.0 9.9 0.00022 38.4 -2.2 27 643-670 10-36 (314)
368 KOG0587|consensus 27.8 12 0.00027 42.0 -1.5 44 641-684 25-69 (953)
369 KOG4721|consensus 25.1 24 0.00053 37.8 0.0 27 638-665 127-153 (904)
370 KOG0983|consensus 24.6 20 0.00042 34.7 -0.7 38 641-678 98-136 (391)
371 KOG0610|consensus 24.4 8.5 0.00018 39.4 -3.2 38 641-678 83-121 (459)
372 KOG1033|consensus 23.5 37 0.00079 36.1 1.0 43 640-682 54-97 (516)
373 KOG0584|consensus 23.5 32 0.0007 37.3 0.6 45 640-685 45-89 (632)
374 KOG0984|consensus 23.4 12 0.00027 34.5 -2.1 41 641-681 52-93 (282)
375 PRK12274 serine/threonine prot 21.2 29 0.00063 32.6 -0.2 21 640-660 7-27 (218)
376 KOG1094|consensus 21.1 18 0.00038 39.0 -1.8 30 641-670 544-573 (807)
No 1
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=5.6e-54 Score=504.64 Aligned_cols=498 Identities=26% Similarity=0.283 Sum_probs=403.2
Q ss_pred cccCCCCCceEEECcCCCCc-chh-hhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCC
Q psy3329 11 RRNLDNPGLITINLNANPIQ-PVE-GAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLT 88 (694)
Q Consensus 11 ~~~~~~~~L~~L~Ls~~~l~-~i~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~ 88 (694)
..|..+++|+.|+|++|.+. .+| ..+..+++|++|++++|.+.+..|. ..+++|++|++++|.+.+..+..++.++
T Consensus 87 ~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~ 164 (968)
T PLN00113 87 SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFS 164 (968)
T ss_pred hHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCC
Confidence 45677889999999999887 678 4455889999999999888766553 5678899999999998877777788999
Q ss_pred CCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEe
Q psy3329 89 SLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLN 168 (694)
Q Consensus 89 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~ 168 (694)
+|++|++++|.+.+..|..+.++++|++|++++|.+.. .+|..++++++|++|++++|.+.+..+..+.++++|++|+
T Consensus 165 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 242 (968)
T PLN00113 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG--QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242 (968)
T ss_pred CCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcC--cCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEE
Confidence 99999999999988888889999999999999998873 5567888999999999999998877777888999999999
Q ss_pred CCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCc
Q psy3329 169 LAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNC 248 (694)
Q Consensus 169 l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n 248 (694)
+++|.+.+.....+ . .+++|+.|++++|.+.+.+|. .+..+++|+.|++++|.+....+. .+..+++|+.|++++|
T Consensus 243 L~~n~l~~~~p~~l-~-~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~l~~n 318 (968)
T PLN00113 243 LVYNNLTGPIPSSL-G-NLKNLQYLFLYQNKLSGPIPP-SIFSLQKLISLDLSDNSLSGEIPE-LVIQLQNLEILHLFSN 318 (968)
T ss_pred CcCceeccccChhH-h-CCCCCCEEECcCCeeeccCch-hHhhccCcCEEECcCCeeccCCCh-hHcCCCCCcEEECCCC
Confidence 99998765333222 2 788899999999988776664 477888999999998888765443 3577888999999999
Q ss_pred CCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCcCch
Q psy3329 249 GLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESG 328 (694)
Q Consensus 249 ~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 328 (694)
.+.+..+..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+.+..+.
T Consensus 319 ~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~ 398 (968)
T PLN00113 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398 (968)
T ss_pred ccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCH
Confidence 88877777788888999999999988888888888888899999998888877777788888888888888888877777
Q ss_pred hhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccchhhhhhhhcc-
Q psy3329 329 LFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNE- 407 (694)
Q Consensus 329 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~- 407 (694)
.+..+++|+.|++++|.+++..+..|. .++.|+.|++++|.++..... ..+ .+..+..+.....
T Consensus 399 ~~~~~~~L~~L~L~~n~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~~~-----------~~~-~l~~L~~L~L~~n~ 463 (968)
T PLN00113 399 SLGACRSLRRVRLQDNSFSGELPSEFT---KLPLVYFLDISNNNLQGRINS-----------RKW-DMPSLQMLSLARNK 463 (968)
T ss_pred HHhCCCCCCEEECcCCEeeeECChhHh---cCCCCCEEECcCCcccCccCh-----------hhc-cCCCCcEEECcCce
Confidence 788888888888888888875555565 678888888888887653321 100 0000000000000
Q ss_pred --cccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcch
Q psy3329 408 --TVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSEL 485 (694)
Q Consensus 408 --~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 485 (694)
.........++|+.|++++|.+++..+..+ ..+++|+.|+|++|.+++..|..+.++++|++|+|++|.+++.+|.
T Consensus 464 ~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 541 (968)
T PLN00113 464 FFGGLPDSFGSKRLENLDLSRNQFSGAVPRKL--GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541 (968)
T ss_pred eeeecCcccccccceEEECcCCccCCccChhh--hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh
Confidence 001111125789999999999999988888 8899999999999999998888899999999999999999999999
Q ss_pred hhhhhcccCCCcEEECCCCcccccChhhhcCCCcccEEEccCCccccccCc
Q psy3329 486 SFQFLDVLLELESLDLSNNNLTHISPTVLRHNRAITSIKLVGNPWKCDCNI 536 (694)
Q Consensus 486 ~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~~~~l~~l~l~~N~~~c~c~~ 536 (694)
.| ..+++|+.|+|++|++++.+|..+..+++|+.+++++|++.+.+|.
T Consensus 542 ~~---~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 589 (968)
T PLN00113 542 SF---SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589 (968)
T ss_pred hH---hCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence 88 8899999999999999999999999999999999999999987764
No 2
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=1.3e-47 Score=450.71 Aligned_cols=491 Identities=24% Similarity=0.246 Sum_probs=406.5
Q ss_pred ccCCCCCceEEECcCCCCc-chhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCC
Q psy3329 12 RNLDNPGLITINLNANPIQ-PVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSL 90 (694)
Q Consensus 12 ~~~~~~~L~~L~Ls~~~l~-~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L 90 (694)
.|..+++|++|+|++|.++ .+|. ..+++|++|++++|.+.+..|..+..+++|++|++++|.+.+..|..+.++++|
T Consensus 113 ~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 190 (968)
T PLN00113 113 IFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSL 190 (968)
T ss_pred HhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCC
Confidence 4568899999999999987 4553 457899999999999988888889999999999999999987778789999999
Q ss_pred CEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCC
Q psy3329 91 EYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLA 170 (694)
Q Consensus 91 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~ 170 (694)
++|++++|.+.+..|..++++++|+.|++++|.+.. .+|..++++++|++|++++|.+.+..+..+.++++|++|+++
T Consensus 191 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 268 (968)
T PLN00113 191 EFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG--EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLY 268 (968)
T ss_pred CeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC--cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECc
Confidence 999999999998889999999999999999998873 566788999999999999999988777889999999999999
Q ss_pred CCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCC
Q psy3329 171 ENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGL 250 (694)
Q Consensus 171 ~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i 250 (694)
+|.+.+.....+. .+++|++|++++|.+.+.+|. .+..+++|+.|++++|.+.+..+. .+..+++|+.|++++|.+
T Consensus 269 ~n~l~~~~p~~l~--~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~l~~n~~~~~~~~-~~~~l~~L~~L~L~~n~l 344 (968)
T PLN00113 269 QNKLSGPIPPSIF--SLQKLISLDLSDNSLSGEIPE-LVIQLQNLEILHLFSNNFTGKIPV-ALTSLPRLQVLQLWSNKF 344 (968)
T ss_pred CCeeeccCchhHh--hccCcCEEECcCCeeccCCCh-hHcCCCCCcEEECCCCccCCcCCh-hHhcCCCCCEEECcCCCC
Confidence 9988754322222 688999999999998777664 578899999999999988766543 357889999999999999
Q ss_pred CcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCcCchhh
Q psy3329 251 SRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESGLF 330 (694)
Q Consensus 251 ~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 330 (694)
.+..+..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+++..+..+
T Consensus 345 ~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~ 424 (968)
T PLN00113 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424 (968)
T ss_pred cCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhH
Confidence 87666778888999999999999998888888888999999999999988888888899999999999999988888888
Q ss_pred cCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCc-ccccccccccchhccccchhhhhh-hh---
Q psy3329 331 QNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDS-TKQYSMRTIPTQIWKNFDFLVILF-IL--- 405 (694)
Q Consensus 331 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~-~~~~~~~~ip~~~~~~~~~l~~~~-~~--- 405 (694)
..++.|+.|++++|.+++..+..+. .+++|+.|++++|++....+. .....+ ..+.... .+
T Consensus 425 ~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~n~~~~~~p~~~~~~~L-----------~~L~ls~n~l~~~ 490 (968)
T PLN00113 425 TKLPLVYFLDISNNNLQGRINSRKW---DMPSLQMLSLARNKFFGGLPDSFGSKRL-----------ENLDLSRNQFSGA 490 (968)
T ss_pred hcCCCCCEEECcCCcccCccChhhc---cCCCCcEEECcCceeeeecCcccccccc-----------eEEECcCCccCCc
Confidence 8899999999999998886665554 678899999999887632211 000000 0000000 00
Q ss_pred cccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcch
Q psy3329 406 NETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSEL 485 (694)
Q Consensus 406 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 485 (694)
....+.. +++|+.|++++|.+.+..|..+ ..+++|+.|+|++|.+++.+|..|.++++|+.|+|++|++++.+|.
T Consensus 491 ~~~~~~~---l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (968)
T PLN00113 491 VPRKLGS---LSELMQLKLSENKLSGEIPDEL--SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565 (968)
T ss_pred cChhhhh---hhccCEEECcCCcceeeCChHH--cCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCCh
Confidence 0011233 7899999999999999998888 8999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCCcEEECCCCcccccChhhhcCCCcccEEEccCCccccc
Q psy3329 486 SFQFLDVLLELESLDLSNNNLTHISPTVLRHNRAITSIKLVGNPWKCD 533 (694)
Q Consensus 486 ~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~~~~l~~l~l~~N~~~c~ 533 (694)
.+ ..++.|+.|++++|++.+.+|.. ..+..+....+.+|+..|.
T Consensus 566 ~l---~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 566 NL---GNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCG 609 (968)
T ss_pred hH---hcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccC
Confidence 88 88999999999999999987753 3344566677889998885
No 3
>KOG4194|consensus
Probab=100.00 E-value=1.9e-49 Score=393.24 Aligned_cols=445 Identities=27% Similarity=0.369 Sum_probs=267.2
Q ss_pred EECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCC
Q psy3329 69 LDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQS 148 (694)
Q Consensus 69 L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n 148 (694)
|++++|+++.+....|.++++|+.+++..|.++.+ |.......+|+.|+|.+|.|..+.. ..+..++.|+.|||+.|
T Consensus 83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~I-P~f~~~sghl~~L~L~~N~I~sv~s--e~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRI-PRFGHESGHLEKLDLRHNLISSVTS--EELSALPALRSLDLSRN 159 (873)
T ss_pred eeccccccccCcHHHHhcCCcceeeeeccchhhhc-ccccccccceeEEeeeccccccccH--HHHHhHhhhhhhhhhhc
Confidence 55555555544444445555555555555555444 2222222335555555555544333 34444555555555555
Q ss_pred CCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCcc
Q psy3329 149 GISNLPDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAA 228 (694)
Q Consensus 149 ~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 228 (694)
.|+.++...|..-.++++|+|++|.|+++....|. .+.+|..|.|+.|++ ..+|...|.++++|+.|+|..|.+...
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~--~lnsL~tlkLsrNri-ttLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFD--SLNSLLTLKLSRNRI-TTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hhhcccCCCCCCCCCceEEeecccccccccccccc--ccchheeeecccCcc-cccCHHHhhhcchhhhhhccccceeee
Confidence 55555555555555555555555555555444443 344555666666665 556666677777777777777776655
Q ss_pred chhhhccCCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcC
Q psy3329 229 DLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLK 308 (694)
Q Consensus 229 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 308 (694)
... .+.++++|+.|.+..|+|..+...+|..+.++++|+|+.|++...-..++.+++.|+.|+|+.|.|..+....+..
T Consensus 237 e~l-tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf 315 (873)
T KOG4194|consen 237 EGL-TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF 315 (873)
T ss_pred hhh-hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh
Confidence 433 3477777777777777777777777777777777777777777766667777777777777777777777777777
Q ss_pred CCCCcEEeccCCcccCcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccc
Q psy3329 309 MTSLKTLILSGNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTI 388 (694)
Q Consensus 309 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~i 388 (694)
+++|+.|+|+.|+|+.++++.|..+..|++|+|+.|.++.+....|. .+.+|++|||++|.+....+
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~---~lssL~~LdLr~N~ls~~IE---------- 382 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV---GLSSLHKLDLRSNELSWCIE---------- 382 (873)
T ss_pred cccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH---HhhhhhhhcCcCCeEEEEEe----------
Confidence 77777777777777777777777677777777777766666665554 44444444444444321100
Q ss_pred cchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCC
Q psy3329 389 PTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRN 468 (694)
Q Consensus 389 p~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 468 (694)
. ....| .++++|+.|+|.+|+|..++..+|.
T Consensus 383 ------------------------------------------D-aa~~f--~gl~~LrkL~l~gNqlk~I~krAfs---- 413 (873)
T KOG4194|consen 383 ------------------------------------------D-AAVAF--NGLPSLRKLRLTGNQLKSIPKRAFS---- 413 (873)
T ss_pred ------------------------------------------c-chhhh--ccchhhhheeecCceeeecchhhhc----
Confidence 0 01122 3455555555555555555555554
Q ss_pred CCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCcccccChhhhcCCCcccEEEccCCccccccCcHHHHHHHHhccC
Q psy3329 469 ITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHISPTVLRHNRAITSIKLVGNPWKCDCNIADMWEWATREKG 548 (694)
Q Consensus 469 L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~~~~l~~l~l~~N~~~c~c~~~~~~~~~~~~~~ 548 (694)
.++.|++|||.+|-|..+-|++|+.+ .|+.|.+..-.|.|||++.|+.+|+..++.
T Consensus 414 -----------------------gl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~l 469 (873)
T KOG4194|consen 414 -----------------------GLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKL 469 (873)
T ss_pred -----------------------cCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhccc
Confidence 45555555555555555555666666 778888888899999999999999988766
Q ss_pred CCc-eeecCCCCccccccc-cCCCCceEEEeecccCCCCCCCCcccccccchhHHHHhhhcC
Q psy3329 549 DIG-VLVGSTTPTEIGFGA-SRKKKGLVCYFDIFTTPTRKRPGRELFASTNKTWARYVKEAD 608 (694)
Q Consensus 549 ~~~-~~~~~~~~~~~~~~~-~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (694)
+.. ...|+.|+...+..+ ....+.++|. .+..|+......+.....|......|.+.+
T Consensus 470 q~sv~a~CayPe~Lad~~i~svd~~~lvC~--DspkpqI~~qPe~~~al~g~nirftC~a~s 529 (873)
T KOG4194|consen 470 QSSVIAKCAYPEPLADQSIVSVDTANLVCD--DSPKPQIVTQPETVSALIGENIRFTCNAYS 529 (873)
T ss_pred ccceeeeccCCcccccceeEeechhhceec--CCCCcceecCchHhhhhhccceEEEEEecc
Confidence 543 345677777766554 6677889996 333343333333333333344444455555
No 4
>KOG4194|consensus
Probab=100.00 E-value=1.3e-40 Score=330.61 Aligned_cols=392 Identities=24% Similarity=0.332 Sum_probs=328.9
Q ss_pred CceEEECcCCCCcchh-hhhhc--CCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEe
Q psy3329 18 GLITINLNANPIQPVE-GAFLV--ARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLM 94 (694)
Q Consensus 18 ~L~~L~Ls~~~l~~i~-~~~~~--~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~ 94 (694)
+-..|+++.+.+..+. ..+.. .+.-+.|++++|++..+.+..|.++++|+.+++..|.++.||.. .....+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f-~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRF-GHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccc-cccccceeEEe
Confidence 4567889999998764 22222 23456799999999999999999999999999999999998652 34456699999
Q ss_pred CCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCC
Q psy3329 95 LNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENEL 174 (694)
Q Consensus 95 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 174 (694)
|.+|.|+.+..+.+..++.|+.|||+.|.++.+.. ..+..-.++++|+|++|.|+.+....|..+.+|..|.|+.|++
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~--~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNri 209 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPK--PSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRI 209 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccC--CCCCCCCCceEEeeccccccccccccccccchheeeecccCcc
Confidence 99999999999999999999999999999987654 4566778999999999999999999999999999999999999
Q ss_pred CCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCC
Q psy3329 175 IDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLP 254 (694)
Q Consensus 175 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~ 254 (694)
+.++...|. ++++|+.|+|..|.+ ..+.-..|..+++|+.|.|..|.+...... .+..+.++++|+|+.|+++.+.
T Consensus 210 ttLp~r~Fk--~L~~L~~LdLnrN~i-rive~ltFqgL~Sl~nlklqrN~I~kL~DG-~Fy~l~kme~l~L~~N~l~~vn 285 (873)
T KOG4194|consen 210 TTLPQRSFK--RLPKLESLDLNRNRI-RIVEGLTFQGLPSLQNLKLQRNDISKLDDG-AFYGLEKMEHLNLETNRLQAVN 285 (873)
T ss_pred cccCHHHhh--hcchhhhhhccccce-eeehhhhhcCchhhhhhhhhhcCcccccCc-ceeeecccceeecccchhhhhh
Confidence 999888775 799999999999998 555456799999999999999998877654 4588999999999999999999
Q ss_pred cccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCcCchhhcCCC
Q psy3329 255 ANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNLT 334 (694)
Q Consensus 255 ~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 334 (694)
..++.+++.|+.|++++|.|..+-++.+..+++|+.|+|+.|+|+.+++..|..+..|++|+|++|.+..+....|.+++
T Consensus 286 ~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ls 365 (873)
T KOG4194|consen 286 EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLS 365 (873)
T ss_pred cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhh
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999999
Q ss_pred CCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccchhhhhhhhcccccccCC
Q psy3329 335 HLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNETVFHENY 414 (694)
Q Consensus 335 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~ 414 (694)
+|+.|||+.|.++...++.-....+++.|+.|++.+|++..++ ... |.+
T Consensus 366 sL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~------------krA-----------------fsg-- 414 (873)
T KOG4194|consen 366 SLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIP------------KRA-----------------FSG-- 414 (873)
T ss_pred hhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecc------------hhh-----------------hcc--
Confidence 9999999999998855443322225677777777777664333 222 444
Q ss_pred CCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEcc
Q psy3329 415 TYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLS 451 (694)
Q Consensus 415 ~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls 451 (694)
++.|++|+|.+|.|..+.+.+| ..+ .|+.|.++
T Consensus 415 -l~~LE~LdL~~NaiaSIq~nAF--e~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 415 -LEALEHLDLGDNAIASIQPNAF--EPM-ELKELVMN 447 (873)
T ss_pred -CcccceecCCCCcceeeccccc--ccc-hhhhhhhc
Confidence 6666666666666666666666 444 55555554
No 5
>KOG0472|consensus
Probab=100.00 E-value=1.4e-38 Score=302.99 Aligned_cols=476 Identities=26% Similarity=0.334 Sum_probs=366.6
Q ss_pred cCcccCCCCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCC
Q psy3329 9 NDRRNLDNPGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLT 88 (694)
Q Consensus 9 ~~~~~~~~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~ 88 (694)
....+++-..++.+++++|.+..+.+.+.++..+.+|++++|.+... |.+++.+..++.|+.++|+++.+++. ++.+.
T Consensus 37 e~e~wW~qv~l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~~l-p~aig~l~~l~~l~vs~n~ls~lp~~-i~s~~ 114 (565)
T KOG0472|consen 37 EGENWWEQVDLQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLSQL-PAAIGELEALKSLNVSHNKLSELPEQ-IGSLI 114 (565)
T ss_pred chhhhhhhcchhhhhhccCchhhccHhhhcccceeEEEeccchhhhC-CHHHHHHHHHHHhhcccchHhhccHH-Hhhhh
Confidence 34567778889999999999998888888999999999999998888 55688899999999999999888665 77888
Q ss_pred CCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEe
Q psy3329 89 SLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLN 168 (694)
Q Consensus 89 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~ 168 (694)
+|..|+.++|.+... ++.++.+..|+.++..+|++.. +|..+.++.+|..+++.+|.+..+++.... ++.|++|+
T Consensus 115 ~l~~l~~s~n~~~el-~~~i~~~~~l~dl~~~~N~i~s---lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld 189 (565)
T KOG0472|consen 115 SLVKLDCSSNELKEL-PDSIGRLLDLEDLDATNNQISS---LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLD 189 (565)
T ss_pred hhhhhhccccceeec-CchHHHHhhhhhhhcccccccc---CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcc
Confidence 999999999999888 4567888899999999998874 556788888999999999999998887666 88899999
Q ss_pred CCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCc
Q psy3329 169 LAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNC 248 (694)
Q Consensus 169 l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n 248 (694)
...|.+..++.... .+.+|+.|++..|.+ ..+| .|..|..|++|.++.|++...+.. ....++++.+|++.+|
T Consensus 190 ~~~N~L~tlP~~lg---~l~~L~~LyL~~Nki-~~lP--ef~gcs~L~Elh~g~N~i~~lpae-~~~~L~~l~vLDLRdN 262 (565)
T KOG0472|consen 190 CNSNLLETLPPELG---GLESLELLYLRRNKI-RFLP--EFPGCSLLKELHVGENQIEMLPAE-HLKHLNSLLVLDLRDN 262 (565)
T ss_pred cchhhhhcCChhhc---chhhhHHHHhhhccc-ccCC--CCCccHHHHHHHhcccHHHhhHHH-Hhcccccceeeecccc
Confidence 99998887654432 577888888999988 6676 488899999999999888776654 3468889999999999
Q ss_pred CCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCC--CCcEE-------eccC
Q psy3329 249 GLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMT--SLKTL-------ILSG 319 (694)
Q Consensus 249 ~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L-------~L~~ 319 (694)
++++.|. .+.-+.+|+.||+++|.+++.. ..++++ .|+.|.+.+|.+..+....+.+-+ -|++| .++.
T Consensus 263 klke~Pd-e~clLrsL~rLDlSNN~is~Lp-~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~ 339 (565)
T KOG0472|consen 263 KLKEVPD-EICLLRSLERLDLSNNDISSLP-YSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQ 339 (565)
T ss_pred ccccCch-HHHHhhhhhhhcccCCccccCC-cccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCC
Confidence 9998884 4566788999999999887654 457888 888999999988766544433211 11111 1121
Q ss_pred Ccc------c--CcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCccc----------
Q psy3329 320 NKL------E--TLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTK---------- 381 (694)
Q Consensus 320 n~l------~--~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~---------- 381 (694)
..= + .........+.+.++|++++-+++.+|..+|..+ .-.-...++++.|++..+|....
T Consensus 340 se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~-~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 340 SEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAA-KSEIVTSVNFSKNQLCELPKRLVELKELVTDLV 418 (565)
T ss_pred CcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHh-hhcceEEEecccchHhhhhhhhHHHHHHHHHHH
Confidence 110 0 0011112345678899999999999999998632 23447889999999987775311
Q ss_pred --ccccccccchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccC
Q psy3329 382 --QYSMRTIPTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLP 459 (694)
Q Consensus 382 --~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 459 (694)
...+..+|..+ ..+++|..|+|++|.+..+|.+. +.+..|+.||+|.|++..+|
T Consensus 419 lsnn~isfv~~~l---------------------~~l~kLt~L~L~NN~Ln~LP~e~---~~lv~Lq~LnlS~NrFr~lP 474 (565)
T KOG0472|consen 419 LSNNKISFVPLEL---------------------SQLQKLTFLDLSNNLLNDLPEEM---GSLVRLQTLNLSFNRFRMLP 474 (565)
T ss_pred hhcCccccchHHH---------------------Hhhhcceeeecccchhhhcchhh---hhhhhhheecccccccccch
Confidence 11111122111 12788999999999988887665 56778999999999888776
Q ss_pred CCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCcccccChhhhcCCCcccEEEccCCccc
Q psy3329 460 PNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHISPTVLRHNRAITSIKLVGNPWK 531 (694)
Q Consensus 460 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~~~~l~~l~l~~N~~~ 531 (694)
.. +..+..++.+-.++|++..+.+..+ .++.+|..|||.+|.+..++| .++++.++++++++||||.
T Consensus 475 ~~-~y~lq~lEtllas~nqi~~vd~~~l---~nm~nL~tLDL~nNdlq~IPp-~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 475 EC-LYELQTLETLLASNNQIGSVDPSGL---KNMRNLTTLDLQNNDLQQIPP-ILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HH-HhhHHHHHHHHhccccccccChHHh---hhhhhcceeccCCCchhhCCh-hhccccceeEEEecCCccC
Confidence 53 3455667777778899998888756 899999999999999988766 4799999999999999997
No 6
>KOG0472|consensus
Probab=100.00 E-value=2e-37 Score=295.13 Aligned_cols=440 Identities=25% Similarity=0.299 Sum_probs=351.7
Q ss_pred cccCCCCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCC
Q psy3329 11 RRNLDNPGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSL 90 (694)
Q Consensus 11 ~~~~~~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L 90 (694)
+...++..++++++.+|.+.++|.+++.+..++.|+.++|+++.+ |..+..+..|+.|+.++|.+..++++ ++.+..|
T Consensus 62 ~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls~l-p~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l 139 (565)
T KOG0472|consen 62 EDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLSEL-PEQIGSLISLVKLDCSSNELKELPDS-IGRLLDL 139 (565)
T ss_pred HhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHhhc-cHHHhhhhhhhhhhccccceeecCch-HHHHhhh
Confidence 456788899999999999999999999999999999999999888 67788999999999999999998776 8889999
Q ss_pred CEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCC
Q psy3329 91 EYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLA 170 (694)
Q Consensus 91 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~ 170 (694)
+.++..+|+++.. |..+..+.+|..+++.+|++.... ...-+++.|++||...|-+..+|+. ++.+.+|..|++.
T Consensus 140 ~dl~~~~N~i~sl-p~~~~~~~~l~~l~~~~n~l~~l~---~~~i~m~~L~~ld~~~N~L~tlP~~-lg~l~~L~~LyL~ 214 (565)
T KOG0472|consen 140 EDLDATNNQISSL-PEDMVNLSKLSKLDLEGNKLKALP---ENHIAMKRLKHLDCNSNLLETLPPE-LGGLESLELLYLR 214 (565)
T ss_pred hhhhccccccccC-chHHHHHHHHHHhhccccchhhCC---HHHHHHHHHHhcccchhhhhcCChh-hcchhhhHHHHhh
Confidence 9999999999998 667888999999999999998543 3444489999999999999988874 7889999999999
Q ss_pred CCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCC
Q psy3329 171 ENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGL 250 (694)
Q Consensus 171 ~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i 250 (694)
.|++...+ .|- .|..|.++.++.|.+ ..+|.+....++++.+||+..|++...+.. +..+.+|+.|++++|.|
T Consensus 215 ~Nki~~lP--ef~--gcs~L~Elh~g~N~i-~~lpae~~~~L~~l~vLDLRdNklke~Pde--~clLrsL~rLDlSNN~i 287 (565)
T KOG0472|consen 215 RNKIRFLP--EFP--GCSLLKELHVGENQI-EMLPAEHLKHLNSLLVLDLRDNKLKEVPDE--ICLLRSLERLDLSNNDI 287 (565)
T ss_pred hcccccCC--CCC--ccHHHHHHHhcccHH-HhhHHHHhcccccceeeeccccccccCchH--HHHhhhhhhhcccCCcc
Confidence 99988765 332 788999999999998 888888888999999999999999887754 46778999999999999
Q ss_pred CcCCcccccCCCCccEEeCCCCCCcccch-----------------------------------------hhcCCCCCCc
Q psy3329 251 SRLPANTFHRFTCLQELDISHNPLIDAFT-----------------------------------------ALLSPLESLE 289 (694)
Q Consensus 251 ~~~~~~~~~~~~~L~~L~L~~n~~~~~~~-----------------------------------------~~~~~l~~L~ 289 (694)
+.++. .++++ .|+.|.+.+|.+..+-. .......+.+
T Consensus 288 s~Lp~-sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tk 365 (565)
T KOG0472|consen 288 SSLPY-SLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTK 365 (565)
T ss_pred ccCCc-ccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhh
Confidence 99984 67888 89999999998742100 0112244667
Q ss_pred EEECcCCCCcccChhhhcCCC--CCcEEeccCCcccCcCchhhcCCCCC-CEEeCCCCCCcccCccccccCCCCCCCCee
Q psy3329 290 HLDMGYSNLQRISRSTFLKMT--SLKTLILSGNKLETLESGLFQNLTHL-SVLELNNCGLTRLNETVFHENYTYPDLEEL 366 (694)
Q Consensus 290 ~L~L~~n~l~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~l~~l~~L-~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L 366 (694)
.|++++-+++.++...|..-. -....+++.|++..++.. +..++.+ +.+.+++|.++.++... . .+++|..|
T Consensus 366 iL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~-L~~lkelvT~l~lsnn~isfv~~~l-~---~l~kLt~L 440 (565)
T KOG0472|consen 366 ILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKR-LVELKELVTDLVLSNNKISFVPLEL-S---QLQKLTFL 440 (565)
T ss_pred hhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhh-hHHHHHHHHHHHhhcCccccchHHH-H---hhhcceee
Confidence 788888888888877775432 366788888888877654 2333333 34566666666554433 3 67899999
Q ss_pred eCCCCCCcCCCCcccccccccccchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCcc
Q psy3329 367 RLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLR 446 (694)
Q Consensus 367 ~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~ 446 (694)
++++|.+.++|.. . .. +..|+.|+++.|.|..+|... ..+..++
T Consensus 441 ~L~NN~Ln~LP~e------------~------------------~~---lv~Lq~LnlS~NrFr~lP~~~---y~lq~lE 484 (565)
T KOG0472|consen 441 DLSNNLLNDLPEE------------M------------------GS---LVRLQTLNLSFNRFRMLPECL---YELQTLE 484 (565)
T ss_pred ecccchhhhcchh------------h------------------hh---hhhhheecccccccccchHHH---hhHHHHH
Confidence 9999988765542 2 11 667999999999887665433 2345566
Q ss_pred EEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCcccccChh
Q psy3329 447 SLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHISPT 512 (694)
Q Consensus 447 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~ 512 (694)
.+-.++|++..+++..+.++.+|.+|||.+|.+..++|. + +++++|++|++++|.+. .++.
T Consensus 485 tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~-L---gnmtnL~hLeL~gNpfr-~Pr~ 545 (565)
T KOG0472|consen 485 TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPI-L---GNMTNLRHLELDGNPFR-QPRH 545 (565)
T ss_pred HHHhccccccccChHHhhhhhhcceeccCCCchhhCChh-h---ccccceeEEEecCCccC-CCHH
Confidence 666777999999888888999999999999999977664 4 89999999999999998 4443
No 7
>KOG0618|consensus
Probab=99.97 E-value=1e-34 Score=304.28 Aligned_cols=444 Identities=28% Similarity=0.369 Sum_probs=255.4
Q ss_pred ceEEECcCCCCcchh-hhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCC
Q psy3329 19 LITINLNANPIQPVE-GAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNR 97 (694)
Q Consensus 19 L~~L~Ls~~~l~~i~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~ 97 (694)
++.|+++.|.+-..| +....+-+|+.|++++|.+... |..+..+.+|+.|+++.|.+...+ ....++.+|++|.|.+
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~f-p~~it~l~~L~~ln~s~n~i~~vp-~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSF-PIQITLLSHLRQLNLSRNYIRSVP-SSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccccC-CchhhhHHHHhhcccchhhHhhCc-hhhhhhhcchhheecc
Confidence 666666666666655 4444555577777776666554 555666677777777777666654 3366667777777776
Q ss_pred CcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCC-------------------CCCCCCcccc
Q psy3329 98 CNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQS-------------------GISNLPDNVF 158 (694)
Q Consensus 98 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n-------------------~i~~~~~~~~ 158 (694)
|.+... |..+..+++|+.|++++|.+.. +|..+..+..++.+..++| .+..-.....
T Consensus 101 n~l~~l-P~~~~~lknl~~LdlS~N~f~~---~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i 176 (1081)
T KOG0618|consen 101 NRLQSL-PASISELKNLQYLDLSFNHFGP---IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDI 176 (1081)
T ss_pred chhhcC-chhHHhhhcccccccchhccCC---CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcch
Confidence 666665 5566667777777777776653 3344445555555555555 3222222222
Q ss_pred CCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCC
Q psy3329 159 ANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLT 238 (694)
Q Consensus 159 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~ 238 (694)
..+.. .|++.+|.+...+.. .+.+|+.+....|.+. .+ --..++|+.|+.++|.++..... ....
T Consensus 177 ~~l~~--~ldLr~N~~~~~dls-----~~~~l~~l~c~rn~ls-~l----~~~g~~l~~L~a~~n~l~~~~~~---p~p~ 241 (1081)
T KOG0618|consen 177 YNLTH--QLDLRYNEMEVLDLS-----NLANLEVLHCERNQLS-EL----EISGPSLTALYADHNPLTTLDVH---PVPL 241 (1081)
T ss_pred hhhhe--eeecccchhhhhhhh-----hccchhhhhhhhcccc-eE----EecCcchheeeeccCcceeeccc---cccc
Confidence 22222 244444443311110 3334444444433331 11 01223444444444444422211 1223
Q ss_pred CccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEecc
Q psy3329 239 KLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILS 318 (694)
Q Consensus 239 ~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 318 (694)
+|+.++++.|+++.++ +++..+.+|+.++..+|.+. .+|..+....+|+.|.+..|++..+++ ...+...|++|+|.
T Consensus 242 nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~-~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPP-FLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCC-cccccceeeeeeeh
Confidence 4555555555555554 44455555555555555542 223333344445555555555544442 23334555555555
Q ss_pred CCcccCcCchhhcCCCC-CCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccc
Q psy3329 319 GNKLETLESGLFQNLTH-LSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFD 397 (694)
Q Consensus 319 ~n~l~~~~~~~l~~l~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~ 397 (694)
.|++...+...|.-... |..|+.+.|.+...+...- ...+.|+.|.+.+|.+++
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e---~~~~~Lq~LylanN~Ltd---------------------- 373 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE---NNHAALQELYLANNHLTD---------------------- 373 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccc---hhhHHHHHHHHhcCcccc----------------------
Confidence 55555444433333322 4444444444444331111 133445555555555542
Q ss_pred hhhhhhhhcccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCC
Q psy3329 398 FLVILFILNETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANN 477 (694)
Q Consensus 398 ~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 477 (694)
..|.-...+.+|+.|+|++|++..++...+ .++..|+.|+||+|+++.++ .....+..|++|...+|
T Consensus 374 ----------~c~p~l~~~~hLKVLhLsyNrL~~fpas~~--~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ahsN 440 (1081)
T KOG0618|consen 374 ----------SCFPVLVNFKHLKVLHLSYNRLNSFPASKL--RKLEELEELNLSGNKLTTLP-DTVANLGRLHTLRAHSN 440 (1081)
T ss_pred ----------cchhhhccccceeeeeecccccccCCHHHH--hchHHhHHHhcccchhhhhh-HHHHhhhhhHHHhhcCC
Confidence 122222238899999999999999998888 88999999999999999988 44688999999999999
Q ss_pred ccCCCcchhhhhhcccCCCcEEECCCCccccc-ChhhhcCCCcccEEEccCCcc
Q psy3329 478 NLSMTSELSFQFLDVLLELESLDLSNNNLTHI-SPTVLRHNRAITSIKLVGNPW 530 (694)
Q Consensus 478 ~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~-~~~~~~~~~~l~~l~l~~N~~ 530 (694)
++...+ .+ ..++.|+.+|+|.|+|+.. .|.... -++|++||++||++
T Consensus 441 ~l~~fP--e~---~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 441 QLLSFP--EL---AQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTR 488 (1081)
T ss_pred ceeech--hh---hhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCcc
Confidence 998765 34 7899999999999999984 444433 38999999999996
No 8
>KOG0618|consensus
Probab=99.96 E-value=1e-31 Score=281.88 Aligned_cols=460 Identities=24% Similarity=0.268 Sum_probs=339.6
Q ss_pred EEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcC
Q psy3329 21 TINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNL 100 (694)
Q Consensus 21 ~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l 100 (694)
.+|.+..+++-||..+.....++.|+++.|.+...+-+...+.-+|+.|++++|.+...+.. +..+.+|+.|+++.|.|
T Consensus 2 ~vd~s~~~l~~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~-it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 2 HVDASDEQLELIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQ-ITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred CcccccccCcccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccccCCch-hhhHHHHhhcccchhhH
Confidence 46788889999996666666699999999977665545566677799999999999887544 77889999999999999
Q ss_pred CccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchh
Q psy3329 101 TYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDVA 180 (694)
Q Consensus 101 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 180 (694)
... |.+..++.+|++|.|.+|.+. .+|..+..+++|+.|+++.|.+..+|. .+..+..+..+..++|. .+...
T Consensus 81 ~~v-p~s~~~~~~l~~lnL~~n~l~---~lP~~~~~lknl~~LdlS~N~f~~~Pl-~i~~lt~~~~~~~s~N~--~~~~l 153 (1081)
T KOG0618|consen 81 RSV-PSSCSNMRNLQYLNLKNNRLQ---SLPASISELKNLQYLDLSFNHFGPIPL-VIEVLTAEEELAASNNE--KIQRL 153 (1081)
T ss_pred hhC-chhhhhhhcchhheeccchhh---cCchhHHhhhcccccccchhccCCCch-hHHhhhHHHHHhhhcch--hhhhh
Confidence 988 578899999999999999987 456788999999999999999988876 45667777888888882 11111
Q ss_pred hhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccC
Q psy3329 181 TTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHR 260 (694)
Q Consensus 181 ~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~ 260 (694)
.-..++.+++..|.+.+.+.. ....++. .|+|..|.+.... +..+++|+.+....|++..+.. .
T Consensus 154 -----g~~~ik~~~l~~n~l~~~~~~-~i~~l~~--~ldLr~N~~~~~d----ls~~~~l~~l~c~rn~ls~l~~----~ 217 (1081)
T KOG0618|consen 154 -----GQTSIKKLDLRLNVLGGSFLI-DIYNLTH--QLDLRYNEMEVLD----LSNLANLEVLHCERNQLSELEI----S 217 (1081)
T ss_pred -----ccccchhhhhhhhhcccchhc-chhhhhe--eeecccchhhhhh----hhhccchhhhhhhhcccceEEe----c
Confidence 112267777777776555543 2444444 5888888776222 3667788888888887776542 3
Q ss_pred CCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCcCchhhcCCCCCCEEe
Q psy3329 261 FTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNLTHLSVLE 340 (694)
Q Consensus 261 ~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 340 (694)
-++|+.|+.++|.++..... ..-.+|+++++++|+++.++ .++..|.+|+.++..+|.++.++... ....+|+.|.
T Consensus 218 g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~lp~ri-~~~~~L~~l~ 293 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVALPLRI-SRITSLVSLS 293 (1081)
T ss_pred CcchheeeeccCcceeeccc--cccccceeeecchhhhhcch-HHHHhcccceEecccchhHHhhHHHH-hhhhhHHHHH
Confidence 36788888888877743322 23357788888888888777 77778888888888888886665543 4467777777
Q ss_pred CCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccchhhhhhh----hcccccccCCCC
Q psy3329 341 LNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFI----LNETVFHENYTY 416 (694)
Q Consensus 341 L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~----~~~~~~~~~~~~ 416 (694)
+..|.+..+++..- ....|++|+|..|++..+|+... .++... +..+.. +...--.+...+
T Consensus 294 ~~~nel~yip~~le----~~~sL~tLdL~~N~L~~lp~~~l-----~v~~~~------l~~ln~s~n~l~~lp~~~e~~~ 358 (1081)
T KOG0618|consen 294 AAYNELEYIPPFLE----GLKSLRTLDLQSNNLPSLPDNFL-----AVLNAS------LNTLNVSSNKLSTLPSYEENNH 358 (1081)
T ss_pred hhhhhhhhCCCccc----ccceeeeeeehhccccccchHHH-----hhhhHH------HHHHhhhhccccccccccchhh
Confidence 88887777766432 46777888888887766554210 000000 000000 000000111236
Q ss_pred CCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCC
Q psy3329 417 PDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLEL 496 (694)
Q Consensus 417 ~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L 496 (694)
+.|+.|.+.+|.++.-....+ .+..+|+.|+|++|+|..++...+.++..|++|+||+|+++.++ ... .++..|
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l--~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp-~tv---a~~~~L 432 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVL--VNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLP-DTV---ANLGRL 432 (1081)
T ss_pred HHHHHHHHhcCcccccchhhh--ccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhh-HHH---Hhhhhh
Confidence 789999999999998776667 88999999999999999999999999999999999999999765 455 789999
Q ss_pred cEEECCCCcccccChhhhcCCCcccEEEccCCccc
Q psy3329 497 ESLDLSNNNLTHISPTVLRHNRAITSIKLVGNPWK 531 (694)
Q Consensus 497 ~~L~ls~N~l~~~~~~~~~~~~~l~~l~l~~N~~~ 531 (694)
++|..-+|++...+ .+..++.|+.+|++.|.+.
T Consensus 433 ~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 433 HTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred HHHhhcCCceeech--hhhhcCcceEEecccchhh
Confidence 99999999998875 5678999999999999764
No 9
>KOG0444|consensus
Probab=99.96 E-value=3.2e-31 Score=265.76 Aligned_cols=371 Identities=26% Similarity=0.354 Sum_probs=286.3
Q ss_pred CCCCCceEEECcCCCCc--chhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCC
Q psy3329 14 LDNPGLITINLNANPIQ--PVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLE 91 (694)
Q Consensus 14 ~~~~~L~~L~Ls~~~l~--~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~ 91 (694)
+-++.++-+|+++|.++ .+|.....+++++.|.|...++..+ |+.++.+.+|++|.+++|++..+... ++.++.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~v-PeEL~~lqkLEHLs~~HN~L~~vhGE-Ls~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQV-PEELSRLQKLEHLSMAHNQLISVHGE-LSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhC-hHHHHHHhhhhhhhhhhhhhHhhhhh-hccchhhH
Confidence 34677888899999888 5788888889999999988888777 78889999999999999998877544 88889999
Q ss_pred EEeCCCCcCC--ccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeC
Q psy3329 92 YLMLNRCNLT--YISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNL 169 (694)
Q Consensus 92 ~L~L~~n~l~--~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l 169 (694)
.+++.+|++. |+ |..+-++..|+.|+|++|++. ..|..+.+.+++-.|+|++|+|..||...|.++..|-.|+|
T Consensus 82 sv~~R~N~LKnsGi-P~diF~l~dLt~lDLShNqL~---EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGI-PTDIFRLKDLTILDLSHNQLR---EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred HHhhhccccccCCC-Cchhcccccceeeecchhhhh---hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcc
Confidence 9999999875 45 556678899999999999887 45667888889999999999999999888889999999999
Q ss_pred CCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcC
Q psy3329 170 AENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCG 249 (694)
Q Consensus 170 ~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~ 249 (694)
++|.+..++...- .+.+|++|+|++|.+ .......+..+++|+.|.+++.+-+-...+..+..+.+|..++++.|+
T Consensus 158 S~NrLe~LPPQ~R---RL~~LqtL~Ls~NPL-~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~ 233 (1255)
T KOG0444|consen 158 SNNRLEMLPPQIR---RLSMLQTLKLSNNPL-NHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENN 233 (1255)
T ss_pred ccchhhhcCHHHH---HHhhhhhhhcCCChh-hHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccC
Confidence 9998887665443 677888888888876 333334455677778888887765555445556777888888888888
Q ss_pred CCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCccc--CcCc
Q psy3329 250 LSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLE--TLES 327 (694)
Q Consensus 250 i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~ 327 (694)
+..+| +.+..+++|+.|+|++|+++..-. ......+|+.|+|+.|+++.++ .++.+++.|+.|.+.+|+++ +++.
T Consensus 234 Lp~vP-ecly~l~~LrrLNLS~N~iteL~~-~~~~W~~lEtLNlSrNQLt~LP-~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 234 LPIVP-ECLYKLRNLRRLNLSGNKITELNM-TEGEWENLETLNLSRNQLTVLP-DAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred CCcch-HHHhhhhhhheeccCcCceeeeec-cHHHHhhhhhhccccchhccch-HHHhhhHHHHHHHhccCcccccCCcc
Confidence 88777 567778888888888888876422 2233467888888888887766 57778888888888888664 5554
Q ss_pred hhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccchhhhhhhhcc
Q psy3329 328 GLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNE 407 (694)
Q Consensus 328 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~ 407 (694)
+ ++.+..|+.+..++|.+.-+|.+.. .|+.|+.|.|+.|++..+|. .+
T Consensus 311 G-IGKL~~Levf~aanN~LElVPEglc----RC~kL~kL~L~~NrLiTLPe------------aI--------------- 358 (1255)
T KOG0444|consen 311 G-IGKLIQLEVFHAANNKLELVPEGLC----RCVKLQKLKLDHNRLITLPE------------AI--------------- 358 (1255)
T ss_pred c-hhhhhhhHHHHhhccccccCchhhh----hhHHHHHhcccccceeechh------------hh---------------
Confidence 4 6778888888888888877777665 68888888888888765443 22
Q ss_pred cccccCCCCCCCceEEcCCCCCcccCCC
Q psy3329 408 TVFHENYTYPDLEELRLSGNPLHVLPTG 435 (694)
Q Consensus 408 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~ 435 (694)
+-++.|+.||+..|.--..||.
T Consensus 359 ------HlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 359 ------HLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred ------hhcCCcceeeccCCcCccCCCC
Confidence 1167788888888876666554
No 10
>KOG4237|consensus
Probab=99.96 E-value=3.5e-30 Score=245.60 Aligned_cols=330 Identities=21% Similarity=0.323 Sum_probs=252.7
Q ss_pred CCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcC-CCCcccChhhhcCCCCCcEEe
Q psy3329 238 TKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGY-SNLQRISRSTFLKMTSLKTLI 316 (694)
Q Consensus 238 ~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 316 (694)
+.-.+++|..|+|+.+|+.+|+.+++|+.|+|++|.|..+-|.+|.+++++..|-+.+ |+|+.++...|+++..|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 5678899999999999999999999999999999999999999999999999988766 899999999999999999999
Q ss_pred ccCCcccCcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCc---ccccccccccchhc
Q psy3329 317 LSGNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDS---TKQYSMRTIPTQIW 393 (694)
Q Consensus 317 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~---~~~~~~~~ip~~~~ 393 (694)
+.-|++..+....|..+++|..|.+.+|.+..+....|. .+.+++.+.+..|++...-.- .....+..+-.+..
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~---~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsga 223 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQ---GLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGA 223 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhcccccc---chhccchHhhhcCccccccccchhhhHHhhchhhcccc
Confidence 999999999999999999999999999999999888887 788999999999885422110 00000000000001
Q ss_pred cccchhhhh----hhhcccccccCCCCCCCce-EEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCC
Q psy3329 394 KNFDFLVIL----FILNETVFHENYTYPDLEE-LRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRN 468 (694)
Q Consensus 394 ~~~~~l~~~----~~~~~~~~~~~~~~~~L~~-L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 468 (694)
+......+. .......|.. ....+.+ +....+.....+...| ..+++|++|+|++|.|+.+.+.+|.+...
T Consensus 224 rc~~p~rl~~~Ri~q~~a~kf~c--~~esl~s~~~~~d~~d~~cP~~cf--~~L~~L~~lnlsnN~i~~i~~~aFe~~a~ 299 (498)
T KOG4237|consen 224 RCVSPYRLYYKRINQEDARKFLC--SLESLPSRLSSEDFPDSICPAKCF--KKLPNLRKLNLSNNKITRIEDGAFEGAAE 299 (498)
T ss_pred eecchHHHHHHHhcccchhhhhh--hHHhHHHhhccccCcCCcChHHHH--hhcccceEeccCCCccchhhhhhhcchhh
Confidence 111111110 0111111211 0111111 1222223334444556 89999999999999999999999999999
Q ss_pred CCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCcccccChhhhcCCCcccEEEccCCccccccCcHHHHHHHHhccC
Q psy3329 469 ITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHISPTVLRHNRAITSIKLVGNPWKCDCNIADMWEWATREKG 548 (694)
Q Consensus 469 L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~~~~l~~l~l~~N~~~c~c~~~~~~~~~~~~~~ 548 (694)
+++|.|..|+|..+....| .++..|+.|+|.+|+|+.+.|.+|..+.+|..+++-+|||.|+|.+.|+..|+++++
T Consensus 300 l~eL~L~~N~l~~v~~~~f---~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~- 375 (498)
T KOG4237|consen 300 LQELYLTRNKLEFVSSGMF---QGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS- 375 (498)
T ss_pred hhhhhcCcchHHHHHHHhh---hccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC-
Confidence 9999999999999999999 889999999999999999999999999999999999999999999999999999855
Q ss_pred CCceeecCCCCccccccc-cCCCCceEEEee
Q psy3329 549 DIGVLVGSTTPTEIGFGA-SRKKKGLVCYFD 578 (694)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~-~~~~~~~~c~~~ 578 (694)
....+-|..|..+.++.+ .+....+.|..+
T Consensus 376 ~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ 406 (498)
T KOG4237|consen 376 VVGNPRCQSPGFVRQIPISDVAFGDFRCGGP 406 (498)
T ss_pred CCCCCCCCCCchhccccchhccccccccCCc
Confidence 555555555555554443 233344555533
No 11
>KOG4237|consensus
Probab=99.96 E-value=4.4e-31 Score=251.68 Aligned_cols=308 Identities=25% Similarity=0.291 Sum_probs=213.1
Q ss_pred eEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCC-C
Q psy3329 20 ITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNR-C 98 (694)
Q Consensus 20 ~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~-n 98 (694)
..++.+...++.+|..+ .+....++|..|.|+.+++.+|+.+++|+.|||++|.|+.|.|.+|.++..|..|-+.+ |
T Consensus 49 ~~VdCr~~GL~eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred ceEEccCCCcccCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 46678888899998544 45678899999999999999999999999999999999999999999999998887777 8
Q ss_pred cCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcc
Q psy3329 99 NLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLD 178 (694)
Q Consensus 99 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 178 (694)
+|+.++..+|+++..|+.|.+.-|++..+.. ..+..+++|..|.+.+|.+..+....|..+..++.+.+..|.+...-
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~--~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQ--DALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhH--HHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence 9999999999999999999999998886443 67889999999999999999999989999999999999888744321
Q ss_pred hhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCc-CCCcCCccc
Q psy3329 179 VATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNC-GLSRLPANT 257 (694)
Q Consensus 179 ~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n-~i~~~~~~~ 257 (694)
+++.+.... ..+. ..++......-..+.+.++..+....+......+..--.+.+ -....|...
T Consensus 205 -------nL~wla~~~-a~~~-------ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~c 269 (498)
T KOG4237|consen 205 -------NLPWLADDL-AMNP-------IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKC 269 (498)
T ss_pred -------ccchhhhHH-hhch-------hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHH
Confidence 111111100 0000 012222222222222222222222211111111111111122 223334455
Q ss_pred ccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCcCchhhcCCCCCC
Q psy3329 258 FHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNLTHLS 337 (694)
Q Consensus 258 ~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 337 (694)
|..+++|++|++++|+++++-+.+|.++..+++|.|..|++..+....|.++.+|+.|+|++|+|+.+.+..|..+.+|.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 66777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred EEeCCCCCC
Q psy3329 338 VLELNNCGL 346 (694)
Q Consensus 338 ~L~L~~n~l 346 (694)
+|++-.|.+
T Consensus 350 ~l~l~~Np~ 358 (498)
T KOG4237|consen 350 TLNLLSNPF 358 (498)
T ss_pred eeehccCcc
Confidence 777666543
No 12
>KOG0444|consensus
Probab=99.96 E-value=1.1e-30 Score=261.87 Aligned_cols=370 Identities=29% Similarity=0.380 Sum_probs=204.9
Q ss_pred CCCCCeEECCCCCCC-ccCCCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCC
Q psy3329 63 LTTLNKLDLSGNPLR-IIEPGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLD 141 (694)
Q Consensus 63 l~~L~~L~Ls~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~ 141 (694)
++-.+-.|+++|.++ .-.|.....|+.++.|.|...++..+ |+.++.|.+|++|.+.+|++..+ -..+..++.|+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~v-PeEL~~lqkLEHLs~~HN~L~~v---hGELs~Lp~LR 81 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQV-PEELSRLQKLEHLSMAHNQLISV---HGELSDLPRLR 81 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhC-hHHHHHHhhhhhhhhhhhhhHhh---hhhhccchhhH
Confidence 344445555555555 22333344455555555555555544 44555555555555555554421 12344444444
Q ss_pred EEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcC
Q psy3329 142 TLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLS 221 (694)
Q Consensus 142 ~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~ 221 (694)
.+.+.. |.+....++..+. .+..|+.|+|++|++ .++|. .+...+++-.|+|+
T Consensus 82 sv~~R~------------------------N~LKnsGiP~diF-~l~dLt~lDLShNqL-~EvP~-~LE~AKn~iVLNLS 134 (1255)
T KOG0444|consen 82 SVIVRD------------------------NNLKNSGIPTDIF-RLKDLTILDLSHNQL-REVPT-NLEYAKNSIVLNLS 134 (1255)
T ss_pred HHhhhc------------------------cccccCCCCchhc-ccccceeeecchhhh-hhcch-hhhhhcCcEEEEcc
Confidence 444444 4443333332222 445555555555555 44443 35555666666666
Q ss_pred CCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCc-c
Q psy3329 222 GNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQ-R 300 (694)
Q Consensus 222 ~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~-~ 300 (694)
+|++..++... +.+++.|-.|+|++|++..+|+. ...+..|++|.|++|.+...-...+..+++|+.|.+++.+-+ .
T Consensus 135 ~N~IetIPn~l-finLtDLLfLDLS~NrLe~LPPQ-~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~ 212 (1255)
T KOG0444|consen 135 YNNIETIPNSL-FINLTDLLFLDLSNNRLEMLPPQ-IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLD 212 (1255)
T ss_pred cCccccCCchH-HHhhHhHhhhccccchhhhcCHH-HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhh
Confidence 66665555432 34556666666666666666643 455666666666666665544444455556666666654322 2
Q ss_pred cChhhhcCCCCCcEEeccCCcccCcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcc
Q psy3329 301 ISRSTFLKMTSLKTLILSGNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDST 380 (694)
Q Consensus 301 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~ 380 (694)
-.|.++..+.+|..+|++.|.+..++ +.+..+++|+.|+|++|+|+.+....- ...+|++|++|.|+++.+|
T Consensus 213 N~Ptsld~l~NL~dvDlS~N~Lp~vP-ecly~l~~LrrLNLS~N~iteL~~~~~----~W~~lEtLNlSrNQLt~LP--- 284 (1255)
T KOG0444|consen 213 NIPTSLDDLHNLRDVDLSENNLPIVP-ECLYKLRNLRRLNLSGNKITELNMTEG----EWENLETLNLSRNQLTVLP--- 284 (1255)
T ss_pred cCCCchhhhhhhhhccccccCCCcch-HHHhhhhhhheeccCcCceeeeeccHH----HHhhhhhhccccchhccch---
Confidence 22345566666667777766665543 334556667777777776666543322 3456667777777665433
Q ss_pred cccccccccchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCCc--ccCCCCCCCcCCCCccEEEccCCcCCcc
Q psy3329 381 KQYSMRTIPTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPLH--VLPTGNLLPPQLSRLRSLDLSRCKIDYL 458 (694)
Q Consensus 381 ~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~--~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 458 (694)
..+++ ++.|+.|.+.+|+++ |+|.+ + +.+.+|+++..++|.+.-.
T Consensus 285 ---------~avcK---------------------L~kL~kLy~n~NkL~FeGiPSG-I--GKL~~Levf~aanN~LElV 331 (1255)
T KOG0444|consen 285 ---------DAVCK---------------------LTKLTKLYANNNKLTFEGIPSG-I--GKLIQLEVFHAANNKLELV 331 (1255)
T ss_pred ---------HHHhh---------------------hHHHHHHHhccCcccccCCccc-h--hhhhhhHHHHhhccccccC
Confidence 22221 566666666666544 44433 3 6677777777777766544
Q ss_pred CCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCcccccCh
Q psy3329 459 PPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHISP 511 (694)
Q Consensus 459 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~~~ 511 (694)
|..++.|..|+.|.|+.|++... |+++ .-++.|+.||+..|.--..+|
T Consensus 332 -PEglcRC~kL~kL~L~~NrLiTL-PeaI---HlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 332 -PEGLCRCVKLQKLKLDHNRLITL-PEAI---HLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred -chhhhhhHHHHHhcccccceeec-hhhh---hhcCCcceeeccCCcCccCCC
Confidence 34467777777777777777644 3444 566777777777765444333
No 13
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.87 E-value=2.1e-21 Score=211.80 Aligned_cols=257 Identities=28% Similarity=0.308 Sum_probs=136.4
Q ss_pred ccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccCCCCccEEeC
Q psy3329 190 LDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDI 269 (694)
Q Consensus 190 L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L 269 (694)
-..|+++.+.+ ..+|.. +. ++|+.|++.+|+++..+. .+++|+.|++++|+++.++. ..++|+.|++
T Consensus 203 ~~~LdLs~~~L-tsLP~~-l~--~~L~~L~L~~N~Lt~LP~-----lp~~Lk~LdLs~N~LtsLP~----lp~sL~~L~L 269 (788)
T PRK15387 203 NAVLNVGESGL-TTLPDC-LP--AHITTLVIPDNNLTSLPA-----LPPELRTLEVSGNQLTSLPV----LPPGLLELSI 269 (788)
T ss_pred CcEEEcCCCCC-CcCCcc-hh--cCCCEEEccCCcCCCCCC-----CCCCCcEEEecCCccCcccC----cccccceeec
Confidence 44556666655 344432 21 356666666666655431 23566666666666665542 1245666666
Q ss_pred CCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCcCchhhcCCCCCCEEeCCCCCCccc
Q psy3329 270 SHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNLTHLSVLELNNCGLTRL 349 (694)
Q Consensus 270 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 349 (694)
++|.+... |.. ..+|+.|++++|+++.++. ..++|+.|++++|++..++. ...+|+.|++++|+++.+
T Consensus 270 s~N~L~~L-p~l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~----lp~~L~~L~Ls~N~L~~L 337 (788)
T PRK15387 270 FSNPLTHL-PAL---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSL 337 (788)
T ss_pred cCCchhhh-hhc---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC----CcccccccccccCccccc
Confidence 66665432 221 2345666666666665542 23556666666666665543 123456666666666655
Q ss_pred CccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCC
Q psy3329 350 NETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPL 429 (694)
Q Consensus 350 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 429 (694)
+. ...+|+.|++++|+++.+|.. .++|+.|++++|.+
T Consensus 338 P~-------lp~~Lq~LdLS~N~Ls~LP~l------------------------------------p~~L~~L~Ls~N~L 374 (788)
T PRK15387 338 PT-------LPSGLQELSVSDNQLASLPTL------------------------------------PSELYKLWAYNNRL 374 (788)
T ss_pred cc-------cccccceEecCCCccCCCCCC------------------------------------Ccccceehhhcccc
Confidence 42 123566666666666544320 33455556666666
Q ss_pred cccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCccccc
Q psy3329 430 HVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHI 509 (694)
Q Consensus 430 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~ 509 (694)
+.++. ...+|+.|+|++|.|++++.. .++|+.|++++|++++++ .. ..+|+.|++++|+|+.+
T Consensus 375 ~~LP~------l~~~L~~LdLs~N~Lt~LP~l----~s~L~~LdLS~N~LssIP-~l------~~~L~~L~Ls~NqLt~L 437 (788)
T PRK15387 375 TSLPA------LPSGLKELIVSGNRLTSLPVL----PSELKELMVSGNRLTSLP-ML------PSGLLSLSVYRNQLTRL 437 (788)
T ss_pred ccCcc------cccccceEEecCCcccCCCCc----ccCCCEEEccCCcCCCCC-cc------hhhhhhhhhccCccccc
Confidence 55432 123456666666666654432 245666666666665432 11 12455566666666543
Q ss_pred ChhhhcCCCcccEEEccCCcccc
Q psy3329 510 SPTVLRHNRAITSIKLVGNPWKC 532 (694)
Q Consensus 510 ~~~~~~~~~~l~~l~l~~N~~~c 532 (694)
|..+..++.|..+++++|++.+
T Consensus 438 -P~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 438 -PESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred -ChHHhhccCCCeEECCCCCCCc
Confidence 3445555666666666666654
No 14
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.87 E-value=1.6e-21 Score=212.57 Aligned_cols=265 Identities=26% Similarity=0.290 Sum_probs=133.5
Q ss_pred CCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcE
Q psy3329 138 GKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRT 217 (694)
Q Consensus 138 ~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~ 217 (694)
..-..|+++++.++.+|+.. . ++|+.|++.+|.++.++. .+++|++|++++|.+
T Consensus 201 ~~~~~LdLs~~~LtsLP~~l-~--~~L~~L~L~~N~Lt~LP~------lp~~Lk~LdLs~N~L----------------- 254 (788)
T PRK15387 201 NGNAVLNVGESGLTTLPDCL-P--AHITTLVIPDNNLTSLPA------LPPELRTLEVSGNQL----------------- 254 (788)
T ss_pred CCCcEEEcCCCCCCcCCcch-h--cCCCEEEccCCcCCCCCC------CCCCCcEEEecCCcc-----------------
Confidence 34556677777766665532 1 256666666666554331 234455555555544
Q ss_pred EEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCC
Q psy3329 218 LYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSN 297 (694)
Q Consensus 218 L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~ 297 (694)
+..+. ..++|+.|++++|.++.++. ..++|+.|++++|++.... . ..++|+.|+|++|.
T Consensus 255 --------tsLP~-----lp~sL~~L~Ls~N~L~~Lp~----lp~~L~~L~Ls~N~Lt~LP-~---~p~~L~~LdLS~N~ 313 (788)
T PRK15387 255 --------TSLPV-----LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTSLP-V---LPPGLQELSVSDNQ 313 (788)
T ss_pred --------CcccC-----cccccceeeccCCchhhhhh----chhhcCEEECcCCcccccc-c---cccccceeECCCCc
Confidence 43321 12344444444444444332 1133444555555444321 1 12345555555555
Q ss_pred CcccChhhhcCCCCCcEEeccCCcccCcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCC
Q psy3329 298 LQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLP 377 (694)
Q Consensus 298 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~ 377 (694)
++.++. ...+|+.|++++|.++.++. + ..+|+.|+|++|+|+.++. ..++|+.|++++|+++.+|
T Consensus 314 L~~Lp~----lp~~L~~L~Ls~N~L~~LP~--l--p~~Lq~LdLS~N~Ls~LP~-------lp~~L~~L~Ls~N~L~~LP 378 (788)
T PRK15387 314 LASLPA----LPSELCKLWAYNNQLTSLPT--L--PSGLQELSVSDNQLASLPT-------LPSELYKLWAYNNRLTSLP 378 (788)
T ss_pred cccCCC----CcccccccccccCccccccc--c--ccccceEecCCCccCCCCC-------CCcccceehhhccccccCc
Confidence 554432 11245555555555554432 1 1355566666666555443 1234555566666555333
Q ss_pred CcccccccccccchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCc
Q psy3329 378 DSTKQYSMRTIPTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDY 457 (694)
Q Consensus 378 ~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 457 (694)
.. ..+|+.|++++|.+++++.. .++|+.|++++|.|++
T Consensus 379 ~l------------------------------------~~~L~~LdLs~N~Lt~LP~l------~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 379 AL------------------------------------PSGLKELIVSGNRLTSLPVL------PSELKELMVSGNRLTS 416 (788)
T ss_pred cc------------------------------------ccccceEEecCCcccCCCCc------ccCCCEEEccCCcCCC
Confidence 10 23456666666666654421 2456666666666666
Q ss_pred cCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCcccccChhhh
Q psy3329 458 LPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHISPTVL 514 (694)
Q Consensus 458 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 514 (694)
++.. ..+|+.|++++|+|+.+ |..+ ..+++|+.|+|++|+|++..+..+
T Consensus 417 IP~l----~~~L~~L~Ls~NqLt~L-P~sl---~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 417 LPML----PSGLLSLSVYRNQLTRL-PESL---IHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCcc----hhhhhhhhhccCccccc-ChHH---hhccCCCeEECCCCCCCchHHHHH
Confidence 5431 23566666666666643 4444 556666666666666666555544
No 15
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.87 E-value=5.6e-20 Score=216.73 Aligned_cols=311 Identities=23% Similarity=0.261 Sum_probs=150.2
Q ss_pred hhhhcCCCCcEEEccCCcC------CccChhhccCC-CCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccChh
Q psy3329 34 GAFLVARSLLYLYMQECTL------SKINPQFFTNL-TTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISPS 106 (694)
Q Consensus 34 ~~~~~~~~L~~L~l~~n~l------~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 106 (694)
.+|..+++|+.|.+..+.. ....|..|..+ .+|+.|.+.++.+..++.. | ...+|++|++.+|.+..+ +.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~-f-~~~~L~~L~L~~s~l~~L-~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSN-F-RPENLVKLQMQGSKLEKL-WD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCc-C-CccCCcEEECcCcccccc-cc
Confidence 5666777777776654321 11223444444 3477777777666666443 3 356677777777766654 44
Q ss_pred hhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCC-CCCcchhhhccc
Q psy3329 107 AFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENE-LIDLDVATTLGQ 185 (694)
Q Consensus 107 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~~ 185 (694)
.+..+++|+.|+++++... ..+| .+..+++|+.|++++|......+..+.++++|+.|++++|. +..++.. .
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l--~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~--i-- 701 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNL--KEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG--I-- 701 (1153)
T ss_pred ccccCCCCCEEECCCCCCc--CcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc--C--
Confidence 5566677777777665321 1222 25566677777776654333333445666666666666542 3222211 1
Q ss_pred CCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcC-------Ccccc
Q psy3329 186 NLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRL-------PANTF 258 (694)
Q Consensus 186 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~-------~~~~~ 258 (694)
++++|+.|++++|...+.+|. ..++|+.|++++|.+...+.. ..+++|+.|.+.++....+ .+..+
T Consensus 702 ~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~~lP~~---~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~ 774 (1153)
T PLN03210 702 NLKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAIEEFPSN---LRLENLDELILCEMKSEKLWERVQPLTPLMT 774 (1153)
T ss_pred CCCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCcccccccc---ccccccccccccccchhhccccccccchhhh
Confidence 455666666666544333331 134556666665555433321 1345555555544322111 11111
Q ss_pred cCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCC-CCcccChhhhcCCCCCcEEeccCCcccCcCchhhcCCCCCC
Q psy3329 259 HRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYS-NLQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNLTHLS 337 (694)
Q Consensus 259 ~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 337 (694)
...++|+.|++++|.....+|..++.+++|+.|+|++| .+..++. .+ ++++|+.|+|++|......+. ...+|+
T Consensus 775 ~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~-~~-~L~sL~~L~Ls~c~~L~~~p~---~~~nL~ 849 (1153)
T PLN03210 775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT-GI-NLESLESLDLSGCSRLRTFPD---ISTNIS 849 (1153)
T ss_pred hccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC-CC-CccccCEEECCCCCccccccc---cccccC
Confidence 22344555555555544444555555555555555544 2333321 11 344555555554422111111 123444
Q ss_pred EEeCCCCCCcccCccccccCCCCCCCCeeeCCC
Q psy3329 338 VLELNNCGLTRLNETVFHENYTYPDLEELRLSG 370 (694)
Q Consensus 338 ~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~ 370 (694)
.|+|++|.++.+|... . .+++|+.|++++
T Consensus 850 ~L~Ls~n~i~~iP~si-~---~l~~L~~L~L~~ 878 (1153)
T PLN03210 850 DLNLSRTGIEEVPWWI-E---KFSNLSFLDMNG 878 (1153)
T ss_pred EeECCCCCCccChHHH-h---cCCCCCEEECCC
Confidence 5555555444443322 1 344444444444
No 16
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.86 E-value=4.4e-20 Score=217.60 Aligned_cols=338 Identities=21% Similarity=0.265 Sum_probs=253.3
Q ss_pred cCcccCCCCCceEEECcCCCCc-------chhhhhhcC-CCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccC
Q psy3329 9 NDRRNLDNPGLITINLNANPIQ-------PVEGAFLVA-RSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIE 80 (694)
Q Consensus 9 ~~~~~~~~~~L~~L~Ls~~~l~-------~i~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~ 80 (694)
...+|..+++|+.|.+..+... .+|+.|..+ .+|+.|.+.++.+..+ |..| ...+|+.|++++|.+..++
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~l-P~~f-~~~~L~~L~L~~s~l~~L~ 627 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCM-PSNF-RPENLVKLQMQGSKLEKLW 627 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCC-CCcC-CccCCcEEECcCccccccc
Confidence 3457999999999999765422 456656665 4699999999988877 4555 5789999999999998876
Q ss_pred CCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCC-CCCCCccccC
Q psy3329 81 PGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSG-ISNLPDNVFA 159 (694)
Q Consensus 81 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~ 159 (694)
.+ +..+++|+.|+|+++......| .+..+++|+.|++++|... ..+|..+.++++|+.|++++|. +..++...
T Consensus 628 ~~-~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L--~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-- 701 (1153)
T PLN03210 628 DG-VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSL--VELPSSIQYLNKLEDLDMSRCENLEILPTGI-- 701 (1153)
T ss_pred cc-cccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCc--cccchhhhccCCCCEEeCCCCCCcCccCCcC--
Confidence 54 7889999999999875433334 3788999999999998543 4667889999999999999864 55665432
Q ss_pred CCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccc------hhhh
Q psy3329 160 NNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAAD------LSVA 233 (694)
Q Consensus 160 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------~~~~ 233 (694)
++++|+.|++++|..... .+ ....+|++|++++|.+ ..+|.. ..+++|+.|.+.++...... ....
T Consensus 702 ~l~sL~~L~Lsgc~~L~~-~p----~~~~nL~~L~L~~n~i-~~lP~~--~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~ 773 (1153)
T PLN03210 702 NLKSLYRLNLSGCSRLKS-FP----DISTNISWLDLDETAI-EEFPSN--LRLENLDELILCEMKSEKLWERVQPLTPLM 773 (1153)
T ss_pred CCCCCCEEeCCCCCCccc-cc----cccCCcCeeecCCCcc-cccccc--ccccccccccccccchhhccccccccchhh
Confidence 789999999999853221 11 1356899999999998 566643 25788998888774321110 0011
Q ss_pred ccCCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCC-CcccChhhhcCCCCC
Q psy3329 234 LKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSN-LQRISRSTFLKMTSL 312 (694)
Q Consensus 234 l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L 312 (694)
...+++|+.|++++|......+..+.++++|+.|++++|...+.+|... .+++|++|+|++|. +..++ . ...+|
T Consensus 774 ~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p-~---~~~nL 848 (1153)
T PLN03210 774 TMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP-D---ISTNI 848 (1153)
T ss_pred hhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc-c---ccccc
Confidence 2345789999999995443334678999999999999987767677655 68999999999984 33332 1 24689
Q ss_pred cEEeccCCcccCcCchhhcCCCCCCEEeCCCC-CCcccCccccccCCCCCCCCeeeCCCCC
Q psy3329 313 KTLILSGNKLETLESGLFQNLTHLSVLELNNC-GLTRLNETVFHENYTYPDLEELRLSGNP 372 (694)
Q Consensus 313 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~~~~~~~L~~L~Ls~n~ 372 (694)
+.|+|++|.++.++. .+..+++|+.|++++| .+..++.... .++.|+.+++++|.
T Consensus 849 ~~L~Ls~n~i~~iP~-si~~l~~L~~L~L~~C~~L~~l~~~~~----~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 849 SDLNLSRTGIEEVPW-WIEKFSNLSFLDMNGCNNLQRVSLNIS----KLKHLETVDFSDCG 904 (1153)
T ss_pred CEeECCCCCCccChH-HHhcCCCCCEEECCCCCCcCccCcccc----cccCCCeeecCCCc
Confidence 999999999998764 5788999999999985 5666665432 67888999998874
No 17
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.78 E-value=1.4e-18 Score=191.25 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=175.2
Q ss_pred CCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEE
Q psy3329 213 TKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLD 292 (694)
Q Consensus 213 ~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~ 292 (694)
.+...|+++++.++..+.. -.+.|+.|++++|+++.++...+ ++|+.|++++|.+... |..+. ++|+.|+
T Consensus 178 ~~~~~L~L~~~~LtsLP~~----Ip~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLTTIPAC----IPEQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTSI-PATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcCcCCcc----cccCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccccC-Chhhh--ccccEEE
Confidence 3466777777777665421 12568888888888887775432 4788888888887653 33332 4688888
Q ss_pred CcCCCCcccChhhhcCCCCCcEEeccCCcccCcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCC
Q psy3329 293 MGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNP 372 (694)
Q Consensus 293 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~ 372 (694)
|++|.+..++.. + ..+|+.|++++|++..++.. + .++|+.|++++|+++.++... .++|+.|++++|.
T Consensus 248 Ls~N~L~~LP~~-l--~s~L~~L~Ls~N~L~~LP~~-l--~~sL~~L~Ls~N~Lt~LP~~l------p~sL~~L~Ls~N~ 315 (754)
T PRK15370 248 LSINRITELPER-L--PSALQSLDLFHNKISCLPEN-L--PEELRYLSVYDNSIRTLPAHL------PSGITHLNVQSNS 315 (754)
T ss_pred CcCCccCcCChh-H--hCCCCEEECcCCccCccccc-c--CCCCcEEECCCCccccCcccc------hhhHHHHHhcCCc
Confidence 888888876543 2 24788888888888876543 2 257888888888888776432 2468888888888
Q ss_pred CcCCCCcccccccccccchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccC
Q psy3329 373 LHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSR 452 (694)
Q Consensus 373 l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~ 452 (694)
++.++. .+ .++|+.|++++|.++.++.. + .++|+.|+|++
T Consensus 316 Lt~LP~------------~l-----------------------~~sL~~L~Ls~N~Lt~LP~~-l----~~sL~~L~Ls~ 355 (754)
T PRK15370 316 LTALPE------------TL-----------------------PPGLKTLEAGENALTSLPAS-L----PPELQVLDVSK 355 (754)
T ss_pred cccCCc------------cc-----------------------cccceeccccCCccccCChh-h----cCcccEEECCC
Confidence 865432 11 46788899999988876542 2 36889999999
Q ss_pred CcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCcccccC---hhhhcCCCcccEEEccCCc
Q psy3329 453 CKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNNLTHIS---PTVLRHNRAITSIKLVGNP 529 (694)
Q Consensus 453 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~~---~~~~~~~~~l~~l~l~~N~ 529 (694)
|+|+.++... .++|+.|+|++|+++.+++. + . ..|+.|++++|+|++++ |..+..++.+..+++.+||
T Consensus 356 N~L~~LP~~l---p~~L~~LdLs~N~Lt~LP~~-l---~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Np 426 (754)
T PRK15370 356 NQITVLPETL---PPTITTLDVSRNALTNLPEN-L---P--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNP 426 (754)
T ss_pred CCCCcCChhh---cCCcCEEECCCCcCCCCCHh-H---H--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCC
Confidence 9988765532 36889999999999876543 3 2 36888899999988653 2334445778889999999
Q ss_pred ccc
Q psy3329 530 WKC 532 (694)
Q Consensus 530 ~~c 532 (694)
+..
T Consensus 427 ls~ 429 (754)
T PRK15370 427 FSE 429 (754)
T ss_pred ccH
Confidence 874
No 18
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.76 E-value=3.3e-18 Score=188.32 Aligned_cols=162 Identities=23% Similarity=0.303 Sum_probs=71.1
Q ss_pred CcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEE
Q psy3329 164 LRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRL 243 (694)
Q Consensus 164 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L 243 (694)
...|+++++.++.++.. -.++|+.|++++|.+ ..+|...+ ++|+.|++++|.++..+.. -.++|+.|
T Consensus 180 ~~~L~L~~~~LtsLP~~-----Ip~~L~~L~Ls~N~L-tsLP~~l~---~nL~~L~Ls~N~LtsLP~~----l~~~L~~L 246 (754)
T PRK15370 180 KTELRLKILGLTTIPAC-----IPEQITTLILDNNEL-KSLPENLQ---GNIKTLYANSNQLTSIPAT----LPDTIQEM 246 (754)
T ss_pred ceEEEeCCCCcCcCCcc-----cccCCcEEEecCCCC-CcCChhhc---cCCCEEECCCCccccCChh----hhccccEE
Confidence 44555555555544321 123455555555555 23443221 3555555555555433211 11345555
Q ss_pred EccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCccc
Q psy3329 244 SLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLE 323 (694)
Q Consensus 244 ~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 323 (694)
++++|++..++.. + .++|+.|++++|.+.. +|..+. ++|+.|++++|+++.++.. + .++|+.|++++|.++
T Consensus 247 ~Ls~N~L~~LP~~-l--~s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~-l--p~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 247 ELSINRITELPER-L--PSALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLPAH-L--PSGITHLNVQSNSLT 317 (754)
T ss_pred ECcCCccCcCChh-H--hCCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCccc-c--hhhHHHHHhcCCccc
Confidence 5555555544422 1 1245555555555443 222221 2455555555555443321 1 123444555555444
Q ss_pred CcCchhhcCCCCCCEEeCCCCCCcccC
Q psy3329 324 TLESGLFQNLTHLSVLELNNCGLTRLN 350 (694)
Q Consensus 324 ~~~~~~l~~l~~L~~L~L~~n~l~~~~ 350 (694)
.++... .++|+.|++++|.++.++
T Consensus 318 ~LP~~l---~~sL~~L~Ls~N~Lt~LP 341 (754)
T PRK15370 318 ALPETL---PPGLKTLEAGENALTSLP 341 (754)
T ss_pred cCCccc---cccceeccccCCccccCC
Confidence 433221 134444445554444443
No 19
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.72 E-value=1.8e-18 Score=177.60 Aligned_cols=286 Identities=23% Similarity=0.277 Sum_probs=144.9
Q ss_pred EEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccch---hhhccCCCCccEEEccCcCCCcCC------cccccCCC
Q psy3329 192 SLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADL---SVALKPLTKLHRLSLRNCGLSRLP------ANTFHRFT 262 (694)
Q Consensus 192 ~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~---~~~l~~l~~L~~L~l~~n~i~~~~------~~~~~~~~ 262 (694)
.|+|..+.+.+.-....+..++.|+.++++++.++.... ...+...++++.++++++.+...+ ...+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 355666665433333455666667777777777654321 223344556667776666554211 12233444
Q ss_pred CccEEeCCCCCCcccchhhcCCC---CCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCcCchhhcCC-CCCCE
Q psy3329 263 CLQELDISHNPLIDAFTALLSPL---ESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETLESGLFQNL-THLSV 338 (694)
Q Consensus 263 ~L~~L~L~~n~~~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~ 338 (694)
+|+.|++++|.+.+..+..+..+ ++|++|++++|.++..... .....+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~--------------------~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR--------------------LLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH--------------------HHHHHHHhCCCCceE
Confidence 55555555555543332222222 2245555544444321100 111122333 44555
Q ss_pred EeCCCCCCcccC----ccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccchhhhhhhhcccccccCC
Q psy3329 339 LELNNCGLTRLN----ETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNETVFHENY 414 (694)
Q Consensus 339 L~L~~n~l~~~~----~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~ 414 (694)
|++++|.++... ...+. .++.|++|++++|.++... +..++.. +..
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~---~~~~L~~L~l~~n~l~~~~-------~~~l~~~------------------l~~-- 191 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALR---ANRDLKELNLANNGIGDAG-------IRALAEG------------------LKA-- 191 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHH---hCCCcCEEECcCCCCchHH-------HHHHHHH------------------HHh--
Confidence 555555544211 11111 3345555555555543210 0001110 011
Q ss_pred CCCCCceEEcCCCCCcccCCC----CCCCcCCCCccEEEccCCcCCccCCCC-----CCCCCCCCEEEccCCccCCCcch
Q psy3329 415 TYPDLEELRLSGNPLHVLPTG----NLLPPQLSRLRSLDLSRCKIDYLPPNV-----FNNTRNITSLNLANNNLSMTSEL 485 (694)
Q Consensus 415 ~~~~L~~L~Ls~n~l~~~~~~----~~~~~~l~~L~~L~Ls~n~l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~~~~ 485 (694)
+++|+.|++++|.+++.... .+ ..+++|++|++++|.+++..... ....+.|++|++++|.++.....
T Consensus 192 -~~~L~~L~L~~n~i~~~~~~~l~~~~--~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~ 268 (319)
T cd00116 192 -NCNLEVLDLNNNGLTDEGASALAETL--ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAK 268 (319)
T ss_pred -CCCCCEEeccCCccChHHHHHHHHHh--cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHH
Confidence 45666666666666543221 22 45677888888888777521111 11347888888888888732222
Q ss_pred hh-hhhcccCCCcEEECCCCccccc----ChhhhcCC-CcccEEEccCCcc
Q psy3329 486 SF-QFLDVLLELESLDLSNNNLTHI----SPTVLRHN-RAITSIKLVGNPW 530 (694)
Q Consensus 486 ~~-~~l~~l~~L~~L~ls~N~l~~~----~~~~~~~~-~~l~~l~l~~N~~ 530 (694)
.+ ..+..+++|+.+++++|.++.. ....+... +.++.+++.+|||
T Consensus 269 ~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 269 DLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 11 2336667889999999998864 33344444 6788888888886
No 20
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.68 E-value=2.4e-17 Score=169.27 Aligned_cols=207 Identities=21% Similarity=0.180 Sum_probs=123.1
Q ss_pred EEECcCCCCc--chhhhhhcCCCCcEEEccCCcCCcc----ChhhccCCCCCCeEECCCCCCCc------cCCCCCCCCC
Q psy3329 21 TINLNANPIQ--PVEGAFLVARSLLYLYMQECTLSKI----NPQFFTNLTTLNKLDLSGNPLRI------IEPGVFDPLT 88 (694)
Q Consensus 21 ~L~Ls~~~l~--~i~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~~~~------~~~~~~~~l~ 88 (694)
.|+|..+.++ .....+..+..|+.|+++++.++.. .+..+...+.|++|+++++.+.. ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566666665 3345666677788888888776432 23345666778888888776652 1122356677
Q ss_pred CCCEEeCCCCcCCccChhhhcCCCC---CCEEECCCCcCCccc--hhhhhhcCC-CCCCEEEccCCCCCCCC----cccc
Q psy3329 89 SLEYLMLNRCNLTYISPSAFDNLNH---LKTLELSQNKLKSHI--DWTLVLGNL-GKLDTLDLRQSGISNLP----DNVF 158 (694)
Q Consensus 89 ~L~~L~L~~n~l~~~~~~~l~~l~~---L~~L~l~~n~l~~~~--~~~~~~~~l-~~L~~L~L~~n~i~~~~----~~~~ 158 (694)
+|++|++++|.+....+..+..+.+ |+.|++++|.+...+ .+...+..+ ++|+.|++++|.++... ...+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887655555555444 888888888776311 222345566 78888888888877322 2345
Q ss_pred CCCCCCcEEeCCCCCCCCcchhhhc--ccCCCcccEEeCCCCCCCCCCC---hhhhhcCCCCcEEEcCCCCCCc
Q psy3329 159 ANNTWLRNLNLAENELIDLDVATTL--GQNLVHLDSLDLSNCHLKGPLS---EDAFVNATKLRTLYLSGNPLSA 227 (694)
Q Consensus 159 ~~~~~L~~L~l~~n~l~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~~---~~~~~~~~~L~~L~L~~n~l~~ 227 (694)
..+++|++|++++|.+.+....... ...+++|++|++++|.+.+... ...+..+++|+.|++++|.+++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 6677888888888887653221110 0123456666666655521110 0123344555555555555544
No 21
>KOG0617|consensus
Probab=99.50 E-value=2.8e-16 Score=133.62 Aligned_cols=157 Identities=25% Similarity=0.382 Sum_probs=91.9
Q ss_pred cCCCCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCE
Q psy3329 13 NLDNPGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEY 92 (694)
Q Consensus 13 ~~~~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~ 92 (694)
+.++.+++.|.||+|.++.+|..+..+.+|+.|++.+|+++.+ |..++.++.|+.|+++-|++...+.+ |+.++.|++
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~l-p~~issl~klr~lnvgmnrl~~lprg-fgs~p~lev 106 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEEL-PTSISSLPKLRILNVGMNRLNILPRG-FGSFPALEV 106 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhc-ChhhhhchhhhheecchhhhhcCccc-cCCCchhhh
Confidence 3345556666666666666666666666666666666666665 44566666666666666665544333 666666666
Q ss_pred EeCCCCcCCc-cChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCC
Q psy3329 93 LMLNRCNLTY-ISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAE 171 (694)
Q Consensus 93 L~L~~n~l~~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~ 171 (694)
|||.+|++.. ..|..|..++.|+.|+++.|.+. -+|..++++++|+.|.+..|.+-.++. .++.+..|++|.+.+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe---~lp~dvg~lt~lqil~lrdndll~lpk-eig~lt~lrelhiqg 182 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE---ILPPDVGKLTNLQILSLRDNDLLSLPK-EIGDLTRLRELHIQG 182 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc---cCChhhhhhcceeEEeeccCchhhCcH-HHHHHHHHHHHhccc
Confidence 6666665543 33455555666666666666554 334455666666666666666555553 244555555555555
Q ss_pred CCCC
Q psy3329 172 NELI 175 (694)
Q Consensus 172 n~l~ 175 (694)
|.++
T Consensus 183 nrl~ 186 (264)
T KOG0617|consen 183 NRLT 186 (264)
T ss_pred ceee
Confidence 5544
No 22
>KOG0617|consensus
Probab=99.50 E-value=4.7e-16 Score=132.27 Aligned_cols=111 Identities=29% Similarity=0.461 Sum_probs=71.7
Q ss_pred CCCCceEEcCCCCCcc-cCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccC
Q psy3329 416 YPDLEELRLSGNPLHV-LPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLL 494 (694)
Q Consensus 416 ~~~L~~L~Ls~n~l~~-~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~ 494 (694)
+|.|+.|||.+|++.. ..|+.| -.+..|+.|+|+.|.+.-++++ .+++++||.|.+..|.+-..+. .+ +.++
T Consensus 101 ~p~levldltynnl~e~~lpgnf--f~m~tlralyl~dndfe~lp~d-vg~lt~lqil~lrdndll~lpk-ei---g~lt 173 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNF--FYMTTLRALYLGDNDFEILPPD-VGKLTNLQILSLRDNDLLSLPK-EI---GDLT 173 (264)
T ss_pred CchhhhhhccccccccccCCcch--hHHHHHHHHHhcCCCcccCChh-hhhhcceeEEeeccCchhhCcH-HH---HHHH
Confidence 5555666666555543 234444 3566677777777777777666 4777888888888887765543 33 7778
Q ss_pred CCcEEECCCCcccccChhh--hcCCCcccEEEccCCccccc
Q psy3329 495 ELESLDLSNNNLTHISPTV--LRHNRAITSIKLVGNPWKCD 533 (694)
Q Consensus 495 ~L~~L~ls~N~l~~~~~~~--~~~~~~l~~l~l~~N~~~c~ 533 (694)
.|++|.+.+|+++.++|+. +.-..+-+...+..|||.-.
T Consensus 174 ~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 174 RLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred HHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 8888888888888777652 11122334556778888653
No 23
>KOG3207|consensus
Probab=99.30 E-value=5.6e-13 Score=130.49 Aligned_cols=169 Identities=24% Similarity=0.278 Sum_probs=111.3
Q ss_pred hcCCCCCCEEEccCCCCCCCCc-cccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcC
Q psy3329 134 LGNLGKLDTLDLRQSGISNLPD-NVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNA 212 (694)
Q Consensus 134 ~~~l~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~ 212 (694)
-.++.+|+...|.++.+..... .....|++++.|+|+.|-+........+...+++|+.|+++.|.+........-..+
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 3456677777777766654443 345667778888888877776666555556788888888888877443333333356
Q ss_pred CCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccc-hhhcCCCCCCcEE
Q psy3329 213 TKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAF-TALLSPLESLEHL 291 (694)
Q Consensus 213 ~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~-~~~~~~l~~L~~L 291 (694)
++|+.|.|+.|.++.......+..+|+|+.|++..|..-.+.......+..|+.|+|++|++.... ....+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 788888888888886666666677888888888888533333333445567888888887765532 1234556666666
Q ss_pred ECcCCCCcccC
Q psy3329 292 DMGYSNLQRIS 302 (694)
Q Consensus 292 ~L~~n~l~~~~ 302 (694)
+++.+.+..+.
T Consensus 277 nls~tgi~si~ 287 (505)
T KOG3207|consen 277 NLSSTGIASIA 287 (505)
T ss_pred hccccCcchhc
Confidence 66666665443
No 24
>KOG3207|consensus
Probab=99.28 E-value=1.2e-12 Score=128.14 Aligned_cols=187 Identities=23% Similarity=0.248 Sum_probs=120.7
Q ss_pred CCCCCCEEeCCCCcCCccCh-hhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCcc-ccCCCCC
Q psy3329 86 PLTSLEYLMLNRCNLTYISP-SAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDN-VFANNTW 163 (694)
Q Consensus 86 ~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~~~~ 163 (694)
++.+|+.+.|.++....... .....|++++.|+|+.|-+.....+......+|+|+.|+++.|.+...... .-..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 46677777777776655432 345667888888888887776656666677788888888888877643322 1224677
Q ss_pred CcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEE
Q psy3329 164 LRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRL 243 (694)
Q Consensus 164 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L 243 (694)
|+.|.++.|.++.-++..... .+++|+.|++..|.. -.+.......+..|+.|+|++|++.+.+.......++.|+.|
T Consensus 199 lK~L~l~~CGls~k~V~~~~~-~fPsl~~L~L~~N~~-~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILL-TFPSLEVLYLEANEI-ILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hheEEeccCCCCHHHHHHHHH-hCCcHHHhhhhcccc-cceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 888888888877544443333 788888888888742 112222344566788888888887766644455777888888
Q ss_pred EccCcCCCcCCcccc------cCCCCccEEeCCCCCC
Q psy3329 244 SLRNCGLSRLPANTF------HRFTCLQELDISHNPL 274 (694)
Q Consensus 244 ~l~~n~i~~~~~~~~------~~~~~L~~L~L~~n~~ 274 (694)
+++.+.+.++..... ..+++|+.|++..|++
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 888887776532111 2344555555555554
No 25
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.25 E-value=4.5e-12 Score=113.86 Aligned_cols=123 Identities=29% Similarity=0.335 Sum_probs=32.4
Q ss_pred CcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhcc-CCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCc
Q psy3329 24 LNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFT-NLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTY 102 (694)
Q Consensus 24 Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 102 (694)
|..+.|..++. +.++.++++|+|++|.|+.+. .+. .+.+|+.|++++|.++.+.. +..++.|++|++++|.|+.
T Consensus 4 lt~~~i~~~~~-~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~ 78 (175)
T PF14580_consen 4 LTANMIEQIAQ-YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISS 78 (175)
T ss_dssp -----------------------------------S--TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S
T ss_pred ccccccccccc-ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCc
Confidence 33444444442 334445677777777766653 233 45667777777777766643 5666777777777777766
Q ss_pred cChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCC
Q psy3329 103 ISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISN 152 (694)
Q Consensus 103 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~ 152 (694)
+.+.....+++|+.|++++|++.+...+ ..+..+++|+.|++.+|.++.
T Consensus 79 i~~~l~~~lp~L~~L~L~~N~I~~l~~l-~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 79 ISEGLDKNLPNLQELYLSNNKISDLNEL-EPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -CHHHHHH-TT--EEE-TTS---SCCCC-GGGGG-TT--EEE-TT-GGGG
T ss_pred cccchHHhCCcCCEEECcCCcCCChHHh-HHHHcCCCcceeeccCCcccc
Confidence 6432223466677777777766654443 234556666666666665543
No 26
>KOG1909|consensus
Probab=99.24 E-value=4.3e-12 Score=121.12 Aligned_cols=160 Identities=26% Similarity=0.347 Sum_probs=89.3
Q ss_pred CCCcccEEeCCCCCCCCCCChhh-------------hhcCCCCcEEEcCCCCCCccch---hhhccCCCCccEEEccCcC
Q psy3329 186 NLVHLDSLDLSNCHLKGPLSEDA-------------FVNATKLRTLYLSGNPLSAADL---SVALKPLTKLHRLSLRNCG 249 (694)
Q Consensus 186 ~~~~L~~L~l~~n~~~~~~~~~~-------------~~~~~~L~~L~L~~n~l~~~~~---~~~l~~l~~L~~L~l~~n~ 249 (694)
.+..|++|.|.+|.+ |...-.. ...-++|+++...+|++.+.+. ...+..++.|+.+.++.|.
T Consensus 118 s~~~L~eL~L~N~Gl-g~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~ 196 (382)
T KOG1909|consen 118 SCTDLEELYLNNCGL-GPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNG 196 (382)
T ss_pred hccCHHHHhhhcCCC-ChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEeccc
Confidence 455566666666655 3222111 2234677777777777655442 2234556777777777776
Q ss_pred CCcC----CcccccCCCCccEEeCCCCCCcc----cchhhcCCCCCCcEEECcCCCCcccChhhh-----cCCCCCcEEe
Q psy3329 250 LSRL----PANTFHRFTCLQELDISHNPLID----AFTALLSPLESLEHLDMGYSNLQRISRSTF-----LKMTSLKTLI 316 (694)
Q Consensus 250 i~~~----~~~~~~~~~~L~~L~L~~n~~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~ 316 (694)
|..- ....|..|++|+.|+|.+|-++. .+...+..+++|+.|++++|.+..-...+| ...|+|+.|.
T Consensus 197 I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~ 276 (382)
T KOG1909|consen 197 IRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLE 276 (382)
T ss_pred ccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceec
Confidence 6521 22445667777777777776654 233445566667777777776664433333 2345666666
Q ss_pred ccCCcccCcC----chhhcCCCCCCEEeCCCCCC
Q psy3329 317 LSGNKLETLE----SGLFQNLTHLSVLELNNCGL 346 (694)
Q Consensus 317 L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l 346 (694)
|.+|.|+.-. ...+...+.|..|+|++|.+
T Consensus 277 l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 277 LAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 6666555211 11223345555555555555
No 27
>KOG1909|consensus
Probab=99.23 E-value=2.3e-12 Score=122.95 Aligned_cols=197 Identities=24% Similarity=0.296 Sum_probs=126.9
Q ss_pred hhcCCCCCcEEeccCCcccCcCc----hhhcCCCCCCEEeCCCCCCcccCccc----------cccCCCCCCCCeeeCCC
Q psy3329 305 TFLKMTSLKTLILSGNKLETLES----GLFQNLTHLSVLELNNCGLTRLNETV----------FHENYTYPDLEELRLSG 370 (694)
Q Consensus 305 ~~~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~n~l~~~~~~~----------~~~~~~~~~L~~L~Ls~ 370 (694)
++.++++|+.|+||+|.+..-.+ ..+.++..|+.|.|.+|.+....... -.....-+.|+.+...+
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~r 166 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGR 166 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeec
Confidence 34455666666666665543222 22345666777777777665433222 11222557788888888
Q ss_pred CCCcCCCCcccccccccccchhccccchhhhhhhhcccccccCCCCCCCceEEcCCCCCcccCC----CCCCCcCCCCcc
Q psy3329 371 NPLHVLPDSTKQYSMRTIPTQIWKNFDFLVILFILNETVFHENYTYPDLEELRLSGNPLHVLPT----GNLLPPQLSRLR 446 (694)
Q Consensus 371 n~l~~~~~~~~~~~~~~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~----~~~~~~~l~~L~ 446 (694)
|++...+..... ..|.. .+.|+.+.++.|.|..-.. ..| ..+++|+
T Consensus 167 Nrlen~ga~~~A-------------------------~~~~~---~~~leevr~~qN~I~~eG~~al~eal--~~~~~Le 216 (382)
T KOG1909|consen 167 NRLENGGATALA-------------------------EAFQS---HPTLEEVRLSQNGIRPEGVTALAEAL--EHCPHLE 216 (382)
T ss_pred cccccccHHHHH-------------------------HHHHh---ccccceEEEecccccCchhHHHHHHH--HhCCcce
Confidence 887654431100 01222 6788888888887754322 234 6789999
Q ss_pred EEEccCCcCCc----cCCCCCCCCCCCCEEEccCCccCCCcchhh--hhhcccCCCcEEECCCCccccc----ChhhhcC
Q psy3329 447 SLDLSRCKIDY----LPPNVFNNTRNITSLNLANNNLSMTSELSF--QFLDVLLELESLDLSNNNLTHI----SPTVLRH 516 (694)
Q Consensus 447 ~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~l~~L~~L~ls~N~l~~~----~~~~~~~ 516 (694)
+|||..|.++. .....++.+++|+.|++++|.+..-...+| ..-...++|+++.+.+|.++.- ....+..
T Consensus 217 vLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~e 296 (382)
T KOG1909|consen 217 VLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAE 296 (382)
T ss_pred eeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhc
Confidence 99999998876 334556778899999999999876544333 1124578999999999998862 2233455
Q ss_pred CCcccEEEccCCccc
Q psy3329 517 NRAITSIKLVGNPWK 531 (694)
Q Consensus 517 ~~~l~~l~l~~N~~~ 531 (694)
.+.|..|++++|.+.
T Consensus 297 k~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 297 KPDLEKLNLNGNRLG 311 (382)
T ss_pred chhhHHhcCCccccc
Confidence 788999999999994
No 28
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.19 E-value=4.8e-11 Score=107.23 Aligned_cols=113 Identities=30% Similarity=0.352 Sum_probs=47.0
Q ss_pred CCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCC
Q psy3329 416 YPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLE 495 (694)
Q Consensus 416 ~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~ 495 (694)
+..+++|+|.+|.|+.+.... ..+.+|+.|||++|.|+.+.. +..++.|++|++++|+|+.+.+... ..+++
T Consensus 18 ~~~~~~L~L~~n~I~~Ie~L~---~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~i~~~l~---~~lp~ 89 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTIENLG---ATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISSISEGLD---KNLPN 89 (175)
T ss_dssp ------------------S-----TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S-CHHHH---HH-TT
T ss_pred ccccccccccccccccccchh---hhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCccccchH---HhCCc
Confidence 567899999999999875432 257899999999999999864 7889999999999999998755332 46899
Q ss_pred CcEEECCCCcccccCh-hhhcCCCcccEEEccCCccccccCc
Q psy3329 496 LESLDLSNNNLTHISP-TVLRHNRAITSIKLVGNPWKCDCNI 536 (694)
Q Consensus 496 L~~L~ls~N~l~~~~~-~~~~~~~~l~~l~l~~N~~~c~c~~ 536 (694)
|++|++++|+|..... ..+..+++|+.|++.+||+.-....
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~Y 131 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNY 131 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTH
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhH
Confidence 9999999999988533 5677899999999999999544433
No 29
>PLN03150 hypothetical protein; Provisional
Probab=99.12 E-value=1.2e-10 Score=128.56 Aligned_cols=113 Identities=22% Similarity=0.283 Sum_probs=102.6
Q ss_pred CCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCc
Q psy3329 418 DLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELE 497 (694)
Q Consensus 418 ~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~ 497 (694)
.++.|+|++|.+.+..+..+ ..+++|+.|+|++|.+++..|..+..+++|+.|+|++|++++.+|..+ +.+++|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i--~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l---~~L~~L~ 493 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDI--SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL---GQLTSLR 493 (623)
T ss_pred EEEEEECCCCCccccCCHHH--hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHH---hcCCCCC
Confidence 47889999999999888888 899999999999999999888889999999999999999999999888 8999999
Q ss_pred EEECCCCcccccChhhhcCC-CcccEEEccCCccccccC
Q psy3329 498 SLDLSNNNLTHISPTVLRHN-RAITSIKLVGNPWKCDCN 535 (694)
Q Consensus 498 ~L~ls~N~l~~~~~~~~~~~-~~l~~l~l~~N~~~c~c~ 535 (694)
.|+|++|+++|.+|..+... ..+..+++.+|+..|.++
T Consensus 494 ~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred EEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999999988877653 466789999999999765
No 30
>KOG1259|consensus
Probab=99.10 E-value=2.4e-11 Score=113.25 Aligned_cols=135 Identities=30% Similarity=0.366 Sum_probs=100.0
Q ss_pred CCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEE
Q psy3329 236 PLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTL 315 (694)
Q Consensus 236 ~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 315 (694)
....|+++++++|.|+.+. ++..-.|.++.|++++|.+..+- .+..+++|++|||++|.++.+.. .-.++.++++|
T Consensus 282 TWq~LtelDLS~N~I~~iD-ESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls~~~G-wh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLITQID-ESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLAECVG-WHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchhhhh-hhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhHhhhh-hHhhhcCEeee
Confidence 3466888888888888776 45666788888888888876553 36678888888888888877653 33467788888
Q ss_pred eccCCcccCcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCC
Q psy3329 316 ILSGNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPD 378 (694)
Q Consensus 316 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~ 378 (694)
.|++|.+..+.. +..+-+|..||+++|+|..+.... ...++|.|+.+.|.+|++..+++
T Consensus 358 ~La~N~iE~LSG--L~KLYSLvnLDl~~N~Ie~ldeV~--~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIETLSG--LRKLYSLVNLDLSSNQIEELDEVN--HIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHhhhhh--hHhhhhheeccccccchhhHHHhc--ccccccHHHHHhhcCCCccccch
Confidence 888888876643 667778888888888887754322 22278889999999998876654
No 31
>KOG1259|consensus
Probab=99.05 E-value=2.2e-11 Score=113.48 Aligned_cols=134 Identities=26% Similarity=0.338 Sum_probs=102.8
Q ss_pred CCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeC
Q psy3329 16 NPGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLML 95 (694)
Q Consensus 16 ~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L 95 (694)
.+.|+++|||+|.|+.+.++..-.|.++.|++++|++..+.. ++.+++|+.||||+|.++.+. ++-..+.+.+.|.|
T Consensus 283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls~~~-Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLAECV-GWHLKLGNIKTLKL 359 (490)
T ss_pred HhhhhhccccccchhhhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhHhhh-hhHhhhcCEeeeeh
Confidence 346788888888888888888888888888888888877743 778888888888888877653 33345677888888
Q ss_pred CCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCc
Q psy3329 96 NRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPD 155 (694)
Q Consensus 96 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 155 (694)
+.|.+... ..++++-+|..|++++|++..+... ..++++|.|+++.|.+|.+..++.
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV-~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEV-NHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHh-cccccccHHHHHhhcCCCccccch
Confidence 88887776 4577788888888888888765443 457788888888888888776654
No 32
>KOG0532|consensus
Probab=99.02 E-value=1.4e-11 Score=124.57 Aligned_cols=197 Identities=27% Similarity=0.384 Sum_probs=112.6
Q ss_pred CCCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEe
Q psy3329 15 DNPGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLM 94 (694)
Q Consensus 15 ~~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~ 94 (694)
++..-...+|+.|.+..+|..+..+-.|+.+.+..|.+..+ |.++..+..|++|+|+.|+++..+.. +..|+ |+.|.
T Consensus 73 ~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~i-p~~i~~L~~lt~l~ls~NqlS~lp~~-lC~lp-Lkvli 149 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTI-PEAICNLEALTFLDLSSNQLSHLPDG-LCDLP-LKVLI 149 (722)
T ss_pred cccchhhhhccccccccCchHHHHHHHHHHHHHHhccceec-chhhhhhhHHHHhhhccchhhcCChh-hhcCc-ceeEE
Confidence 34445556666666666666666666666666666666555 55566666666666666666665544 33343 66666
Q ss_pred CCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCC
Q psy3329 95 LNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENEL 174 (694)
Q Consensus 95 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 174 (694)
+++|+++.+ |..++.+.+|..|+.+.|.+. .+|..++++.+|+.|++..|++..+++... .
T Consensus 150 ~sNNkl~~l-p~~ig~~~tl~~ld~s~nei~---slpsql~~l~slr~l~vrRn~l~~lp~El~-~-------------- 210 (722)
T KOG0532|consen 150 VSNNKLTSL-PEEIGLLPTLAHLDVSKNEIQ---SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-S-------------- 210 (722)
T ss_pred EecCccccC-CcccccchhHHHhhhhhhhhh---hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-C--------------
Confidence 666666666 444556666666666666655 344556666666666666666666554322 2
Q ss_pred CCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCC-CCccEEEccCc
Q psy3329 175 IDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPL-TKLHRLSLRNC 248 (694)
Q Consensus 175 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l-~~L~~L~l~~n 248 (694)
-.|..||++.|++ ..+|. .|.+|+.|++|.|.+|.+..-+......+. .=.+.|+..-|
T Consensus 211 -------------LpLi~lDfScNki-s~iPv-~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 211 -------------LPLIRLDFSCNKI-SYLPV-DFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred -------------CceeeeecccCce-eecch-hhhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchhc
Confidence 2344455555554 44443 366666666666666666554433322222 22344555444
No 33
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.00 E-value=6e-10 Score=117.69 Aligned_cols=86 Identities=40% Similarity=0.570 Sum_probs=45.1
Q ss_pred CCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCc
Q psy3329 418 DLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELE 497 (694)
Q Consensus 418 ~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~ 497 (694)
.|++|.+++|.+...+. .+ ..+.++..+.+.+|++..+ +..++.+++++.|++++|.++.+.+ + ..+.+++
T Consensus 210 ~L~~l~~~~N~~~~~~~-~~--~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~~--~---~~~~~l~ 280 (394)
T COG4886 210 ALEELDLSNNSIIELLS-SL--SNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSISS--L---GSLTNLR 280 (394)
T ss_pred hhhhhhhcCCcceecch-hh--hhcccccccccCCceeeec-cchhccccccceecccccccccccc--c---cccCccC
Confidence 35555555553222221 11 4455555555666655543 2224555566666666666665544 2 5566666
Q ss_pred EEECCCCcccccChh
Q psy3329 498 SLDLSNNNLTHISPT 512 (694)
Q Consensus 498 ~L~ls~N~l~~~~~~ 512 (694)
.|++++|.++..++.
T Consensus 281 ~L~~s~n~~~~~~~~ 295 (394)
T COG4886 281 ELDLSGNSLSNALPL 295 (394)
T ss_pred EEeccCccccccchh
Confidence 666666666655443
No 34
>KOG0531|consensus
Probab=98.96 E-value=9.4e-11 Score=123.84 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=127.6
Q ss_pred CccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEecc
Q psy3329 239 KLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILS 318 (694)
Q Consensus 239 ~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 318 (694)
.++.+.+..|.+..+. ..+..+++|+.|++.+|.+..+... +..+++|++|++++|.|+.+. .+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~~~-~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAKIL-NHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhhhh-cccccccceeeeeccccchhhcccc-hhhhhcchheecccccccccc--chhhccchhhheec
Confidence 3333344444444321 1233445555555555554443221 344556666666666666554 24455556666666
Q ss_pred CCcccCcCchhhcCCCCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCCCCcCCCCcccccccccccchhccccch
Q psy3329 319 GNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGNPLHVLPDSTKQYSMRTIPTQIWKNFDF 398 (694)
Q Consensus 319 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ip~~~~~~~~~ 398 (694)
+|.+..+.. +..++.|+.+++++|++..+...... .+..++.+++.+|.+..+....
T Consensus 149 ~N~i~~~~~--~~~l~~L~~l~l~~n~i~~ie~~~~~---~~~~l~~l~l~~n~i~~i~~~~------------------ 205 (414)
T KOG0531|consen 149 GNLISDISG--LESLKSLKLLDLSYNRIVDIENDELS---ELISLEELDLGGNSIREIEGLD------------------ 205 (414)
T ss_pred cCcchhccC--CccchhhhcccCCcchhhhhhhhhhh---hccchHHHhccCCchhcccchH------------------
Confidence 666665543 44466666666666666665541011 4566777777777665433210
Q ss_pred hhhhhhhcccccccCCCCCCCceEEcCCCCCcccCCCCCCCcCCC--CccEEEccCCcCCccCCCCCCCCCCCCEEEccC
Q psy3329 399 LVILFILNETVFHENYTYPDLEELRLSGNPLHVLPTGNLLPPQLS--RLRSLDLSRCKIDYLPPNVFNNTRNITSLNLAN 476 (694)
Q Consensus 399 l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~l~--~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 476 (694)
. +..+..+++..|.++.+.+.. .+. +|+.+++++|++..++ ..+..+..+..|++.+
T Consensus 206 -------------~---~~~l~~~~l~~n~i~~~~~l~----~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~ 264 (414)
T KOG0531|consen 206 -------------L---LKKLVLLSLLDNKISKLEGLN----ELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSS 264 (414)
T ss_pred -------------H---HHHHHHhhcccccceeccCcc----cchhHHHHHHhcccCcccccc-ccccccccccccchhh
Confidence 0 223333455666655443322 122 2667777777766553 2245666777777777
Q ss_pred CccCCCcchhhhhhcccCCCcEEECCCCccccc---Chh-hhcCCCcccEEEccCCcccc
Q psy3329 477 NNLSMTSELSFQFLDVLLELESLDLSNNNLTHI---SPT-VLRHNRAITSIKLVGNPWKC 532 (694)
Q Consensus 477 N~l~~~~~~~~~~l~~l~~L~~L~ls~N~l~~~---~~~-~~~~~~~l~~l~l~~N~~~c 532 (694)
|++...... ...+.+..+....|.+... ... .....+.++.+.+.+||..-
T Consensus 265 n~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 265 NRISNLEGL-----ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred ccccccccc-----cccchHHHhccCcchhcchhhhhccccccccccccccccccCcccc
Confidence 777654332 3455566666666665532 111 13345666777777777654
No 35
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.96 E-value=5.4e-10 Score=82.46 Aligned_cols=59 Identities=47% Similarity=0.679 Sum_probs=29.6
Q ss_pred CccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCcEEECCCCc
Q psy3329 444 RLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELESLDLSNNN 505 (694)
Q Consensus 444 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ls~N~ 505 (694)
+|++|++++|+|+.+++.+|.++++|++|++++|+++.+.+..| ..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f---~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAF---SNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTT---TTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHH---cCCCCCCEEeCcCCc
Confidence 44455555555555555555555555555555555554444444 444455555555444
No 36
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.95 E-value=7.2e-10 Score=81.79 Aligned_cols=61 Identities=43% Similarity=0.733 Sum_probs=58.5
Q ss_pred CCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCcc
Q psy3329 417 PDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNL 479 (694)
Q Consensus 417 ~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 479 (694)
|+|+.|++++|.++.+++..| .++++|++|++++|.++.+++.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f--~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSF--SNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTT--TTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHH--cCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 578999999999999999999 9999999999999999999999999999999999999986
No 37
>KOG0531|consensus
Probab=98.93 E-value=1.1e-10 Score=123.32 Aligned_cols=246 Identities=28% Similarity=0.354 Sum_probs=159.3
Q ss_pred hcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCCCE
Q psy3329 37 LVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHLKT 116 (694)
Q Consensus 37 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 116 (694)
..+..++.++++.|.+..+ -..+..+.+|+.|++.+|.|..+... +..+++|++|++++|.|+.+ ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~~-~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKI-LNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhhh-hcccccccceeeeeccccchhhcccc-hhhhhcchheeccccccccc--cchhhccchhh
Confidence 3455666666777766653 23466777777788888777776543 56677788888888877777 34566667788
Q ss_pred EECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCc-cccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeC
Q psy3329 117 LELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPD-NVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDL 195 (694)
Q Consensus 117 L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l 195 (694)
|++++|.+..+.. +..++.|+.+++++|.+..+.. . ...+.+++.+.+.+|.+..+.... .+..+..+++
T Consensus 145 L~l~~N~i~~~~~----~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~----~~~~l~~~~l 215 (414)
T KOG0531|consen 145 LNLSGNLISDISG----LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLD----LLKKLVLLSL 215 (414)
T ss_pred heeccCcchhccC----CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchH----HHHHHHHhhc
Confidence 8888887775543 4446777788888887777665 2 456677777788887776554333 2333444466
Q ss_pred CCCCCCCCCChhhhhcCC--CCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCCC
Q psy3329 196 SNCHLKGPLSEDAFVNAT--KLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHNP 273 (694)
Q Consensus 196 ~~n~~~~~~~~~~~~~~~--~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~ 273 (694)
..|.+.. +. .+.... +|+.+++++|.+.... ..+..+..+..+++..+.+..+.. +...+.+..+....+.
T Consensus 216 ~~n~i~~-~~--~l~~~~~~~L~~l~l~~n~i~~~~--~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~ 288 (414)
T KOG0531|consen 216 LDNKISK-LE--GLNELVMLHLRELYLSGNRISRSP--EGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNK 288 (414)
T ss_pred cccccee-cc--CcccchhHHHHHHhcccCcccccc--ccccccccccccchhhcccccccc--ccccchHHHhccCcch
Confidence 6666521 11 122222 3788888888877652 134667888888888888776643 4455667777777777
Q ss_pred Cccc---chh-hcCCCCCCcEEECcCCCCcccC
Q psy3329 274 LIDA---FTA-LLSPLESLEHLDMGYSNLQRIS 302 (694)
Q Consensus 274 ~~~~---~~~-~~~~l~~L~~L~L~~n~l~~~~ 302 (694)
+... ... .....+.++.+.+..|.+....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 289 LALSEAISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred hcchhhhhccccccccccccccccccCcccccc
Confidence 6532 111 1455677888888888776554
No 38
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.91 E-value=1.2e-09 Score=115.30 Aligned_cols=198 Identities=32% Similarity=0.427 Sum_probs=146.0
Q ss_pred EEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCC-CCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCc
Q psy3329 21 TINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLT-TLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCN 99 (694)
Q Consensus 21 ~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~ 99 (694)
.++++.+.+......+...+.++.|++.+|.+..+.+ ....+. +|+.|++++|++..++ ..+..+++|+.|++++|.
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~-~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPP-LIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCcc-ccccchhhcccccccccchhhhh-hhhhccccccccccCCch
Confidence 5777777775444455566889999999998888854 345553 8999999999988874 237888999999999999
Q ss_pred CCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcch
Q psy3329 100 LTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDV 179 (694)
Q Consensus 100 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 179 (694)
+..++ ...+.++.|+.|++++|++..+. ........|+++.+++|.+...+ ..+..+.++..+.+.+|.+....
T Consensus 175 l~~l~-~~~~~~~~L~~L~ls~N~i~~l~---~~~~~~~~L~~l~~~~N~~~~~~-~~~~~~~~l~~l~l~~n~~~~~~- 248 (394)
T COG4886 175 LSDLP-KLLSNLSNLNNLDLSGNKISDLP---PEIELLSALEELDLSNNSIIELL-SSLSNLKNLSGLELSNNKLEDLP- 248 (394)
T ss_pred hhhhh-hhhhhhhhhhheeccCCccccCc---hhhhhhhhhhhhhhcCCcceecc-hhhhhcccccccccCCceeeecc-
Confidence 98884 33447888999999999888544 33445566899999988544333 23677778888888888876531
Q ss_pred hhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchh
Q psy3329 180 ATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLS 231 (694)
Q Consensus 180 ~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 231 (694)
... ..++.++.|++++|.+ ..++. +....+++.|+++++.+......
T Consensus 249 -~~~-~~l~~l~~L~~s~n~i-~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 249 -ESI-GNLSNLETLDLSNNQI-SSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -chh-ccccccceeccccccc-ccccc--ccccCccCEEeccCccccccchh
Confidence 122 2677799999999988 55543 77889999999999988766544
No 39
>KOG4658|consensus
Probab=98.89 E-value=1e-09 Score=123.65 Aligned_cols=321 Identities=24% Similarity=0.284 Sum_probs=187.1
Q ss_pred cCCCCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCc--CCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCC
Q psy3329 13 NLDNPGLITINLNANPIQPVEGAFLVARSLLYLYMQECT--LSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSL 90 (694)
Q Consensus 13 ~~~~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L 90 (694)
..+....+.+.+-++.+..++... .++.|+.|-+..|. +..+....|..++.|++|||++|.--+-.|..++.+-+|
T Consensus 519 ~~~~~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred ccchhheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 344457788888888888777544 34578888888875 677777778889999999999875444456668888999
Q ss_pred CEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCC--CCCCccccCCCCCCcEEe
Q psy3329 91 EYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGI--SNLPDNVFANNTWLRNLN 168 (694)
Q Consensus 91 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i--~~~~~~~~~~~~~L~~L~ 168 (694)
++|+++++.+..+ |..++++.+|.+|++..+.-.. .++.....+.+|++|.+..... +......+.++.+|+.+.
T Consensus 598 ryL~L~~t~I~~L-P~~l~~Lk~L~~Lnl~~~~~l~--~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls 674 (889)
T KOG4658|consen 598 RYLDLSDTGISHL-PSGLGNLKKLIYLNLEVTGRLE--SIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLS 674 (889)
T ss_pred hcccccCCCcccc-chHHHHHHhhheeccccccccc--cccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhe
Confidence 9999999988877 7788889999999988775432 2245566688899988876541 122222334444555544
Q ss_pred CCCCCCCCcchhhhcccCCCccc----EEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhh----cc-CCCC
Q psy3329 169 LAENELIDLDVATTLGQNLVHLD----SLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVA----LK-PLTK 239 (694)
Q Consensus 169 l~~n~l~~~~~~~~~~~~~~~L~----~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~----l~-~l~~ 239 (694)
...... ...... .....|. .+.+.++.. ... ...+..+.+|+.|.+.++.+........ .. .+++
T Consensus 675 ~~~~s~---~~~e~l-~~~~~L~~~~~~l~~~~~~~-~~~-~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~ 748 (889)
T KOG4658|consen 675 ITISSV---LLLEDL-LGMTRLRSLLQSLSIEGCSK-RTL-ISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPN 748 (889)
T ss_pred eecchh---HhHhhh-hhhHHHHHHhHhhhhccccc-cee-ecccccccCcceEEEEcCCCchhhcccccccchhhhHHH
Confidence 432221 000000 0122222 222222222 111 2246677888888888887754332110 01 1223
Q ss_pred ccEEEccCcCCCcCCcccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCccc-ChhhhcCCCCCcEEecc
Q psy3329 240 LHRLSLRNCGLSRLPANTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRI-SRSTFLKMTSLKTLILS 318 (694)
Q Consensus 240 L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~ 318 (694)
+..+.+.++.....+ .+.-..++|+.|.+..+...+.+......+..+..+.+..+.+... .-...++++++..+.+.
T Consensus 749 l~~~~~~~~~~~r~l-~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~ 827 (889)
T KOG4658|consen 749 LSKVSILNCHMLRDL-TWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLS 827 (889)
T ss_pred HHHHHhhcccccccc-chhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccC
Confidence 444444444222222 1122347888888888877766655555556666655666655554 23344555666655555
Q ss_pred CCcccCcCchh---hcCCCCCCEEeCCCC
Q psy3329 319 GNKLETLESGL---FQNLTHLSVLELNNC 344 (694)
Q Consensus 319 ~n~l~~~~~~~---l~~l~~L~~L~L~~n 344 (694)
.=.+..+.... +..+|.+.++.+.+|
T Consensus 828 ~~~l~~~~ve~~p~l~~~P~~~~~~i~~~ 856 (889)
T KOG4658|consen 828 FLKLEELIVEECPKLGKLPLLSTLTIVGC 856 (889)
T ss_pred ccchhheehhcCcccccCccccccceecc
Confidence 54433332211 344566666666665
No 40
>KOG4658|consensus
Probab=98.89 E-value=1.1e-09 Score=123.44 Aligned_cols=333 Identities=24% Similarity=0.248 Sum_probs=208.2
Q ss_pred CCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCC--CCccCCCCCCCCCCCCEEeCCCCcCCccC
Q psy3329 27 NPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNP--LRIIEPGVFDPLTSLEYLMLNRCNLTYIS 104 (694)
Q Consensus 27 ~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~--~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 104 (694)
..+..+|. .......+...+.+|.+..+.. . ..++.|++|-+.+|. +..++...|..++.|++|||++|.=-+..
T Consensus 511 ~~~~~~~~-~~~~~~~rr~s~~~~~~~~~~~-~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~L 587 (889)
T KOG4658|consen 511 VGLSEIPQ-VKSWNSVRRMSLMNNKIEHIAG-S-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKL 587 (889)
T ss_pred cCcccccc-ccchhheeEEEEeccchhhccC-C-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcC
Confidence 34444542 2234677888888887766632 2 345689999999986 67777777899999999999988555555
Q ss_pred hhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcc
Q psy3329 105 PSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDVATTLG 184 (694)
Q Consensus 105 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 184 (694)
|..++.+.+|++|+++++.+. .+|..++++..|.+|++..+......+.....+++|++|.+...............
T Consensus 588 P~~I~~Li~LryL~L~~t~I~---~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el 664 (889)
T KOG4658|consen 588 PSSIGELVHLRYLDLSDTGIS---HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKEL 664 (889)
T ss_pred ChHHhhhhhhhcccccCCCcc---ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhh
Confidence 899999999999999999987 67789999999999999988866666777778999999999776532222111111
Q ss_pred cCCCcccEEeCCCCCCCCCCChhhhhcCCCCc----EEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccC
Q psy3329 185 QNLVHLDSLDLSNCHLKGPLSEDAFVNATKLR----TLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHR 260 (694)
Q Consensus 185 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~----~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~ 260 (694)
.++.+|+.+....... .+ ...+..++.|. .+.+.++..... ...+..+.+|+.|.+.++.+.++.......
T Consensus 665 ~~Le~L~~ls~~~~s~--~~-~e~l~~~~~L~~~~~~l~~~~~~~~~~--~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~ 739 (889)
T KOG4658|consen 665 ENLEHLENLSITISSV--LL-LEDLLGMTRLRSLLQSLSIEGCSKRTL--ISSLGSLGNLEELSILDCGISEIVIEWEES 739 (889)
T ss_pred hcccchhhheeecchh--Hh-HhhhhhhHHHHHHhHhhhhccccccee--ecccccccCcceEEEEcCCCchhhcccccc
Confidence 2555555555533322 01 11233333333 333322222222 224577899999999999887654322211
Q ss_pred ------CCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEeccCCcccCc-CchhhcCC
Q psy3329 261 ------FTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLILSGNKLETL-ESGLFQNL 333 (694)
Q Consensus 261 ------~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l 333 (694)
++++..+.+.++...... .+..-.++|+.|.+..+.....+......+..+..+.+..+.+.+. .....+.+
T Consensus 740 ~~~~~~f~~l~~~~~~~~~~~r~l-~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l 818 (889)
T KOG4658|consen 740 LIVLLCFPNLSKVSILNCHMLRDL-TWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGL 818 (889)
T ss_pred cchhhhHHHHHHHHhhcccccccc-chhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCC
Confidence 234444444444332221 1223468999999998866655445556666677666776666665 23344555
Q ss_pred CCCCEEeCCCCCCcccCccccccCCCCCCCCeeeCCCC
Q psy3329 334 THLSVLELNNCGLTRLNETVFHENYTYPDLEELRLSGN 371 (694)
Q Consensus 334 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~n 371 (694)
+++..+.+..=.+..+..........+|.+.++.+.++
T Consensus 819 ~~i~~~~l~~~~l~~~~ve~~p~l~~~P~~~~~~i~~~ 856 (889)
T KOG4658|consen 819 PQLYWLPLSFLKLEELIVEECPKLGKLPLLSTLTIVGC 856 (889)
T ss_pred ceeEecccCccchhheehhcCcccccCccccccceecc
Confidence 55555555443333322222111225677777777775
No 41
>KOG0532|consensus
Probab=98.88 E-value=1.7e-10 Score=117.04 Aligned_cols=177 Identities=23% Similarity=0.255 Sum_probs=147.3
Q ss_pred CCCCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEE
Q psy3329 14 LDNPGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYL 93 (694)
Q Consensus 14 ~~~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L 93 (694)
.-|..|+.+.|..|.+..+|..+.++..|++|+|+.|+++.++ ..+..|+ |+.|-+++|+++.++++ ++.+.+|..|
T Consensus 95 ~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp-~~lC~lp-Lkvli~sNNkl~~lp~~-ig~~~tl~~l 171 (722)
T KOG0532|consen 95 CAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLP-DGLCDLP-LKVLIVSNNKLTSLPEE-IGLLPTLAHL 171 (722)
T ss_pred HHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCC-hhhhcCc-ceeEEEecCccccCCcc-cccchhHHHh
Confidence 3445788899999999999999999999999999999998874 4455554 99999999999998776 7889999999
Q ss_pred eCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCC
Q psy3329 94 MLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENE 173 (694)
Q Consensus 94 ~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~ 173 (694)
|.+.|.+..+ |..++.+.+|+.|.+..|++.. +|..+. .=.|..||++.|++..++. .|.++..|++|.|.+|.
T Consensus 172 d~s~nei~sl-psql~~l~slr~l~vrRn~l~~---lp~El~-~LpLi~lDfScNkis~iPv-~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 172 DVSKNEIQSL-PSQLGYLTSLRDLNVRRNHLED---LPEELC-SLPLIRLDFSCNKISYLPV-DFRKMRHLQVLQLENNP 245 (722)
T ss_pred hhhhhhhhhc-hHHhhhHHHHHHHHHhhhhhhh---CCHHHh-CCceeeeecccCceeecch-hhhhhhhheeeeeccCC
Confidence 9999999998 5668999999999999999874 556666 4468999999999999886 58999999999999999
Q ss_pred CCCcchhhhcccCCCcccEEeCCCCC
Q psy3329 174 LIDLDVATTLGQNLVHLDSLDLSNCH 199 (694)
Q Consensus 174 l~~~~~~~~~~~~~~~L~~L~l~~n~ 199 (694)
++.-+......+...-.++|+...|.
T Consensus 246 LqSPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 246 LQSPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred CCCChHHHHhccceeeeeeecchhcc
Confidence 98766554444344456777777663
No 42
>PLN03150 hypothetical protein; Provisional
Probab=98.72 E-value=3.9e-08 Score=108.79 Aligned_cols=107 Identities=24% Similarity=0.281 Sum_probs=73.3
Q ss_pred CcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCCCEEECCC
Q psy3329 42 LLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQ 121 (694)
Q Consensus 42 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~ 121 (694)
++.|+|++|.+.+..|..+..+++|+.|+|++|.+.+..|..++.+++|+.|+|++|.+.+..|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56677777777766677777777777777777777765565677777777777777777776677777777777777777
Q ss_pred CcCCccchhhhhhcCC-CCCCEEEccCCCC
Q psy3329 122 NKLKSHIDWTLVLGNL-GKLDTLDLRQSGI 150 (694)
Q Consensus 122 n~l~~~~~~~~~~~~l-~~L~~L~L~~n~i 150 (694)
|.+. +.+|..+... .++..+++.+|..
T Consensus 500 N~l~--g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 500 NSLS--GRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred Cccc--ccCChHHhhccccCceEEecCCcc
Confidence 7766 3445555442 3556667766643
No 43
>KOG2120|consensus
Probab=98.62 E-value=2.6e-09 Score=99.91 Aligned_cols=178 Identities=25% Similarity=0.268 Sum_probs=113.2
Q ss_pred CCCEEEccCCCCCCC-CccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCC-CCCCCChhhhhcCCCCc
Q psy3329 139 KLDTLDLRQSGISNL-PDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCH-LKGPLSEDAFVNATKLR 216 (694)
Q Consensus 139 ~L~~L~L~~n~i~~~-~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~-~~~~~~~~~~~~~~~L~ 216 (694)
.|++|||+...++.- ....+..|.+|+.|.+.++.+.+. +...+. .-.+|+.|+++.+. ++...-.-.+..|+.|.
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~-I~~~iA-kN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~ 263 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDP-IVNTIA-KNSNLVRLNLSMCSGFTENALQLLLSSCSRLD 263 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcH-HHHHHh-ccccceeeccccccccchhHHHHHHHhhhhHh
Confidence 467777776665521 123355667777777777766542 222222 45667777777764 22222223567788888
Q ss_pred EEEcCCCCCCccchhhhccC-CCCccEEEccCcC--CC--cCCcccccCCCCccEEeCCCCCC-cccchhhcCCCCCCcE
Q psy3329 217 TLYLSGNPLSAADLSVALKP-LTKLHRLSLRNCG--LS--RLPANTFHRFTCLQELDISHNPL-IDAFTALLSPLESLEH 290 (694)
Q Consensus 217 ~L~L~~n~l~~~~~~~~l~~-l~~L~~L~l~~n~--i~--~~~~~~~~~~~~L~~L~L~~n~~-~~~~~~~~~~l~~L~~ 290 (694)
.|+|++|.+........+.+ -++|+.|+++++. +. .+. .....+++|.+|||++|.. +......|..++.|++
T Consensus 264 ~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~-tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~ 342 (419)
T KOG2120|consen 264 ELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLS-TLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQH 342 (419)
T ss_pred hcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHH-HHHHhCCceeeeccccccccCchHHHHHHhcchhee
Confidence 99998887765554433332 3678888888872 22 221 2235789999999998754 3344455677889999
Q ss_pred EECcCCCCcccChhh---hcCCCCCcEEeccCCc
Q psy3329 291 LDMGYSNLQRISRST---FLKMTSLKTLILSGNK 321 (694)
Q Consensus 291 L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~n~ 321 (694)
|.++.|. .++|.. +...|.|.+|+..++-
T Consensus 343 lSlsRCY--~i~p~~~~~l~s~psl~yLdv~g~v 374 (419)
T KOG2120|consen 343 LSLSRCY--DIIPETLLELNSKPSLVYLDVFGCV 374 (419)
T ss_pred eehhhhc--CCChHHeeeeccCcceEEEEecccc
Confidence 9998886 445543 4567899999988763
No 44
>KOG2982|consensus
Probab=98.56 E-value=1.6e-08 Score=94.64 Aligned_cols=81 Identities=21% Similarity=0.428 Sum_probs=49.2
Q ss_pred CCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCC-cccccCCCCccEEeCCCCCCcccchh------hcCC
Q psy3329 212 ATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLP-ANTFHRFTCLQELDISHNPLIDAFTA------LLSP 284 (694)
Q Consensus 212 ~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~-~~~~~~~~~L~~L~L~~n~~~~~~~~------~~~~ 284 (694)
+|++..+.+..|++.+.........++.+..|+++.++|.+.. .+.+..+++|..|.++++.+.+.... .++.
T Consensus 198 Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaR 277 (418)
T KOG2982|consen 198 FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIAR 277 (418)
T ss_pred cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEee
Confidence 4666666666666655554444556667777777777766432 24466777777777777776653321 2345
Q ss_pred CCCCcEEE
Q psy3329 285 LESLEHLD 292 (694)
Q Consensus 285 l~~L~~L~ 292 (694)
+++++.|+
T Consensus 278 L~~v~vLN 285 (418)
T KOG2982|consen 278 LTKVQVLN 285 (418)
T ss_pred ccceEEec
Confidence 66666654
No 45
>KOG2120|consensus
Probab=98.55 E-value=3.5e-09 Score=99.01 Aligned_cols=185 Identities=19% Similarity=0.155 Sum_probs=119.9
Q ss_pred CCCCEEeCCCCcCCccC-hhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCC-CCCCCc-cccCCCCCC
Q psy3329 88 TSLEYLMLNRCNLTYIS-PSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSG-ISNLPD-NVFANNTWL 164 (694)
Q Consensus 88 ~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~-~~~~~~~~L 164 (694)
+.|++|||++..|+... -..+..|.+|+.|.+.++++.+ ++...+..-.+|+.|+++.+. ++.... -.+.+|+.|
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD--~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L 262 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDD--PIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRL 262 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCc--HHHHHHhccccceeeccccccccchhHHHHHHHhhhhH
Confidence 34778888877666422 2345677788888888888774 555667777788888887653 332221 235677888
Q ss_pred cEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCC-CCCC-hhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccE
Q psy3329 165 RNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLK-GPLS-EDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHR 242 (694)
Q Consensus 165 ~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~-~~~~-~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~ 242 (694)
..|+++.+.+....+......--++|+.|+++++.-. +.-. ......+++|..|||++|..-.......+..++.|++
T Consensus 263 ~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~ 342 (419)
T KOG2120|consen 263 DELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQH 342 (419)
T ss_pred hhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchhee
Confidence 8888888876654443333334567888888886420 1111 1123568999999999885433344455688899999
Q ss_pred EEccCcC-CCcCCcccccCCCCccEEeCCCCCC
Q psy3329 243 LSLRNCG-LSRLPANTFHRFTCLQELDISHNPL 274 (694)
Q Consensus 243 L~l~~n~-i~~~~~~~~~~~~~L~~L~L~~n~~ 274 (694)
|.++.|. |..-..-.+...|+|.+|++.++--
T Consensus 343 lSlsRCY~i~p~~~~~l~s~psl~yLdv~g~vs 375 (419)
T KOG2120|consen 343 LSLSRCYDIIPETLLELNSKPSLVYLDVFGCVS 375 (419)
T ss_pred eehhhhcCCChHHeeeeccCcceEEEEeccccC
Confidence 9999884 2211112356778999999988743
No 46
>KOG2982|consensus
Probab=98.46 E-value=7.9e-08 Score=90.13 Aligned_cols=86 Identities=26% Similarity=0.269 Sum_probs=49.8
Q ss_pred CCEEeCCCCcCCccCh-hhh-cCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEE
Q psy3329 90 LEYLMLNRCNLTYISP-SAF-DNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNL 167 (694)
Q Consensus 90 L~~L~L~~n~l~~~~~-~~l-~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L 167 (694)
++.|.+.++.|..... ..| ..++.++.++|.+|.+++-..+...+.++|.|+.|+++.|.+.......-....+|+.|
T Consensus 47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l 126 (418)
T KOG2982|consen 47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL 126 (418)
T ss_pred hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence 4455555555554322 122 34567777888888777655555667777888888887777664433211234455555
Q ss_pred eCCCCCCC
Q psy3329 168 NLAENELI 175 (694)
Q Consensus 168 ~l~~n~l~ 175 (694)
-|.+..+.
T Consensus 127 VLNgT~L~ 134 (418)
T KOG2982|consen 127 VLNGTGLS 134 (418)
T ss_pred EEcCCCCC
Confidence 55555443
No 47
>KOG1859|consensus
Probab=98.46 E-value=1.9e-09 Score=112.31 Aligned_cols=126 Identities=28% Similarity=0.295 Sum_probs=57.8
Q ss_pred CCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEc
Q psy3329 66 LNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDL 145 (694)
Q Consensus 66 L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L 145 (694)
|.+.+.+.|.+..+.. ++.-++.|+.|+|++|+++.. ..+..|++|++|||++|.+..+..+.. ..+. |..|.+
T Consensus 166 L~~a~fsyN~L~~mD~-SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~--~gc~-L~~L~l 239 (1096)
T KOG1859|consen 166 LATASFSYNRLVLMDE-SLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSM--VGCK-LQLLNL 239 (1096)
T ss_pred HhhhhcchhhHHhHHH-HHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccch--hhhh-heeeee
Confidence 4444444444443322 244445555555555555554 244555555555555555543332211 1122 555555
Q ss_pred cCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCC
Q psy3329 146 RQSGISNLPDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHL 200 (694)
Q Consensus 146 ~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~ 200 (694)
++|.++.+-. +.++.+|+.|++++|-+.+..-..++. .+..|+.|+|.+|.+
T Consensus 240 rnN~l~tL~g--ie~LksL~~LDlsyNll~~hseL~pLw-sLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 240 RNNALTTLRG--IENLKSLYGLDLSYNLLSEHSELEPLW-SLSSLIVLWLEGNPL 291 (1096)
T ss_pred cccHHHhhhh--HHhhhhhhccchhHhhhhcchhhhHHH-HHHHHHHHhhcCCcc
Confidence 5555544432 344555555555555444433333322 344455555555544
No 48
>KOG4341|consensus
Probab=98.41 E-value=4e-08 Score=96.53 Aligned_cols=61 Identities=20% Similarity=0.230 Sum_probs=25.1
Q ss_pred CCCCcEEEcCCC-CCCccchhhhccCCCCccEEEccCc-CCCcCCcccc-cCCCCccEEeCCCC
Q psy3329 212 ATKLRTLYLSGN-PLSAADLSVALKPLTKLHRLSLRNC-GLSRLPANTF-HRFTCLQELDISHN 272 (694)
Q Consensus 212 ~~~L~~L~L~~n-~l~~~~~~~~l~~l~~L~~L~l~~n-~i~~~~~~~~-~~~~~L~~L~L~~n 272 (694)
+..|+.|..+++ .+++........++++|+.|.+..| ++++.....+ .+++.|+.+++..+
T Consensus 293 c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~ 356 (483)
T KOG4341|consen 293 CHALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEEC 356 (483)
T ss_pred hhHhhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhccccc
Confidence 444555555443 2223222222344455555555555 2332221111 23344555555444
No 49
>KOG4341|consensus
Probab=98.38 E-value=2.9e-08 Score=97.53 Aligned_cols=230 Identities=23% Similarity=0.194 Sum_probs=138.0
Q ss_pred CCcEEEccCCcCCccC--hhhccCCCCCCeEECCCCCCCccCCCCC----CCCCCCCEEeCCCC-cCCccChh-hhcCCC
Q psy3329 41 SLLYLYMQECTLSKIN--PQFFTNLTTLNKLDLSGNPLRIIEPGVF----DPLTSLEYLMLNRC-NLTYISPS-AFDNLN 112 (694)
Q Consensus 41 ~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~Ls~n~~~~~~~~~~----~~l~~L~~L~L~~n-~l~~~~~~-~l~~l~ 112 (694)
.|+.|.++++.-.+.. ...-..++++++|++.++. .+....+ ..|++|++|++..| .++...-+ .-..++
T Consensus 139 ~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~--~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~ 216 (483)
T KOG4341|consen 139 FLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCK--KITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCR 216 (483)
T ss_pred ccccccccccccCCcchhhHHhhhCCchhhhhhhcce--eccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhh
Confidence 5777888777433322 1223577888888887765 2222212 34678888888875 45554333 234578
Q ss_pred CCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCcccc----CCCCCCcEEeCCCCCCCCcchhhhcccCCC
Q psy3329 113 HLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVF----ANNTWLRNLNLAENELIDLDVATTLGQNLV 188 (694)
Q Consensus 113 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~----~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~ 188 (694)
+|++|+++.+....-..+.....++..++.+.+.+|. +.....+ ..+..+.++++..+...+......+...+.
T Consensus 217 kL~~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~--e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~ 294 (483)
T KOG4341|consen 217 KLKYLNLSWCPQISGNGVQALQRGCKELEKLSLKGCL--ELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCH 294 (483)
T ss_pred hHHHhhhccCchhhcCcchHHhccchhhhhhhhcccc--cccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhh
Confidence 8888888887543223344456667777777666543 2222221 344556666655554332222233334678
Q ss_pred cccEEeCCCCCCCCCCChhh-hhcCCCCcEEEcCCCC-CCccchhhhccCCCCccEEEccCcCCCcC--CcccccCCCCc
Q psy3329 189 HLDSLDLSNCHLKGPLSEDA-FVNATKLRTLYLSGNP-LSAADLSVALKPLTKLHRLSLRNCGLSRL--PANTFHRFTCL 264 (694)
Q Consensus 189 ~L~~L~l~~n~~~~~~~~~~-~~~~~~L~~L~L~~n~-l~~~~~~~~l~~l~~L~~L~l~~n~i~~~--~~~~~~~~~~L 264 (694)
.|+.++.+++...+..+... -..+++|+.|-++.++ +++......-.+++.|+.+++..+..... ....-.+++.|
T Consensus 295 ~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~l 374 (483)
T KOG4341|consen 295 ALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRL 374 (483)
T ss_pred HhhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchh
Confidence 89999998886533332222 2457899999999885 66666555457789999999998854321 11223467888
Q ss_pred cEEeCCCCCC
Q psy3329 265 QELDISHNPL 274 (694)
Q Consensus 265 ~~L~L~~n~~ 274 (694)
+.+.+++|..
T Consensus 375 r~lslshce~ 384 (483)
T KOG4341|consen 375 RVLSLSHCEL 384 (483)
T ss_pred ccCChhhhhh
Confidence 8888887754
No 50
>KOG1859|consensus
Probab=98.33 E-value=1.2e-08 Score=106.48 Aligned_cols=132 Identities=27% Similarity=0.282 Sum_probs=108.1
Q ss_pred CCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCC
Q psy3329 17 PGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLN 96 (694)
Q Consensus 17 ~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~ 96 (694)
..|.+.++++|.+..+..++.-++.++.|+|++|++.... .+..|++|++|||++|.+..++.-.-.++. |+.|.++
T Consensus 164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3688889999999999888999999999999999988874 788999999999999999887764444555 9999999
Q ss_pred CCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCC
Q psy3329 97 RCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLP 154 (694)
Q Consensus 97 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 154 (694)
+|.++.+ ..+.++.+|+.||+++|-+.....+ ..++.+..|+.|.|.+|.+-.-+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL-~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSEL-EPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhh-hHHHHHHHHHHHhhcCCccccCH
Confidence 9988877 5578899999999999988765443 23566788889999998876444
No 51
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.26 E-value=2e-06 Score=74.86 Aligned_cols=122 Identities=28% Similarity=0.432 Sum_probs=39.0
Q ss_pred hhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCC
Q psy3329 35 AFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHL 114 (694)
Q Consensus 35 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 114 (694)
+|..+++|+.+.+.. .+..+...+|..+++|+.+.+.++ +..+....|.++++|+.+.+.+ .+..+....|..+++|
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l 83 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNL 83 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTE
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccc
Confidence 334444444444432 334444444444444444444442 4444444444444444444433 3333333444444444
Q ss_pred CEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCC
Q psy3329 115 KTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWL 164 (694)
Q Consensus 115 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L 164 (694)
+.+.+..+ +..++. ..+.++ +|+.+.+.. .+..+....|.++++|
T Consensus 84 ~~i~~~~~-~~~i~~--~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 84 KNIDIPSN-ITEIGS--SSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp CEEEETTT--BEEHT--TTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred cccccCcc-ccEEch--hhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 44444332 222222 223343 444444443 3344444445444443
No 52
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=98.24 E-value=7.9e-07 Score=82.49 Aligned_cols=87 Identities=22% Similarity=0.221 Sum_probs=46.3
Q ss_pred CCCceEEECcCCCCcc-----hhhhhhcCCCCcEEEccCCcCCcc----------ChhhccCCCCCCeEECCCCCCCccC
Q psy3329 16 NPGLITINLNANPIQP-----VEGAFLVARSLLYLYMQECTLSKI----------NPQFFTNLTTLNKLDLSGNPLRIIE 80 (694)
Q Consensus 16 ~~~L~~L~Ls~~~l~~-----i~~~~~~~~~L~~L~l~~n~l~~~----------~~~~~~~l~~L~~L~Ls~n~~~~~~ 80 (694)
+..+..++||+|.|.. +...+.+-.+|+..++++--.... ...++.+|++|+..+||+|.+..-.
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 4566777777777763 224444556666666654211110 1123456666666666666665322
Q ss_pred CC----CCCCCCCCCEEeCCCCcCCc
Q psy3329 81 PG----VFDPLTSLEYLMLNRCNLTY 102 (694)
Q Consensus 81 ~~----~~~~l~~L~~L~L~~n~l~~ 102 (694)
+. .+++-+.|.+|.+++|.+..
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlGp 134 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLGP 134 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCCc
Confidence 21 23445566666666665543
No 53
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=98.21 E-value=2.5e-06 Score=79.30 Aligned_cols=90 Identities=17% Similarity=0.210 Sum_probs=48.7
Q ss_pred cCCCCcEEEcCCCCCCccchh---hhccCCCCccEEEccCcCCCcC--Cc---ccccCCCCccEEeCCCCCCccc----c
Q psy3329 211 NATKLRTLYLSGNPLSAADLS---VALKPLTKLHRLSLRNCGLSRL--PA---NTFHRFTCLQELDISHNPLIDA----F 278 (694)
Q Consensus 211 ~~~~L~~L~L~~n~l~~~~~~---~~l~~l~~L~~L~l~~n~i~~~--~~---~~~~~~~~L~~L~L~~n~~~~~----~ 278 (694)
.-|.|+.+....|++...... ..+.....|+++.+..|.|..- .. .-+..+.+|+.|+|.+|-++.. .
T Consensus 155 ~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~L 234 (388)
T COG5238 155 DKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYL 234 (388)
T ss_pred cCCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHH
Confidence 456777777777766544322 1233345677777777766532 11 1123456666667666665532 2
Q ss_pred hhhcCCCCCCcEEECcCCCCcc
Q psy3329 279 TALLSPLESLEHLDMGYSNLQR 300 (694)
Q Consensus 279 ~~~~~~l~~L~~L~L~~n~l~~ 300 (694)
..++...+.|+.|.+..|.++.
T Consensus 235 a~al~~W~~lrEL~lnDClls~ 256 (388)
T COG5238 235 ADALCEWNLLRELRLNDCLLSN 256 (388)
T ss_pred HHHhcccchhhhccccchhhcc
Confidence 2334444555666666555543
No 54
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.18 E-value=4.5e-06 Score=72.62 Aligned_cols=126 Identities=21% Similarity=0.317 Sum_probs=80.9
Q ss_pred ccCcccCCCCCceEEECcCCCCcchh-hhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCC
Q psy3329 8 YNDRRNLDNPGLITINLNANPIQPVE-GAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDP 86 (694)
Q Consensus 8 ~~~~~~~~~~~L~~L~Ls~~~l~~i~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~ 86 (694)
.+..+|.++.+|+.+.+.. .+..++ ..|..+++|+.+.+.++ +..+...+|.+++.|+.+.+.+ .+..+....|..
T Consensus 3 i~~~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~ 79 (129)
T PF13306_consen 3 IGNNAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSN 79 (129)
T ss_dssp E-TTTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT
T ss_pred ECHHHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccc
Confidence 4567899999999999985 688888 88999999999999884 8888888999999999999976 777788888999
Q ss_pred CCCCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCC
Q psy3329 87 LTSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLD 141 (694)
Q Consensus 87 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~ 141 (694)
+++|+.+++..+ +..+....|.++ +|+.+.+.. .+..+.. ..|.++++|+
T Consensus 80 ~~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~--~~F~~~~~l~ 129 (129)
T PF13306_consen 80 CTNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEE--NAFKNCTKLK 129 (129)
T ss_dssp -TTECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS------GGG------
T ss_pred cccccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECC--ccccccccCC
Confidence 999999999875 777777888888 999999876 4444433 4577776664
No 55
>KOG1644|consensus
Probab=98.11 E-value=5.8e-06 Score=73.65 Aligned_cols=107 Identities=27% Similarity=0.332 Sum_probs=63.8
Q ss_pred CcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccChhhhcCCCCCCEEECCC
Q psy3329 42 LLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQ 121 (694)
Q Consensus 42 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~ 121 (694)
=+.+++++.++..+.. .=.-..+...+||++|++..+.. |.+++.|.+|.|++|.|+.+.|.--.-+++|+.|.+.+
T Consensus 21 e~e~~LR~lkip~ien-lg~~~d~~d~iDLtdNdl~~l~~--lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 21 ERELDLRGLKIPVIEN-LGATLDQFDAIDLTDNDLRKLDN--LPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred ccccccccccccchhh-ccccccccceecccccchhhccc--CCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 3455555555444321 00123455667777777766543 66777777777777777777665555566777777777
Q ss_pred CcCCccchhhhhhcCCCCCCEEEccCCCCCC
Q psy3329 122 NKLKSHIDWTLVLGNLGKLDTLDLRQSGISN 152 (694)
Q Consensus 122 n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~ 152 (694)
|.+..++.+. .+..||+|++|.+-+|.++.
T Consensus 98 Nsi~~l~dl~-pLa~~p~L~~Ltll~Npv~~ 127 (233)
T KOG1644|consen 98 NSIQELGDLD-PLASCPKLEYLTLLGNPVEH 127 (233)
T ss_pred cchhhhhhcc-hhccCCccceeeecCCchhc
Confidence 7766554432 24455666666666665553
No 56
>KOG1644|consensus
Probab=98.07 E-value=7e-06 Score=73.15 Aligned_cols=105 Identities=27% Similarity=0.368 Sum_probs=63.8
Q ss_pred CCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCCCcchhhhhhcccCCCc
Q psy3329 418 DLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSMTSELSFQFLDVLLELE 497 (694)
Q Consensus 418 ~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~ 497 (694)
....+||++|.+..+. .| ..++.|.+|.|++|+|+.+.|..-.-+++|+.|.|.+|+|.... .+..+..++.|+
T Consensus 43 ~~d~iDLtdNdl~~l~--~l--p~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~--dl~pLa~~p~L~ 116 (233)
T KOG1644|consen 43 QFDAIDLTDNDLRKLD--NL--PHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELG--DLDPLASCPKLE 116 (233)
T ss_pred ccceecccccchhhcc--cC--CCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhh--hcchhccCCccc
Confidence 3444555555554332 22 45666777777777777776665555666777777777665432 123336677777
Q ss_pred EEECCCCcccccCh---hhhcCCCcccEEEccCC
Q psy3329 498 SLDLSNNNLTHISP---TVLRHNRAITSIKLVGN 528 (694)
Q Consensus 498 ~L~ls~N~l~~~~~---~~~~~~~~l~~l~l~~N 528 (694)
.|.+-+|..+...- ..+..+++++.+|+.+-
T Consensus 117 ~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 117 YLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred eeeecCCchhcccCceeEEEEecCcceEeehhhh
Confidence 77777777665322 24556788888887654
No 57
>KOG4579|consensus
Probab=98.01 E-value=5.4e-07 Score=74.74 Aligned_cols=106 Identities=17% Similarity=0.220 Sum_probs=51.8
Q ss_pred CCceEEECcCCCCcchhh---hhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEE
Q psy3329 17 PGLITINLNANPIQPVEG---AFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYL 93 (694)
Q Consensus 17 ~~L~~L~Ls~~~l~~i~~---~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L 93 (694)
..+..++|+++++..+++ .+.....|+..+|++|.+...++..-..++.++.|++++|.++.++.+ +..++.|+.|
T Consensus 27 kE~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~l 105 (177)
T KOG4579|consen 27 KELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSL 105 (177)
T ss_pred HHhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhc
Confidence 344555666666655553 233334444455555555555444334444555555555555555433 4555555555
Q ss_pred eCCCCcCCccChhhhcCCCCCCEEECCCCcC
Q psy3329 94 MLNRCNLTYISPSAFDNLNHLKTLELSQNKL 124 (694)
Q Consensus 94 ~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 124 (694)
+++.|.+... |..+..+.+|-.|+..+|.+
T Consensus 106 Nl~~N~l~~~-p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 106 NLRFNPLNAE-PRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred ccccCccccc-hHHHHHHHhHHHhcCCCCcc
Confidence 5555544444 33333344444444444433
No 58
>KOG1187|consensus
Probab=97.94 E-value=8.2e-07 Score=91.13 Aligned_cols=48 Identities=19% Similarity=0.234 Sum_probs=41.1
Q ss_pred ccCCCccccccccCcc----cceeecccceeeehhhhhhhhHHHHHHHhhHh
Q psy3329 625 TRAAPSYINMEKLNSK----SFLTLGNFGLISVGVIILSAMVYFSFYARHLY 672 (694)
Q Consensus 625 ~~~~~s~~~l~~~~~~----~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~ 672 (694)
....|+|.++++|+++ ++||+||||.||+|++.||++||||.......
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~ 112 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSG 112 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCC
Confidence 4567899999999544 89999999999999999999999996666553
No 59
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.92 E-value=8.7e-06 Score=54.68 Aligned_cols=37 Identities=46% Similarity=0.678 Sum_probs=17.8
Q ss_pred CccEEEccCCcCCccCCCCCCCCCCCCEEEccCCccCC
Q psy3329 444 RLRSLDLSRCKIDYLPPNVFNNTRNITSLNLANNNLSM 481 (694)
Q Consensus 444 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 481 (694)
+|++|++++|+|+.+++. +.++++|+.|++++|+|+.
T Consensus 2 ~L~~L~l~~N~i~~l~~~-l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPE-LSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp T-SEEEETSSS-SSHGGH-GTTCTTSSEEEETSSCCSB
T ss_pred cceEEEccCCCCcccCch-HhCCCCCCEEEecCCCCCC
Confidence 455555555555554432 4455555555555555543
No 60
>KOG4579|consensus
Probab=97.90 E-value=1.2e-06 Score=72.78 Aligned_cols=113 Identities=18% Similarity=0.265 Sum_probs=69.5
Q ss_pred ccEEEccCcCCCcCCc--ccccCCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCCCCcccChhhhcCCCCCcEEec
Q psy3329 240 LHRLSLRNCGLSRLPA--NTFHRFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYSNLQRISRSTFLKMTSLKTLIL 317 (694)
Q Consensus 240 L~~L~l~~n~i~~~~~--~~~~~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 317 (694)
+..++|++|.+-.++. ..+.....|+..+|++|.+....+..-...+.++.|+|.+|+|+.++.. +..++.|+.|++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl 107 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNL 107 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhccc
Confidence 3444555554443321 1122334556666666666655555445556677777777777777654 777777777777
Q ss_pred cCCcccCcCchhhcCCCCCCEEeCCCCCCcccCcccc
Q psy3329 318 SGNKLETLESGLFQNLTHLSVLELNNCGLTRLNETVF 354 (694)
Q Consensus 318 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 354 (694)
..|.+...+...+. +.+|-.|+..+|.+..++...|
T Consensus 108 ~~N~l~~~p~vi~~-L~~l~~Lds~~na~~eid~dl~ 143 (177)
T KOG4579|consen 108 RFNPLNAEPRVIAP-LIKLDMLDSPENARAEIDVDLF 143 (177)
T ss_pred ccCccccchHHHHH-HHhHHHhcCCCCccccCcHHHh
Confidence 77777666554444 7777777777777777766644
No 61
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.88 E-value=1.8e-05 Score=53.17 Aligned_cols=38 Identities=21% Similarity=0.246 Sum_probs=19.6
Q ss_pred CceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCcc
Q psy3329 18 GLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKI 55 (694)
Q Consensus 18 ~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~ 55 (694)
+|++|++++|+|+++|..+.++++|+.|++++|.++.+
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCCCC
Confidence 45555555555555554455555555555555555443
No 62
>KOG3665|consensus
Probab=97.87 E-value=1.3e-05 Score=88.57 Aligned_cols=155 Identities=23% Similarity=0.243 Sum_probs=95.3
Q ss_pred CCCCEEeCCCCcCC-ccChhhh-cCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCc
Q psy3329 88 TSLEYLMLNRCNLT-YISPSAF-DNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLR 165 (694)
Q Consensus 88 ~~L~~L~L~~n~l~-~~~~~~l-~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~ 165 (694)
.+|++|++++...- .-.+..+ ..+|+|+.|.+++-.+.. ..+.....++|+|..||+++++++.+ ..++++++|+
T Consensus 122 ~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~-~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq 198 (699)
T KOG3665|consen 122 QNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDN-DDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQ 198 (699)
T ss_pred HhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecc-hhHHHHhhccCccceeecCCCCccCc--HHHhccccHH
Confidence 56788888775332 1223333 347888888888776654 33455677788888888888888877 3467788888
Q ss_pred EEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCC--Ch---hhhhcCCCCcEEEcCCCCCCccchhhhccCCCCc
Q psy3329 166 NLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPL--SE---DAFVNATKLRTLYLSGNPLSAADLSVALKPLTKL 240 (694)
Q Consensus 166 ~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~---~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L 240 (694)
.|.+.+-.+........+. ++++|+.||+|........ .. +.-..+|+|+.||.+++.+........+...++|
T Consensus 199 ~L~mrnLe~e~~~~l~~LF-~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~le~ll~sH~~L 277 (699)
T KOG3665|consen 199 VLSMRNLEFESYQDLIDLF-NLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEILEELLNSHPNL 277 (699)
T ss_pred HHhccCCCCCchhhHHHHh-cccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHHHHHHHHhCccH
Confidence 8888777766543333333 6777777777765542111 00 1112366777777776666655555455555555
Q ss_pred cEEEcc
Q psy3329 241 HRLSLR 246 (694)
Q Consensus 241 ~~L~l~ 246 (694)
+.+.+-
T Consensus 278 ~~i~~~ 283 (699)
T KOG3665|consen 278 QQIAAL 283 (699)
T ss_pred hhhhhh
Confidence 555443
No 63
>KOG3665|consensus
Probab=97.69 E-value=3.2e-05 Score=85.57 Aligned_cols=108 Identities=25% Similarity=0.322 Sum_probs=50.9
Q ss_pred CCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccE
Q psy3329 163 WLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHR 242 (694)
Q Consensus 163 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~ 242 (694)
+|++|++++.....-......+..+|+|++|.+++-.+...--.....++|+|..||+++.+++... +++.+++|++
T Consensus 123 nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl~---GIS~LknLq~ 199 (699)
T KOG3665|consen 123 NLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNLS---GISRLKNLQV 199 (699)
T ss_pred hhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCcH---HHhccccHHH
Confidence 3444444444333223333334455666666665544422111123345566666666665555442 3455566666
Q ss_pred EEccCcCCCcC-CcccccCCCCccEEeCCCCC
Q psy3329 243 LSLRNCGLSRL-PANTFHRFTCLQELDISHNP 273 (694)
Q Consensus 243 L~l~~n~i~~~-~~~~~~~~~~L~~L~L~~n~ 273 (694)
|.+.+-.+..- .-..+..+++|+.||+|...
T Consensus 200 L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~ 231 (699)
T KOG3665|consen 200 LSMRNLEFESYQDLIDLFNLKKLRVLDISRDK 231 (699)
T ss_pred HhccCCCCCchhhHHHHhcccCCCeeeccccc
Confidence 65555444421 11123445566666665543
No 64
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.58 E-value=0.00036 Score=71.09 Aligned_cols=138 Identities=20% Similarity=0.223 Sum_probs=66.5
Q ss_pred hcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCC-cCCccChhhhcCCCCCC
Q psy3329 37 LVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRC-NLTYISPSAFDNLNHLK 115 (694)
Q Consensus 37 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~ 115 (694)
..+.+++.|++++|.++.++ . --.+|++|.++++.--...|+.+ .++|++|++++| .+..+ | .+|+
T Consensus 49 ~~~~~l~~L~Is~c~L~sLP-~---LP~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~sL-P------~sLe 115 (426)
T PRK15386 49 EEARASGRLYIKDCDIESLP-V---LPNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEISGL-P------ESVR 115 (426)
T ss_pred HHhcCCCEEEeCCCCCcccC-C---CCCCCcEEEccCCCCcccCCchh--hhhhhheEccCccccccc-c------cccc
Confidence 34566667777666665552 1 12346666666533222223223 246777777766 44333 2 2466
Q ss_pred EEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeC
Q psy3329 116 TLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDL 195 (694)
Q Consensus 116 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l 195 (694)
.|++..+....+..+| ++|+.|.+.+++........-.-.++|++|++.+|.....+. . -..+|+.|.+
T Consensus 116 ~L~L~~n~~~~L~~LP------ssLk~L~I~~~n~~~~~~lp~~LPsSLk~L~Is~c~~i~LP~--~---LP~SLk~L~l 184 (426)
T PRK15386 116 SLEIKGSATDSIKNVP------NGLTSLSINSYNPENQARIDNLISPSLKTLSLTGCSNIILPE--K---LPESLQSITL 184 (426)
T ss_pred eEEeCCCCCcccccCc------chHhheeccccccccccccccccCCcccEEEecCCCcccCcc--c---ccccCcEEEe
Confidence 6666655554433433 235555554322110000000011457777777665432211 0 2346777777
Q ss_pred CCC
Q psy3329 196 SNC 198 (694)
Q Consensus 196 ~~n 198 (694)
+.+
T Consensus 185 s~n 187 (426)
T PRK15386 185 HIE 187 (426)
T ss_pred ccc
Confidence 665
No 65
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=97.57 E-value=6.6e-05 Score=91.35 Aligned_cols=67 Identities=25% Similarity=0.467 Sum_probs=54.7
Q ss_pred ECCCCcccccChhhhcCCCcccEEEccCCccccccCcHHHHHHHHhccCC---CceeecCCCCccccccc
Q psy3329 500 DLSNNNLTHISPTVLRHNRAITSIKLVGNPWKCDCNIADMWEWATREKGD---IGVLVGSTTPTEIGFGA 566 (694)
Q Consensus 500 ~ls~N~l~~~~~~~~~~~~~l~~l~l~~N~~~c~c~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 566 (694)
||++|+|+.+.+..|..+++|+.|+|++|||.|||.+.||..|++..... .....|..|....+..+
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~CDC~L~WL~~WL~~~~v~v~~~~~i~CasP~~LrG~~L 70 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFECDCGLARLPRWAEEKGVKVRQPEAALCAGPGALAGQPL 70 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccccccccHHHHHHHHhcCccccCCcccCCCCChHHCCCCc
Confidence 68899999999999999999999999999999999999999999875322 22345777776666555
No 66
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.57 E-value=0.00058 Score=69.64 Aligned_cols=54 Identities=13% Similarity=0.135 Sum_probs=27.2
Q ss_pred CCCCccEEeCCCCCCcccchhhcCCCCCCcEEECcCC-CCcccChhhhcCCCCCcEEeccCC
Q psy3329 260 RFTCLQELDISHNPLIDAFTALLSPLESLEHLDMGYS-NLQRISRSTFLKMTSLKTLILSGN 320 (694)
Q Consensus 260 ~~~~L~~L~L~~n~~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n 320 (694)
.+.+++.|++++|.+... |. -..+|++|.++++ .++.++ ..+ .++|+.|++++|
T Consensus 50 ~~~~l~~L~Is~c~L~sL-P~---LP~sLtsL~Lsnc~nLtsLP-~~L--P~nLe~L~Ls~C 104 (426)
T PRK15386 50 EARASGRLYIKDCDIESL-PV---LPNELTEITIENCNNLTTLP-GSI--PEGLEKLTVCHC 104 (426)
T ss_pred HhcCCCEEEeCCCCCccc-CC---CCCCCcEEEccCCCCcccCC-chh--hhhhhheEccCc
Confidence 356667777777655443 21 1235666666653 332222 222 245666666655
No 67
>KOG1947|consensus
Probab=97.35 E-value=8.4e-05 Score=81.08 Aligned_cols=64 Identities=31% Similarity=0.399 Sum_probs=34.5
Q ss_pred CCCcccEEeCCCCCCCCCCChhhhh-cCCCCcEEEcCCCC-CCccchhhhccCCCCccEEEccCcC
Q psy3329 186 NLVHLDSLDLSNCHLKGPLSEDAFV-NATKLRTLYLSGNP-LSAADLSVALKPLTKLHRLSLRNCG 249 (694)
Q Consensus 186 ~~~~L~~L~l~~n~~~~~~~~~~~~-~~~~L~~L~L~~n~-l~~~~~~~~l~~l~~L~~L~l~~n~ 249 (694)
.+.+|+.++++.+..........+. .+++|+.|.+.++. +++.........++.|++|+++.|.
T Consensus 241 ~~~~L~~l~l~~~~~isd~~l~~l~~~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~ 306 (482)
T KOG1947|consen 241 ICRKLKSLDLSGCGLVTDIGLSALASRCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCH 306 (482)
T ss_pred hcCCcCccchhhhhccCchhHHHHHhhCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCc
Confidence 4556666666665521222222222 25666666666665 5555555555566666666666663
No 68
>KOG2123|consensus
Probab=97.27 E-value=1.5e-05 Score=74.53 Aligned_cols=82 Identities=26% Similarity=0.339 Sum_probs=54.9
Q ss_pred CCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCccCh-hhhcCCCCCCEE
Q psy3329 39 ARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYISP-SAFDNLNHLKTL 117 (694)
Q Consensus 39 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L 117 (694)
+.+.+.|++.+|++..| ....+++.|++|.|+-|+|+.+.+ |..|++|++|+|..|.|.++.- ..+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 45667777777777766 235677777777777777777655 6677777777777777666521 234566677777
Q ss_pred ECCCCcC
Q psy3329 118 ELSQNKL 124 (694)
Q Consensus 118 ~l~~n~l 124 (694)
.|..|.-
T Consensus 94 WL~ENPC 100 (388)
T KOG2123|consen 94 WLDENPC 100 (388)
T ss_pred hhccCCc
Confidence 7766643
No 69
>KOG2739|consensus
Probab=97.20 E-value=0.00015 Score=67.79 Aligned_cols=103 Identities=24% Similarity=0.400 Sum_probs=57.7
Q ss_pred CCCCccEEEccCcCCCcCCcccccCCCCccEEeCCCC--CCcccchhhcCCCCCCcEEECcCCCCcccCh-hhhcCCCCC
Q psy3329 236 PLTKLHRLSLRNCGLSRLPANTFHRFTCLQELDISHN--PLIDAFTALLSPLESLEHLDMGYSNLQRISR-STFLKMTSL 312 (694)
Q Consensus 236 ~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~L~~n--~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L 312 (694)
.+..|+.+++.+..++.+. .|..+++|+.|.++.| .+.+.++.....+|+|+++++++|+|..+.. ..+..+.+|
T Consensus 41 ~~~~le~ls~~n~gltt~~--~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL 118 (260)
T KOG2739|consen 41 EFVELELLSVINVGLTTLT--NFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENL 118 (260)
T ss_pred cccchhhhhhhccceeecc--cCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcch
Confidence 3455666666666666553 3556778888888888 4444444444455777777777777653221 123345556
Q ss_pred cEEeccCCcccCcCc---hhhcCCCCCCEEe
Q psy3329 313 KTLILSGNKLETLES---GLFQNLTHLSVLE 340 (694)
Q Consensus 313 ~~L~L~~n~l~~~~~---~~l~~l~~L~~L~ 340 (694)
..|++.+|..+.... ..|.-+++|++|+
T Consensus 119 ~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD 149 (260)
T KOG2739|consen 119 KSLDLFNCSVTNLDDYREKVFLLLPSLKYLD 149 (260)
T ss_pred hhhhcccCCccccccHHHHHHHHhhhhcccc
Confidence 666666665443221 2333444554444
No 70
>KOG2739|consensus
Probab=97.17 E-value=0.00022 Score=66.75 Aligned_cols=88 Identities=26% Similarity=0.287 Sum_probs=42.1
Q ss_pred CCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCC--cCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCC
Q psy3329 62 NLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRC--NLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGK 139 (694)
Q Consensus 62 ~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n--~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~ 139 (694)
.+..|+.|++.+..++.+.. |..+++|++|.++.| .+.+-.+....++++|++|++++|++..+..+ ..+..+.+
T Consensus 41 ~~~~le~ls~~n~gltt~~~--~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl-~pl~~l~n 117 (260)
T KOG2739|consen 41 EFVELELLSVINVGLTTLTN--FPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTL-RPLKELEN 117 (260)
T ss_pred cccchhhhhhhccceeeccc--CCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCcccccccc-chhhhhcc
Confidence 34444555554444443322 444556666666666 33332222233446666666666655543222 12344455
Q ss_pred CCEEEccCCCCCC
Q psy3329 140 LDTLDLRQSGISN 152 (694)
Q Consensus 140 L~~L~L~~n~i~~ 152 (694)
|..|++.+|..+.
T Consensus 118 L~~Ldl~n~~~~~ 130 (260)
T KOG2739|consen 118 LKSLDLFNCSVTN 130 (260)
T ss_pred hhhhhcccCCccc
Confidence 5555555555444
No 71
>KOG2123|consensus
Probab=97.16 E-value=2.9e-05 Score=72.59 Aligned_cols=101 Identities=26% Similarity=0.269 Sum_probs=58.1
Q ss_pred CCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcc
Q psy3329 111 LNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHL 190 (694)
Q Consensus 111 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L 190 (694)
+.+.+.|++.++.+.++. ....++.|+.|.|+-|.|+.+.+ +..|++|++|+|..|.|.+++-...+. ++++|
T Consensus 18 l~~vkKLNcwg~~L~DIs----ic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLk-nlpsL 90 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDIS----ICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLK-NLPSL 90 (388)
T ss_pred HHHhhhhcccCCCccHHH----HHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHh-cCchh
Confidence 335556666666666432 34456677777777777766654 667777777777777776655444433 56666
Q ss_pred cEEeCCCCCCCCCCCh----hhhhcCCCCcEE
Q psy3329 191 DSLDLSNCHLKGPLSE----DAFVNATKLRTL 218 (694)
Q Consensus 191 ~~L~l~~n~~~~~~~~----~~~~~~~~L~~L 218 (694)
+.|.|..|.-.+..+. ..+.-+|+|++|
T Consensus 91 r~LWL~ENPCc~~ag~nYR~~VLR~LPnLkKL 122 (388)
T KOG2123|consen 91 RTLWLDENPCCGEAGQNYRRKVLRVLPNLKKL 122 (388)
T ss_pred hhHhhccCCcccccchhHHHHHHHHcccchhc
Confidence 6666655543333322 123345555554
No 72
>KOG1947|consensus
Probab=97.03 E-value=0.00021 Score=78.00 Aligned_cols=237 Identities=25% Similarity=0.235 Sum_probs=111.5
Q ss_pred cCCCCcEEEccCCc-CCccC-hhhccCCCCCCeEECCCC-CC-CccC---CCCCCCCCCCCEEeCCCCc-CCccChhhhc
Q psy3329 38 VARSLLYLYMQECT-LSKIN-PQFFTNLTTLNKLDLSGN-PL-RIIE---PGVFDPLTSLEYLMLNRCN-LTYISPSAFD 109 (694)
Q Consensus 38 ~~~~L~~L~l~~n~-l~~~~-~~~~~~l~~L~~L~Ls~n-~~-~~~~---~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~ 109 (694)
.++.|+.|.+..+. +.... ......+++|+.|+++++ .. .... ......+.+|+.|+++.+. +++..-..+.
T Consensus 186 ~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~ 265 (482)
T KOG1947|consen 186 SCPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALA 265 (482)
T ss_pred hCchhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHH
Confidence 35667776666652 22211 123456677777777652 11 1110 1123345667777777665 5544334443
Q ss_pred C-CCCCCEEECCCCc-CCccchhhhhhcCCCCCCEEEccCCCCCCC--CccccCCCCCCcEEeCCCCCCCCcchhhhccc
Q psy3329 110 N-LNHLKTLELSQNK-LKSHIDWTLVLGNLGKLDTLDLRQSGISNL--PDNVFANNTWLRNLNLAENELIDLDVATTLGQ 185 (694)
Q Consensus 110 ~-l~~L~~L~l~~n~-l~~~~~~~~~~~~l~~L~~L~L~~n~i~~~--~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 185 (694)
. +++|+.|.+.++. +++ ..+......++.|++|+++++....- ......++++++.|.+....
T Consensus 266 ~~c~~L~~L~l~~c~~lt~-~gl~~i~~~~~~L~~L~l~~c~~~~d~~l~~~~~~c~~l~~l~~~~~~------------ 332 (482)
T KOG1947|consen 266 SRCPNLETLSLSNCSNLTD-EGLVSIAERCPSLRELDLSGCHGLTDSGLEALLKNCPNLRELKLLSLN------------ 332 (482)
T ss_pred hhCCCcceEccCCCCccch-hHHHHHHHhcCcccEEeeecCccchHHHHHHHHHhCcchhhhhhhhcC------------
Confidence 3 6677777766665 333 33444555666777777776554310 11112334444444332221
Q ss_pred CCCcccEEeCCCCCCCC--CCChhhhhcCCCCcEEEcCCCCCCccchhhhccCCCCccEEEccCcCCCcCCcccccCCCC
Q psy3329 186 NLVHLDSLDLSNCHLKG--PLSEDAFVNATKLRTLYLSGNPLSAADLSVALKPLTKLHRLSLRNCGLSRLPANTFHRFTC 263 (694)
Q Consensus 186 ~~~~L~~L~l~~n~~~~--~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~~~ 263 (694)
.+..++.+.+..+.... .........+++++.+.+..+..........+.+++.|+ ..+... ......
T Consensus 333 ~c~~l~~~~l~~~~~~~~d~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~l~gc~~l~-~~l~~~---------~~~~~~ 402 (482)
T KOG1947|consen 333 GCPSLTDLSLSGLLTLTSDDLAELILRSCPKLTDLSLSYCGISDLGLELSLRGCPNLT-ESLELR---------LCRSDS 402 (482)
T ss_pred CCccHHHHHHHHhhccCchhHhHHHHhcCCCcchhhhhhhhccCcchHHHhcCCcccc-hHHHHH---------hccCCc
Confidence 12233333333322111 222234556777777777776644444333445555552 222111 111122
Q ss_pred ccEEeCCCCCCccc-chhhcCC-CCCCcEEECcCCC
Q psy3329 264 LQELDISHNPLIDA-FTALLSP-LESLEHLDMGYSN 297 (694)
Q Consensus 264 L~~L~L~~n~~~~~-~~~~~~~-l~~L~~L~L~~n~ 297 (694)
++.|+++.+..... .-..... +.+++.+++.++.
T Consensus 403 l~~L~l~~~~~~t~~~l~~~~~~~~~~~~l~~~~~~ 438 (482)
T KOG1947|consen 403 LRVLNLSDCRLVTDKGLRCLADSCSNLKDLDLSGCR 438 (482)
T ss_pred cceEecccCccccccchHHHhhhhhccccCCccCcc
Confidence 67777777654321 1111111 4556666666553
No 73
>KOG3653|consensus
Probab=96.85 E-value=0.0002 Score=72.25 Aligned_cols=52 Identities=15% Similarity=0.302 Sum_probs=40.7
Q ss_pred cccccCcccceeecccceeeehhhhhhhhHHHHHHHhhHhHhhhhhhhccccCCC
Q psy3329 633 NMEKLNSKSFLTLGNFGLISVGVIILSAMVYFSFYARHLYRTKQQRIRRNTFKSP 687 (694)
Q Consensus 633 ~l~~~~~~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~~~~~~~~~~~~~~~~ 687 (694)
++..+.--.+||+|+||.||||+|.+ ..||||++....+|-.|.+ |+-|+.|
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~E--k~Iy~lp 259 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNE--KNIYSLP 259 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccC-ceeEEEecCHHHHHHHHhH--HHHHhcc
Confidence 34444455899999999999999955 7999999999999988876 3444444
No 74
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=95.42 E-value=0.0074 Score=33.51 Aligned_cols=16 Identities=38% Similarity=0.565 Sum_probs=7.5
Q ss_pred ccEEEccCCcCCccCC
Q psy3329 445 LRSLDLSRCKIDYLPP 460 (694)
Q Consensus 445 L~~L~Ls~n~l~~~~~ 460 (694)
|++|||++|+|+.+++
T Consensus 2 L~~Ldls~n~l~~ip~ 17 (22)
T PF00560_consen 2 LEYLDLSGNNLTSIPS 17 (22)
T ss_dssp ESEEEETSSEESEEGT
T ss_pred ccEEECCCCcCEeCCh
Confidence 4445555555544433
No 75
>smart00082 LRRCT Leucine rich repeat C-terminal domain.
Probab=94.70 E-value=0.015 Score=40.67 Aligned_cols=18 Identities=33% Similarity=0.988 Sum_probs=17.0
Q ss_pred CccccccCcHHHHHHHHh
Q psy3329 528 NPWKCDCNIADMWEWATR 545 (694)
Q Consensus 528 N~~~c~c~~~~~~~~~~~ 545 (694)
|||.|||.+.|+..|+..
T Consensus 1 NP~~CdC~l~~~~~w~~~ 18 (51)
T smart00082 1 NPFICDCELRWLLRWLQA 18 (51)
T ss_pred CCccCcCCchHHHHHHHh
Confidence 899999999999999876
No 76
>KOG0193|consensus
Probab=94.34 E-value=0.0066 Score=63.67 Aligned_cols=36 Identities=17% Similarity=0.113 Sum_probs=28.6
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhhHhHhhhhh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~~~~~~~ 678 (694)
..||.|.||+||+|.+ -| .||||++-...-.-.|.+
T Consensus 398 ~rIGsGsFGtV~Rg~w-hG-dVAVK~Lnv~~pt~~qlq 433 (678)
T KOG0193|consen 398 ERIGSGSFGTVYRGRW-HG-DVAVKLLNVDDPTPEQLQ 433 (678)
T ss_pred ceeccccccceeeccc-cc-ceEEEEEecCCCCHHHHH
Confidence 7899999999999999 56 589999876655444444
No 77
>KOG4236|consensus
Probab=94.22 E-value=0.011 Score=60.86 Aligned_cols=53 Identities=21% Similarity=0.202 Sum_probs=44.6
Q ss_pred cccccccCcccceeecccceeeehhh-hhhhhHHHHHHHhhHhHhhhhhhhccc
Q psy3329 631 YINMEKLNSKSFLTLGNFGLISVGVI-ILSAMVYFSFYARHLYRTKQQRIRRNT 683 (694)
Q Consensus 631 ~~~l~~~~~~~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~~~~~~~~~~~~ 683 (694)
+..+.++..++++|.|.||+||-|+- ..|+-||||+-..-+|-.+|+..-|+|
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~E 613 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNE 613 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHH
Confidence 44556668899999999999999975 578899999999999999998766654
No 78
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=93.96 E-value=0.037 Score=28.40 Aligned_cols=14 Identities=43% Similarity=0.655 Sum_probs=5.0
Q ss_pred CccEEEccCCcCCc
Q psy3329 444 RLRSLDLSRCKIDY 457 (694)
Q Consensus 444 ~L~~L~Ls~n~l~~ 457 (694)
+|+.|+|++|+|+.
T Consensus 2 ~L~~L~l~~n~L~~ 15 (17)
T PF13504_consen 2 NLRTLDLSNNRLTS 15 (17)
T ss_dssp T-SEEEETSS--SS
T ss_pred ccCEEECCCCCCCC
Confidence 34444444444443
No 79
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=93.62 E-value=0.027 Score=31.25 Aligned_cols=9 Identities=78% Similarity=0.973 Sum_probs=3.2
Q ss_pred eEECCCCCC
Q psy3329 68 KLDLSGNPL 76 (694)
Q Consensus 68 ~L~Ls~n~~ 76 (694)
+|++++|++
T Consensus 4 ~Ldls~n~l 12 (22)
T PF00560_consen 4 YLDLSGNNL 12 (22)
T ss_dssp EEEETSSEE
T ss_pred EEECCCCcC
Confidence 333333333
No 80
>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.
Probab=93.47 E-value=0.027 Score=47.56 Aligned_cols=40 Identities=5% Similarity=-0.095 Sum_probs=32.7
Q ss_pred CcccceeecccceeeehhhhhhhhHHHHHHHhhHhHhhhh
Q psy3329 638 NSKSFLTLGNFGLISVGVIILSAMVYFSFYARHLYRTKQQ 677 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~~~~~~ 677 (694)
.+.+-||.|+.|.||+|+|.+|+.||||+......+...+
T Consensus 14 fd~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i~~ 53 (119)
T PF03109_consen 14 FDPEPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQIEA 53 (119)
T ss_pred CCcchhhheehhhheeeeecccchhhhhhcchHHHHHHHH
Confidence 3457799999999999999999999999977666554443
No 81
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=93.28 E-value=0.061 Score=31.22 Aligned_cols=21 Identities=48% Similarity=0.835 Sum_probs=10.9
Q ss_pred CCccEEEccCCcCCccCCCCC
Q psy3329 443 SRLRSLDLSRCKIDYLPPNVF 463 (694)
Q Consensus 443 ~~L~~L~Ls~n~l~~~~~~~~ 463 (694)
++|+.|+|++|+|+.+++.+|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 345555555555555555444
No 82
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=93.28 E-value=0.061 Score=31.22 Aligned_cols=21 Identities=48% Similarity=0.835 Sum_probs=10.9
Q ss_pred CCccEEEccCCcCCccCCCCC
Q psy3329 443 SRLRSLDLSRCKIDYLPPNVF 463 (694)
Q Consensus 443 ~~L~~L~Ls~n~l~~~~~~~~ 463 (694)
++|+.|+|++|+|+.+++.+|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 345555555555555555444
No 83
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=93.21 E-value=0.016 Score=62.24 Aligned_cols=32 Identities=22% Similarity=0.173 Sum_probs=24.4
Q ss_pred Ccccceeecccceeeehhh-----------------hhhhhHHHHHHHh
Q psy3329 638 NSKSFLTLGNFGLISVGVI-----------------ILSAMVYFSFYAR 669 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l-----------------~~g~~vaV~~~~~ 669 (694)
.-.+.||+|+||+||+|++ .++..||||....
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~ 196 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNM 196 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecc
Confidence 3348999999999999975 3445788887643
No 84
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=92.88 E-value=0.028 Score=57.95 Aligned_cols=30 Identities=17% Similarity=0.166 Sum_probs=24.3
Q ss_pred cceeecccceeeehhh------hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI------ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l------~~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+. ..+..||||+....
T Consensus 13 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~ 48 (338)
T cd05102 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG 48 (338)
T ss_pred eEeccCCcceEEEEEEeccCCcccchhhheeccccc
Confidence 5799999999999964 34568999987643
No 85
>KOG0473|consensus
Probab=92.73 E-value=0.002 Score=59.01 Aligned_cols=98 Identities=16% Similarity=0.179 Sum_probs=66.7
Q ss_pred cCCCCcchh-hhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEEeCCCCcCCcc
Q psy3329 25 NANPIQPVE-GAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYLMLNRCNLTYI 103 (694)
Q Consensus 25 s~~~l~~i~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 103 (694)
+-..++.+| ..+......+.||++.|++..+ ...|+.++.|..|+++.|++...+.+ ++....++.+++..|..+..
T Consensus 26 s~s~~s~~~v~ei~~~kr~tvld~~s~r~vn~-~~n~s~~t~~~rl~~sknq~~~~~~d-~~q~~e~~~~~~~~n~~~~~ 103 (326)
T KOG0473|consen 26 SLSELSEIPVREIASFKRVTVLDLSSNRLVNL-GKNFSILTRLVRLDLSKNQIKFLPKD-AKQQRETVNAASHKNNHSQQ 103 (326)
T ss_pred CHHHhcccchhhhhccceeeeehhhhhHHHhh-ccchHHHHHHHHHhccHhhHhhChhh-HHHHHHHHHHHhhccchhhC
Confidence 333445566 5666777777888877776555 23466667777777877777666544 66667777777777766665
Q ss_pred ChhhhcCCCCCCEEECCCCcCC
Q psy3329 104 SPSAFDNLNHLKTLELSQNKLK 125 (694)
Q Consensus 104 ~~~~l~~l~~L~~L~l~~n~l~ 125 (694)
|.+++..++++++++-++.+.
T Consensus 104 -p~s~~k~~~~k~~e~k~~~~~ 124 (326)
T KOG0473|consen 104 -PKSQKKEPHPKKNEQKKTEFF 124 (326)
T ss_pred -CccccccCCcchhhhccCcch
Confidence 667777777877777777654
No 86
>KOG4308|consensus
Probab=91.84 E-value=0.0047 Score=65.66 Aligned_cols=91 Identities=31% Similarity=0.329 Sum_probs=48.0
Q ss_pred CCCCcEEECcCCCCcccCh----hhhcCCCC-CcEEeccCCcccCcCc----hhhcCC-CCCCEEeCCCCCCcccCcccc
Q psy3329 285 LESLEHLDMGYSNLQRISR----STFLKMTS-LKTLILSGNKLETLES----GLFQNL-THLSVLELNNCGLTRLNETVF 354 (694)
Q Consensus 285 l~~L~~L~L~~n~l~~~~~----~~~~~l~~-L~~L~L~~n~l~~~~~----~~l~~l-~~L~~L~L~~n~l~~~~~~~~ 354 (694)
..++++|.+.+|.++.... ..+...+. +..|++..|.+.+... ..+..+ ..++.++++.|.|+.-.....
T Consensus 203 ~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L 282 (478)
T KOG4308|consen 203 LSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDVGVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDL 282 (478)
T ss_pred cccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchHHHHHHHHHhcccchhhhhhhhhcCCccccchHHH
Confidence 4566666666666552221 22333444 5557777776654321 223333 456777777777765322211
Q ss_pred c-cCCCCCCCCeeeCCCCCCcC
Q psy3329 355 H-ENYTYPDLEELRLSGNPLHV 375 (694)
Q Consensus 355 ~-~~~~~~~L~~L~Ls~n~l~~ 375 (694)
. ....++.++.+.++.|++..
T Consensus 283 ~~~l~~~~~l~~l~l~~n~l~~ 304 (478)
T KOG4308|consen 283 AEVLVSCRQLEELSLSNNPLTD 304 (478)
T ss_pred HHHHhhhHHHHHhhcccCcccc
Confidence 1 11145677777777777653
No 87
>PRK09188 serine/threonine protein kinase; Provisional
Probab=91.52 E-value=0.03 Score=57.44 Aligned_cols=29 Identities=10% Similarity=0.037 Sum_probs=24.1
Q ss_pred ccceeecccceeeehhhh--hhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII--LSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~--~g~~vaV~~~~ 668 (694)
...||+|+||.||+|... +|++||||...
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~ 53 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRV 53 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEec
Confidence 468999999999999875 57888998743
No 88
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=91.48 E-value=0.12 Score=26.55 Aligned_cols=16 Identities=25% Similarity=0.449 Sum_probs=6.2
Q ss_pred CceEEECcCCCCcchh
Q psy3329 18 GLITINLNANPIQPVE 33 (694)
Q Consensus 18 ~L~~L~Ls~~~l~~i~ 33 (694)
+|+.|++++|.++.+|
T Consensus 2 ~L~~L~l~~n~L~~lP 17 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSLP 17 (17)
T ss_dssp T-SEEEETSS--SSE-
T ss_pred ccCEEECCCCCCCCCc
Confidence 4555555555554443
No 89
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=91.39 E-value=0.029 Score=55.52 Aligned_cols=32 Identities=19% Similarity=0.174 Sum_probs=25.2
Q ss_pred cceeecccceeeehhhh----hhhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVII----LSAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~----~g~~vaV~~~~~~~~ 672 (694)
++||+|+||.||+|++. .+..||+|+......
T Consensus 11 ~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~ 46 (266)
T cd05064 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS 46 (266)
T ss_pred eeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC
Confidence 67999999999999864 345899988765533
No 90
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=91.36 E-value=0.19 Score=29.10 Aligned_cols=21 Identities=43% Similarity=0.691 Sum_probs=11.5
Q ss_pred CCCcEEECCCCcccccChhhh
Q psy3329 494 LELESLDLSNNNLTHISPTVL 514 (694)
Q Consensus 494 ~~L~~L~ls~N~l~~~~~~~~ 514 (694)
++|+.|+|++|+|+.+++..|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 355556666666555555444
No 91
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=91.36 E-value=0.19 Score=29.10 Aligned_cols=21 Identities=43% Similarity=0.691 Sum_probs=11.5
Q ss_pred CCCcEEECCCCcccccChhhh
Q psy3329 494 LELESLDLSNNNLTHISPTVL 514 (694)
Q Consensus 494 ~~L~~L~ls~N~l~~~~~~~~ 514 (694)
++|+.|+|++|+|+.+++..|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 355556666666555555444
No 92
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=91.24 E-value=0.032 Score=58.42 Aligned_cols=31 Identities=16% Similarity=0.137 Sum_probs=24.3
Q ss_pred ccceeecccceeeehhh------hhhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVI------ILSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l------~~g~~vaV~~~~~~ 670 (694)
...||+|+||.||+|+. ..+..||||+....
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~ 76 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS 76 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCC
Confidence 37899999999999863 33458999987643
No 93
>KOG2052|consensus
Probab=91.24 E-value=0.034 Score=56.29 Aligned_cols=29 Identities=17% Similarity=0.267 Sum_probs=25.2
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
..||+|.||.|.+|.+. |.-||||+++.+
T Consensus 217 e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr 245 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRWR-GEDVAVKIFSSR 245 (513)
T ss_pred EEecCccccceeecccc-CCceEEEEeccc
Confidence 68999999999999995 557999998754
No 94
>KOG4308|consensus
Probab=90.83 E-value=0.0069 Score=64.38 Aligned_cols=183 Identities=23% Similarity=0.227 Sum_probs=115.2
Q ss_pred ceEEECcCCCCcch-----hhhhhcCCCCcEEEccCCcCCccChhh----ccCC-CCCCeEECCCCCCCccC----CCCC
Q psy3329 19 LITINLNANPIQPV-----EGAFLVARSLLYLYMQECTLSKINPQF----FTNL-TTLNKLDLSGNPLRIIE----PGVF 84 (694)
Q Consensus 19 L~~L~Ls~~~l~~i-----~~~~~~~~~L~~L~l~~n~l~~~~~~~----~~~l-~~L~~L~Ls~n~~~~~~----~~~~ 84 (694)
+..++|.+|.+..- ...+...+.|..|++++|.+....-.. +... ..|++|++..|.++... ...+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 77788888877742 256667788888888888776422111 2222 55677777777766422 2234
Q ss_pred CCCCCCCEEeCCCCcCCc----cChhhhc----CCCCCCEEECCCCcCCccc--hhhhhhcCCCC-CCEEEccCCCCCCC
Q psy3329 85 DPLTSLEYLMLNRCNLTY----ISPSAFD----NLNHLKTLELSQNKLKSHI--DWTLVLGNLGK-LDTLDLRQSGISNL 153 (694)
Q Consensus 85 ~~l~~L~~L~L~~n~l~~----~~~~~l~----~l~~L~~L~l~~n~l~~~~--~~~~~~~~l~~-L~~L~L~~n~i~~~ 153 (694)
.....++.++++.|.+.. ..+.++. ...+++.|++.+|.++... .+...+...++ +..|++..|.+...
T Consensus 169 ~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~ 248 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDV 248 (478)
T ss_pred hcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchH
Confidence 557788888888887642 1223333 4667888888888776422 23334555565 67788888887644
Q ss_pred Cc----cccCCC-CCCcEEeCCCCCCCCcchhh--hcccCCCcccEEeCCCCCCC
Q psy3329 154 PD----NVFANN-TWLRNLNLAENELIDLDVAT--TLGQNLVHLDSLDLSNCHLK 201 (694)
Q Consensus 154 ~~----~~~~~~-~~L~~L~l~~n~l~~~~~~~--~~~~~~~~L~~L~l~~n~~~ 201 (694)
.. ..+..+ ..++.+++..|.+++..... .....+..++.+.++.|.+.
T Consensus 249 g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L~~~l~~~~~l~~l~l~~n~l~ 303 (478)
T KOG4308|consen 249 GVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDLAEVLVSCRQLEELSLSNNPLT 303 (478)
T ss_pred HHHHHHHHhcccchhhhhhhhhcCCccccchHHHHHHHhhhHHHHHhhcccCccc
Confidence 21 223444 56788888888887644322 11125668888999888874
No 95
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=90.74 E-value=0.044 Score=55.85 Aligned_cols=31 Identities=23% Similarity=0.230 Sum_probs=23.9
Q ss_pred ccceeecccceeeehhhh-hhhh----HHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAM----VYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~----vaV~~~~~~ 670 (694)
.+.||+|+||.||+|+.. +|.. ||||+....
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~ 47 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 47 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEecccc
Confidence 378999999999999864 4443 888887543
No 96
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=90.50 E-value=0.045 Score=56.55 Aligned_cols=29 Identities=17% Similarity=0.134 Sum_probs=24.0
Q ss_pred cceeecccceeeehh------hhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGV------IILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~------l~~g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+ ..++..||||+...
T Consensus 13 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~ 47 (343)
T cd05103 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE 47 (343)
T ss_pred ccccCCccceEEEEeeccCCccccceeEEEEEecc
Confidence 579999999999996 45677999998754
No 97
>KOG4250|consensus
Probab=90.23 E-value=0.1 Score=56.19 Aligned_cols=33 Identities=18% Similarity=0.190 Sum_probs=29.4
Q ss_pred ccceeecccceeeehh-hhhhhhHHHHHHHhhHh
Q psy3329 640 KSFLTLGNFGLISVGV-IILSAMVYFSFYARHLY 672 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~~~ 672 (694)
+..||+||||.||+|+ =+-|..||||.+...++
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~ 51 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS 51 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcc
Confidence 3789999999999999 88999999999987553
No 98
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=89.99 E-value=0.067 Score=55.09 Aligned_cols=29 Identities=17% Similarity=0.138 Sum_probs=23.4
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~ 669 (694)
++||.|+||.||+|+..+ |..||||+...
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~ 47 (337)
T cd05054 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE 47 (337)
T ss_pred cccccCcCceEEeccccccccccccceeeeeeccC
Confidence 689999999999997533 35899998753
No 99
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=89.99 E-value=0.048 Score=53.91 Aligned_cols=35 Identities=17% Similarity=0.151 Sum_probs=26.3
Q ss_pred cccceeecccceeeehhhhhh----hhHHHHHHHhhHhH
Q psy3329 639 SKSFLTLGNFGLISVGVIILS----AMVYFSFYARHLYR 673 (694)
Q Consensus 639 ~~~~iG~G~fG~VYkg~l~~g----~~vaV~~~~~~~~~ 673 (694)
-.+.||+|+||.||+|++... ..||||+.......
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~ 46 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD 46 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh
Confidence 347899999999999998643 47888877544333
No 100
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=89.96 E-value=0.05 Score=51.09 Aligned_cols=27 Identities=11% Similarity=0.032 Sum_probs=25.0
Q ss_pred cceeecccceeeehhhhhhhhHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFY 667 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~ 667 (694)
+.||.|+||.||+|...+|+.||||+.
T Consensus 21 ~~i~~G~~g~Vy~~~~~~g~~vavK~~ 47 (198)
T cd05144 21 NQIGVGKESDVYLALDPDGNPVALKFH 47 (198)
T ss_pred CccccCcceEEEEEEcCCCCEEEEEEE
Confidence 789999999999999999999999974
No 101
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=89.79 E-value=0.05 Score=54.24 Aligned_cols=37 Identities=19% Similarity=0.232 Sum_probs=26.6
Q ss_pred cceeecccceeeehh-hhhhhh----HHHHHHHhhHhHhhhh
Q psy3329 641 SFLTLGNFGLISVGV-IILSAM----VYFSFYARHLYRTKQQ 677 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~----vaV~~~~~~~~~~~~~ 677 (694)
+.||.|+||+||+|+ .++|.. ||||+..........+
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~ 54 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHH
Confidence 689999999999998 456653 7888876544433333
No 102
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=89.60 E-value=0.047 Score=56.66 Aligned_cols=30 Identities=7% Similarity=-0.043 Sum_probs=25.3
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|+.. +|..||||+....
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~ 110 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGN 110 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecC
Confidence 68999999999999864 6789999987543
No 103
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=89.54 E-value=0.062 Score=56.23 Aligned_cols=31 Identities=16% Similarity=0.059 Sum_probs=24.1
Q ss_pred cceeecccceeeehh------hhhhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGV------IILSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~------l~~g~~vaV~~~~~~~ 671 (694)
+.||+|+||.||+|+ ..++..||||+.....
T Consensus 44 ~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~ 80 (374)
T cd05106 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA 80 (374)
T ss_pred heecCCCcccEEEEEEecCCcccccceeEEEeccCCC
Confidence 689999999999876 3344589999886543
No 104
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=89.47 E-value=0.06 Score=57.20 Aligned_cols=33 Identities=6% Similarity=-0.026 Sum_probs=28.5
Q ss_pred CcccceeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 638 NSKSFLTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
.+.+.||.|++|.||+|++.+|+.||||+....
T Consensus 120 fd~~plasaSigQVh~A~l~~G~~VaVKv~rp~ 152 (437)
T TIGR01982 120 FEEKPLAAASIAQVHRARLVDGKEVAVKVLRPG 152 (437)
T ss_pred CCCcceeeeehhheEEEEecCCCEEEEEeeCCC
Confidence 345789999999999999999999999997443
No 105
>KOG0597|consensus
Probab=89.43 E-value=0.056 Score=56.49 Aligned_cols=34 Identities=18% Similarity=0.259 Sum_probs=28.0
Q ss_pred cceeecccceeeehhhhhhh-hHHHHHHHhhHhHh
Q psy3329 641 SFLTLGNFGLISVGVIILSA-MVYFSFYARHLYRT 674 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~-~vaV~~~~~~~~~~ 674 (694)
+.||+|+||.||||+=.+-. +||+|+-...++-.
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~ 42 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE 42 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCch
Confidence 36999999999999986654 99998887777666
No 106
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=89.35 E-value=0.062 Score=53.55 Aligned_cols=33 Identities=18% Similarity=0.140 Sum_probs=26.8
Q ss_pred cceeecccceeeehhhhhh------hhHHHHHHHhhHhH
Q psy3329 641 SFLTLGNFGLISVGVIILS------AMVYFSFYARHLYR 673 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g------~~vaV~~~~~~~~~ 673 (694)
+.||+|+||.||+|+..++ ..||||........
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~ 49 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN 49 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH
Confidence 6799999999999998654 68999988765444
No 107
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=89.32 E-value=0.058 Score=54.63 Aligned_cols=31 Identities=16% Similarity=0.230 Sum_probs=23.5
Q ss_pred cceeecccceeeehhhhhh-----------------hhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIILS-----------------AMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-----------------~~vaV~~~~~~~ 671 (694)
+.||+|+||.||+++..++ ..||||+.....
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~ 58 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA 58 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC
Confidence 5799999999999986432 368888765543
No 108
>KOG1026|consensus
Probab=89.28 E-value=0.11 Score=57.24 Aligned_cols=42 Identities=19% Similarity=0.150 Sum_probs=35.1
Q ss_pred cceeecccceeeehhhhhhh------hHHHHHHHhhHhHhhhhhhhcc
Q psy3329 641 SFLTLGNFGLISVGVIILSA------MVYFSFYARHLYRTKQQRIRRN 682 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~------~vaV~~~~~~~~~~~~~~~~~~ 682 (694)
+-||+|.||.||+|...... .||||.+...--...|++-+||
T Consensus 492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~RE 539 (774)
T KOG1026|consen 492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRRE 539 (774)
T ss_pred hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHH
Confidence 78999999999999986553 8999999988877777766655
No 109
>KOG0192|consensus
Probab=89.19 E-value=0.043 Score=56.33 Aligned_cols=32 Identities=19% Similarity=0.190 Sum_probs=25.8
Q ss_pred ccceeecccceeeehhhhhhhhHHHHHHHhhH
Q psy3329 640 KSFLTLGNFGLISVGVIILSAMVYFSFYARHL 671 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~ 671 (694)
...||.|+||+||+|++..-.+||||.+...-
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~ 77 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPD 77 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchh
Confidence 35599999999999999444459999887654
No 110
>KOG3864|consensus
Probab=89.05 E-value=0.082 Score=47.93 Aligned_cols=82 Identities=23% Similarity=0.225 Sum_probs=40.7
Q ss_pred CCEEEccCCCCCCCCccccCCCCCCcEEeCCCCCCCCcchhhhcccCCCcccEEeCCCCCCCCCCChhhhhcCCCCcEEE
Q psy3329 140 LDTLDLRQSGISNLPDNVFANNTWLRNLNLAENELIDLDVATTLGQNLVHLDSLDLSNCHLKGPLSEDAFVNATKLRTLY 219 (694)
Q Consensus 140 L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~ 219 (694)
++.++-++..|....-..+.+++.++.|.+.++.-.+......++...++|+.|++++|.-..+-....+..+++|+.|.
T Consensus 103 IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~ 182 (221)
T KOG3864|consen 103 IEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRRLH 182 (221)
T ss_pred EEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHHHH
Confidence 45555566555554444555666666666666554443344444444555566665555421222222333444444444
Q ss_pred cC
Q psy3329 220 LS 221 (694)
Q Consensus 220 L~ 221 (694)
+.
T Consensus 183 l~ 184 (221)
T KOG3864|consen 183 LY 184 (221)
T ss_pred hc
Confidence 43
No 111
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=88.67 E-value=0.069 Score=56.33 Aligned_cols=30 Identities=20% Similarity=0.208 Sum_probs=23.1
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~~ 670 (694)
++||+|+||.||+|+... +..||||+....
T Consensus 43 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~ 78 (400)
T cd05105 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT 78 (400)
T ss_pred heecCCCCceEEEEEEcccCCCCCceEEEEEecCCC
Confidence 679999999999998521 236899988643
No 112
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=88.55 E-value=0.09 Score=52.04 Aligned_cols=35 Identities=11% Similarity=0.173 Sum_probs=26.8
Q ss_pred cccceeecccceeeehhhh-hhhhHHHHHHHhhHhH
Q psy3329 639 SKSFLTLGNFGLISVGVII-LSAMVYFSFYARHLYR 673 (694)
Q Consensus 639 ~~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~~~ 673 (694)
....||+|+||.||+|+.. ++..||||.......+
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~ 47 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR 47 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH
Confidence 3479999999999999854 5668999876654433
No 113
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=88.35 E-value=0.066 Score=58.27 Aligned_cols=30 Identities=10% Similarity=0.010 Sum_probs=25.4
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|+ ..+|..||||+....
T Consensus 38 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~ 68 (496)
T PTZ00283 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDME 68 (496)
T ss_pred EEEecCCCEEEEEEEEcCCCCEEEEEEEecc
Confidence 689999999999997 457889999987543
No 114
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=88.34 E-value=0.069 Score=52.57 Aligned_cols=30 Identities=20% Similarity=0.155 Sum_probs=26.5
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|...+|..||||.....
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~ 41 (260)
T cd05067 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQG 41 (260)
T ss_pred eeeccCccceEEeeecCCCceEEEEEecCC
Confidence 579999999999999999999999976543
No 115
>KOG3864|consensus
Probab=88.10 E-value=0.13 Score=46.73 Aligned_cols=84 Identities=20% Similarity=0.197 Sum_probs=54.6
Q ss_pred CCCCEEeCCCCcCCccChhhhcCCCCCCEEECCCCcCCccchhhhhhcCCCCCCEEEccCCC-CCCCCccccCCCCCCcE
Q psy3329 88 TSLEYLMLNRCNLTYISPSAFDNLNHLKTLELSQNKLKSHIDWTLVLGNLGKLDTLDLRQSG-ISNLPDNVFANNTWLRN 166 (694)
Q Consensus 88 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~~L~~ 166 (694)
..++.+|-++..|....-+.+..++.++.|.+.+|.--+...+...-+-.++|+.|++++|. |++-.-..+..+++|+.
T Consensus 101 ~~IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~ 180 (221)
T KOG3864|consen 101 VKIEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRR 180 (221)
T ss_pred ceEEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHH
Confidence 45778888888888777777888888888888887544322222222345778888888664 55444445556666666
Q ss_pred EeCCC
Q psy3329 167 LNLAE 171 (694)
Q Consensus 167 L~l~~ 171 (694)
|.+.+
T Consensus 181 L~l~~ 185 (221)
T KOG3864|consen 181 LHLYD 185 (221)
T ss_pred HHhcC
Confidence 65543
No 116
>KOG0575|consensus
Probab=88.10 E-value=0.087 Score=55.66 Aligned_cols=36 Identities=17% Similarity=0.147 Sum_probs=30.1
Q ss_pred ccceeecccceeeehhh-hhhhhHHHHHHHhhHhHhh
Q psy3329 640 KSFLTLGNFGLISVGVI-ILSAMVYFSFYARHLYRTK 675 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~~~~ 675 (694)
-++||+|||..||.++- +.|.+|||||=.+..-+..
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~ 59 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP 59 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc
Confidence 37999999999999998 8999999999776544433
No 117
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=87.96 E-value=0.087 Score=52.48 Aligned_cols=30 Identities=17% Similarity=0.196 Sum_probs=24.7
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+. .+|.+||||+....
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~ 40 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 40 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccc
Confidence 5799999999999975 46789999986543
No 118
>KOG0658|consensus
Probab=87.94 E-value=0.1 Score=51.63 Aligned_cols=28 Identities=14% Similarity=0.269 Sum_probs=23.1
Q ss_pred Ccccceeecccceeeehhhhhh-hhHHHH
Q psy3329 638 NSKSFLTLGNFGLISVGVIILS-AMVYFS 665 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g-~~vaV~ 665 (694)
...+++|.|+||.||+|++..- ..||||
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIK 55 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIK 55 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEE
Confidence 4458999999999999999654 488885
No 119
>KOG0580|consensus
Probab=87.90 E-value=0.11 Score=48.41 Aligned_cols=42 Identities=19% Similarity=0.223 Sum_probs=31.4
Q ss_pred cceeecccceeeehhhhhhh-hHHHHHHHhhHhHh--hhhhhhcc
Q psy3329 641 SFLTLGNFGLISVGVIILSA-MVYFSFYARHLYRT--KQQRIRRN 682 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~-~vaV~~~~~~~~~~--~~~~~~~~ 682 (694)
..+|+|.||.||.|.-.-.- +||+||.-...-+. .+++++||
T Consensus 28 r~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrRE 72 (281)
T KOG0580|consen 28 RPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRRE 72 (281)
T ss_pred ccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhhe
Confidence 78999999999999986554 99999876655443 34456655
No 120
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=87.89 E-value=0.085 Score=52.73 Aligned_cols=31 Identities=19% Similarity=0.063 Sum_probs=24.6
Q ss_pred cceeecccceeeehhh-----hhhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVI-----ILSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-----~~g~~vaV~~~~~~~ 671 (694)
..||+|+||.||+|+. .++..||||......
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~ 46 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN 46 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCC
Confidence 6799999999999984 456788888876433
No 121
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=87.74 E-value=0.078 Score=52.88 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=25.7
Q ss_pred ccceeecccceeeehhhhh-----hhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVIIL-----SAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-----g~~vaV~~~~~~ 670 (694)
.++||+|+||.||+|...+ +..||+|.....
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~ 46 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH 46 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCC
Confidence 3689999999999999987 678888876543
No 122
>KOG0473|consensus
Probab=87.56 E-value=0.021 Score=52.61 Aligned_cols=87 Identities=8% Similarity=0.007 Sum_probs=74.6
Q ss_pred CCCCCceEEECcCCCCcchhhhhhcCCCCcEEEccCCcCCccChhhccCCCCCCeEECCCCCCCccCCCCCCCCCCCCEE
Q psy3329 14 LDNPGLITINLNANPIQPVEGAFLVARSLLYLYMQECTLSKINPQFFTNLTTLNKLDLSGNPLRIIEPGVFDPLTSLEYL 93 (694)
Q Consensus 14 ~~~~~L~~L~Ls~~~l~~i~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~~~~~~~l~~L~~L 93 (694)
.-++..+.||++.|.+..+-..|+.+..+..|+++.|.+... |..+.....++.+++..|..+..|. +++..++++++
T Consensus 39 ~~~kr~tvld~~s~r~vn~~~n~s~~t~~~rl~~sknq~~~~-~~d~~q~~e~~~~~~~~n~~~~~p~-s~~k~~~~k~~ 116 (326)
T KOG0473|consen 39 ASFKRVTVLDLSSNRLVNLGKNFSILTRLVRLDLSKNQIKFL-PKDAKQQRETVNAASHKNNHSQQPK-SQKKEPHPKKN 116 (326)
T ss_pred hccceeeeehhhhhHHHhhccchHHHHHHHHHhccHhhHhhC-hhhHHHHHHHHHHHhhccchhhCCc-cccccCCcchh
Confidence 345678999999999998888889999999999999988776 6778899999999999999887754 49999999999
Q ss_pred eCCCCcCCc
Q psy3329 94 MLNRCNLTY 102 (694)
Q Consensus 94 ~L~~n~l~~ 102 (694)
++-.+.+..
T Consensus 117 e~k~~~~~~ 125 (326)
T KOG0473|consen 117 EQKKTEFFR 125 (326)
T ss_pred hhccCcchH
Confidence 998887543
No 123
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=87.50 E-value=0.075 Score=53.10 Aligned_cols=32 Identities=16% Similarity=0.091 Sum_probs=25.5
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~~~~ 672 (694)
+.||.|+||.||+|+..+ +..||||+......
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~ 48 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE 48 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC
Confidence 578999999999998754 45899999875443
No 124
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=87.45 E-value=0.076 Score=53.27 Aligned_cols=30 Identities=13% Similarity=0.066 Sum_probs=24.7
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+-. +|..||||+....
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~ 41 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLE 41 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEeccc
Confidence 68999999999999765 5678999977543
No 125
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=87.36 E-value=0.08 Score=53.57 Aligned_cols=31 Identities=13% Similarity=0.082 Sum_probs=25.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~ 671 (694)
..||.|+||.||+|+-. +|..||||+.....
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~ 42 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQE 42 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEecccc
Confidence 67999999999999976 67899999876443
No 126
>PHA02882 putative serine/threonine kinase; Provisional
Probab=87.05 E-value=0.1 Score=52.54 Aligned_cols=26 Identities=12% Similarity=0.144 Sum_probs=20.8
Q ss_pred cceeecccceeeehhhhhh----hhHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILS----AMVYFSF 666 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g----~~vaV~~ 666 (694)
++||+|+||.||+|+..++ .++|+|+
T Consensus 18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~ 47 (294)
T PHA02882 18 KLIGCGGFGCVYETQCASDHCINNQAVAKI 47 (294)
T ss_pred eEEecCCCceEEEEEEcCCcccccceEEEe
Confidence 6899999999999998665 3566664
No 127
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=86.91 E-value=0.096 Score=55.26 Aligned_cols=31 Identities=16% Similarity=0.106 Sum_probs=24.9
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~~~ 671 (694)
..||+|+||.||+|+..+ +..||||+.....
T Consensus 43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~ 79 (401)
T cd05107 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA 79 (401)
T ss_pred hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC
Confidence 689999999999998643 3479999886543
No 128
>KOG0595|consensus
Probab=86.59 E-value=0.15 Score=51.34 Aligned_cols=29 Identities=21% Similarity=0.224 Sum_probs=24.6
Q ss_pred eeecccceeeehhhhhh-hhHHHHHHHhhH
Q psy3329 643 LTLGNFGLISVGVIILS-AMVYFSFYARHL 671 (694)
Q Consensus 643 iG~G~fG~VYkg~l~~g-~~vaV~~~~~~~ 671 (694)
||+|.||+||||+..+- ++||||--....
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~ 47 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKK 47 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhc
Confidence 99999999999998654 599998776664
No 129
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=86.53 E-value=0.12 Score=52.98 Aligned_cols=29 Identities=14% Similarity=0.256 Sum_probs=24.6
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+++.. +|..||||+...
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~ 36 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNK 36 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEH
Confidence 57999999999999965 477999998754
No 130
>PTZ00284 protein kinase; Provisional
Probab=86.36 E-value=0.13 Score=55.75 Aligned_cols=28 Identities=18% Similarity=0.119 Sum_probs=23.6
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
..||+|+||.||+|+.. .|..||||+..
T Consensus 135 ~~lG~G~fg~V~~a~~~~~~~~vAvK~i~ 163 (467)
T PTZ00284 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIVR 163 (467)
T ss_pred EEEEeccCEEEEEEEEcCCCeEEEEEEEe
Confidence 68999999999999864 46689999864
No 131
>KOG1027|consensus
Probab=86.13 E-value=0.33 Score=53.49 Aligned_cols=42 Identities=21% Similarity=0.264 Sum_probs=37.1
Q ss_pred Ccccceeecccce-eeehhhhhhhhHHHHHHHhhHhHhhhhhhh
Q psy3329 638 NSKSFLTLGNFGL-ISVGVIILSAMVYFSFYARHLYRTKQQRIR 680 (694)
Q Consensus 638 ~~~~~iG~G~fG~-VYkg~l~~g~~vaV~~~~~~~~~~~~~~~~ 680 (694)
+.+.++|.|.-|+ ||+|+. +|+.||||......+...|.+|+
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~ 554 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQ 554 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHH
Confidence 5668999999987 899999 67799999999999988888865
No 132
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=86.03 E-value=0.15 Score=52.43 Aligned_cols=29 Identities=14% Similarity=0.259 Sum_probs=24.1
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+++.. .|..||||+...
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~ 36 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNK 36 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeH
Confidence 57999999999999875 456899998754
No 133
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=85.81 E-value=0.15 Score=56.29 Aligned_cols=29 Identities=14% Similarity=0.159 Sum_probs=24.5
Q ss_pred ccceeecccceeeehhhhh-----hhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVIIL-----SAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-----g~~vaV~~~~ 668 (694)
.+.||+|+||.||+|+..+ |..||||...
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~ 170 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT 170 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEec
Confidence 3799999999999999876 4688998654
No 134
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=85.77 E-value=0.16 Score=52.25 Aligned_cols=32 Identities=13% Similarity=0.176 Sum_probs=26.6
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~ 672 (694)
..||.|+||.||+|+..+ |..||||+......
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~ 39 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL 39 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH
Confidence 479999999999999864 77999998876543
No 135
>smart00090 RIO RIO-like kinase.
Probab=85.70 E-value=0.14 Score=49.57 Aligned_cols=29 Identities=7% Similarity=-0.035 Sum_probs=25.9
Q ss_pred cceeecccceeeehh--hhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGV--IILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~--l~~g~~vaV~~~~~ 669 (694)
..||.|+||.||+|+ ..+|..||||+...
T Consensus 34 ~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~ 64 (237)
T smart00090 34 GCISTGKEANVYHALDFDGSGKERAVKIYRT 64 (237)
T ss_pred CeeccCcceeEEEEEecCCCCcEEEEEEEEc
Confidence 579999999999998 78999999998754
No 136
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=85.49 E-value=0.16 Score=52.96 Aligned_cols=30 Identities=10% Similarity=0.117 Sum_probs=25.5
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+-. .|..||||+....
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~ 37 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS 37 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHH
Confidence 57999999999999875 5789999988654
No 137
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=85.14 E-value=0.16 Score=49.94 Aligned_cols=32 Identities=19% Similarity=0.106 Sum_probs=27.9
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~ 672 (694)
+.||.|+||.||+|+..++..||+|+......
T Consensus 12 ~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~ 43 (261)
T cd05148 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL 43 (261)
T ss_pred hhhccCCCccEEEeEecCCCcEEEEeccccch
Confidence 67999999999999999999999998765543
No 138
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=85.03 E-value=0.13 Score=51.26 Aligned_cols=32 Identities=13% Similarity=0.119 Sum_probs=25.5
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~ 672 (694)
.+||.|+||.||+|+- .+|..||||+......
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~ 39 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT 39 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC
Confidence 4799999999999975 4667999998765433
No 139
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=84.84 E-value=0.12 Score=52.50 Aligned_cols=30 Identities=13% Similarity=0.062 Sum_probs=24.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|+-. .+..||||+....
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~ 42 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLE 42 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeecc
Confidence 67999999999999865 5568999977544
No 140
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=84.82 E-value=0.16 Score=50.05 Aligned_cols=29 Identities=24% Similarity=0.189 Sum_probs=25.5
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|...++..||||....
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~v~iK~~~~ 40 (261)
T cd05072 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKP 40 (261)
T ss_pred eecCCcCCceEEEEEecCCceEEEEEccC
Confidence 57999999999999999888999987654
No 141
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=84.66 E-value=0.17 Score=50.07 Aligned_cols=32 Identities=19% Similarity=0.189 Sum_probs=25.1
Q ss_pred ccceeecccceeeehhhhhh----hhHHHHHHHhhH
Q psy3329 640 KSFLTLGNFGLISVGVIILS----AMVYFSFYARHL 671 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g----~~vaV~~~~~~~ 671 (694)
.+.||.|+||.||+|+..+. ..||||......
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~ 46 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT 46 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC
Confidence 36899999999999997664 368888776544
No 142
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=84.45 E-value=0.17 Score=50.51 Aligned_cols=32 Identities=16% Similarity=0.036 Sum_probs=25.6
Q ss_pred cceeecccceeeehhhh-----hhhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVII-----LSAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-----~g~~vaV~~~~~~~~ 672 (694)
+.||+|+||.||+|++. .|..||||+......
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~ 46 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE 46 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc
Confidence 67999999999999975 356899998765433
No 143
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=84.41 E-value=0.2 Score=49.26 Aligned_cols=29 Identities=17% Similarity=0.112 Sum_probs=25.6
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|...++..||||....
T Consensus 12 ~~lg~g~~~~vy~~~~~~~~~~~iK~~~~ 40 (260)
T cd05073 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKP 40 (260)
T ss_pred eEecCccceEEEEEEecCCccEEEEecCC
Confidence 67999999999999988888899987654
No 144
>KOG0591|consensus
Probab=84.26 E-value=0.31 Score=46.59 Aligned_cols=26 Identities=15% Similarity=0.178 Sum_probs=22.2
Q ss_pred cceeecccceeeehh-hhhhhhHHHHH
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSF 666 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~ 666 (694)
..||+|.||.|||+. +.+|..||.|-
T Consensus 25 ~~IG~GsFg~vykv~~~~~g~l~a~K~ 51 (375)
T KOG0591|consen 25 KKIGRGSFGEVYKVQCLLDGKLVALKK 51 (375)
T ss_pred HHHcCCcchheEEeeeccCcchhhhhh
Confidence 679999999999985 78898888763
No 145
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=84.18 E-value=0.21 Score=52.52 Aligned_cols=30 Identities=17% Similarity=0.256 Sum_probs=23.9
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+. ..|..||||+....
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~ 37 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKK 37 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHH
Confidence 4699999999999975 44568999987543
No 146
>KOG4257|consensus
Probab=84.07 E-value=0.21 Score=53.04 Aligned_cols=32 Identities=22% Similarity=0.223 Sum_probs=27.6
Q ss_pred Ccccceeecccceeeehhhhhhh-----hHHHHHHHh
Q psy3329 638 NSKSFLTLGNFGLISVGVIILSA-----MVYFSFYAR 669 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g~-----~vaV~~~~~ 669 (694)
+-+.+||.|-||.||+|++.+-. .||||.+..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~ 428 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKT 428 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhcc
Confidence 56689999999999999997762 799998875
No 147
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=83.91 E-value=0.22 Score=50.04 Aligned_cols=34 Identities=18% Similarity=0.157 Sum_probs=24.4
Q ss_pred cceeecccceeeehhhhhh-------------h--hHHHHHHHhhHhHh
Q psy3329 641 SFLTLGNFGLISVGVIILS-------------A--MVYFSFYARHLYRT 674 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-------------~--~vaV~~~~~~~~~~ 674 (694)
+.||+|+||.||+++.... + .||||+......+.
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~ 59 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT 59 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHH
Confidence 5699999999999887542 2 47888776543333
No 148
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=83.53 E-value=0.15 Score=50.84 Aligned_cols=30 Identities=10% Similarity=0.119 Sum_probs=24.5
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+.. +|..||+|.....
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~ 37 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT 37 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecC
Confidence 46899999999999875 5889999866443
No 149
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=83.51 E-value=0.18 Score=50.48 Aligned_cols=28 Identities=21% Similarity=0.174 Sum_probs=22.4
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~ 668 (694)
..||+|+||.||+|+..+ +..||||...
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~ 45 (288)
T cd05061 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN 45 (288)
T ss_pred eeecCCCCcEEEEEEEeccCCCCcceEEEEEECC
Confidence 679999999999997543 4478998754
No 150
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=83.36 E-value=0.18 Score=49.70 Aligned_cols=29 Identities=21% Similarity=0.147 Sum_probs=25.7
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|...++..||||....
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~ 40 (261)
T cd05068 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKP 40 (261)
T ss_pred EEecccCCccEEEEEecCCeEEEEEeeCC
Confidence 68999999999999988888899998754
No 151
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=83.34 E-value=0.19 Score=49.78 Aligned_cols=31 Identities=19% Similarity=0.325 Sum_probs=24.6
Q ss_pred ccceeecccceeeehhhhhh----hhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVIILS----AMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g----~~vaV~~~~~~ 670 (694)
.+.||+|+||.||+|+.... ..||||+....
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~ 43 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG 43 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC
Confidence 46799999999999998643 25899987654
No 152
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=83.26 E-value=0.17 Score=52.21 Aligned_cols=30 Identities=17% Similarity=0.142 Sum_probs=24.5
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+- .+|..||||.....
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~ 51 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP 51 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCch
Confidence 5799999999999985 45668999987643
No 153
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=83.07 E-value=0.23 Score=50.90 Aligned_cols=32 Identities=16% Similarity=0.225 Sum_probs=25.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~~ 672 (694)
..||+|+||.||+|+-. +|..||||+......
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~ 39 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL 39 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh
Confidence 57999999999998864 677999998776543
No 154
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=83.04 E-value=0.25 Score=51.87 Aligned_cols=30 Identities=17% Similarity=0.237 Sum_probs=24.2
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|+- .+|..||||+....
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~ 37 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKK 37 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHH
Confidence 4799999999999986 45668999986543
No 155
>PTZ00036 glycogen synthase kinase; Provisional
Probab=82.97 E-value=0.23 Score=53.21 Aligned_cols=28 Identities=21% Similarity=0.305 Sum_probs=23.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
+.||+|+||.||+|+.. .|..||||...
T Consensus 72 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~ 100 (440)
T PTZ00036 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVL 100 (440)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEe
Confidence 68999999999999875 56789998653
No 156
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=82.84 E-value=0.23 Score=51.41 Aligned_cols=31 Identities=10% Similarity=0.046 Sum_probs=25.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~ 671 (694)
..||+|+||.||+|+-. +|..||||+.....
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~ 38 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD 38 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH
Confidence 47999999999999976 57799999876543
No 157
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=82.42 E-value=0.2 Score=49.34 Aligned_cols=29 Identities=10% Similarity=0.174 Sum_probs=24.9
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
.+.||.|+||.||+|+.. +|..||+|...
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~ 36 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQ 36 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEee
Confidence 357999999999999998 78899998664
No 158
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=82.37 E-value=0.27 Score=50.51 Aligned_cols=29 Identities=14% Similarity=0.259 Sum_probs=23.8
Q ss_pred cceeecccceeeehhhhhh-hhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILS-AMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-~~vaV~~~~~ 669 (694)
..||+|+||.||+|+..+. .+||||+...
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~ 36 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNK 36 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeH
Confidence 5799999999999998654 4788888754
No 159
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=82.32 E-value=0.22 Score=49.00 Aligned_cols=29 Identities=21% Similarity=0.162 Sum_probs=25.4
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|...++..||||....
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~vK~~~~ 40 (261)
T cd05034 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKP 40 (261)
T ss_pred eeeccCcceEEEEEEEcCCceEEEEEecC
Confidence 57999999999999998888899987764
No 160
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=82.05 E-value=0.19 Score=50.00 Aligned_cols=29 Identities=17% Similarity=0.209 Sum_probs=24.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+.. +|.+||||+...
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~ 39 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDL 39 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEecc
Confidence 56999999999999864 467899998653
No 161
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=82.05 E-value=0.23 Score=48.67 Aligned_cols=28 Identities=21% Similarity=0.250 Sum_probs=24.7
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~ 668 (694)
..||+|+||.||+|+..++..||||...
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~ 37 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN 37 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecc
Confidence 5699999999999999988889998754
No 162
>KOG0661|consensus
Probab=81.98 E-value=0.51 Score=48.63 Aligned_cols=37 Identities=16% Similarity=0.193 Sum_probs=30.7
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhhHhHhhhh
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARHLYRTKQQ 677 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~~~~~~~~ 677 (694)
+.+|.|.||.||+|+ ...|..||||--.+..|-+.+.
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~ 53 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC 53 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH
Confidence 468999999999997 5677799999988888776554
No 163
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=81.96 E-value=0.5 Score=26.68 Aligned_cols=14 Identities=64% Similarity=0.926 Sum_probs=5.6
Q ss_pred CCcEEECCCCcccc
Q psy3329 495 ELESLDLSNNNLTH 508 (694)
Q Consensus 495 ~L~~L~ls~N~l~~ 508 (694)
+|++|+|++|+|+.
T Consensus 3 ~L~~L~l~~n~i~~ 16 (24)
T PF13516_consen 3 NLETLDLSNNQITD 16 (24)
T ss_dssp T-SEEE-TSSBEHH
T ss_pred CCCEEEccCCcCCH
Confidence 44444444444443
No 164
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=81.46 E-value=0.25 Score=50.79 Aligned_cols=29 Identities=14% Similarity=0.245 Sum_probs=24.4
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+- .+|..||||+.+.
T Consensus 11 ~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~ 40 (336)
T cd07849 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISP 40 (336)
T ss_pred EEEEecCCeEEEEEEEcCCCCeEEEEEecc
Confidence 6899999999999974 5688999997753
No 165
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=81.44 E-value=0.25 Score=49.64 Aligned_cols=29 Identities=14% Similarity=0.057 Sum_probs=24.7
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|+-. +|..||||+...
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~ 36 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAI 36 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEH
Confidence 57999999999999876 577999998754
No 166
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=81.36 E-value=0.18 Score=50.33 Aligned_cols=30 Identities=23% Similarity=0.018 Sum_probs=24.5
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|+.. +|.+||+|+....
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~ 41 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG 41 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEec
Confidence 57999999999999865 5778999876543
No 167
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=81.24 E-value=0.31 Score=50.82 Aligned_cols=30 Identities=10% Similarity=0.148 Sum_probs=24.8
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+-. .|..||||+....
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~ 37 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKA 37 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHH
Confidence 57999999999999754 4779999987653
No 168
>KOG1095|consensus
Probab=81.24 E-value=0.27 Score=56.44 Aligned_cols=39 Identities=18% Similarity=0.091 Sum_probs=31.3
Q ss_pred ccceeecccceeeehhhhhhh------hHHHHHHHhhHhHhhhhh
Q psy3329 640 KSFLTLGNFGLISVGVIILSA------MVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~------~vaV~~~~~~~~~~~~~~ 678 (694)
..+||+|.||.||+|.+.+-. .||||...+....+.++.
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~ 741 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSD 741 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHH
Confidence 389999999999999998765 388888877766666555
No 169
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=81.22 E-value=0.24 Score=49.26 Aligned_cols=34 Identities=24% Similarity=0.253 Sum_probs=25.4
Q ss_pred cceeecccceeeehhhhh-hh----hHHHHHHHhhHhHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SA----MVYFSFYARHLYRT 674 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~----~vaV~~~~~~~~~~ 674 (694)
+.||.|+||.||+|+..+ |. .||+|+......+.
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~ 51 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK 51 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHH
Confidence 689999999999999753 43 47888776555433
No 170
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=81.18 E-value=0.31 Score=51.09 Aligned_cols=30 Identities=10% Similarity=0.109 Sum_probs=24.4
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+- .+|..||||+....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~ 37 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS 37 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHH
Confidence 5799999999999875 46779999976543
No 171
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=81.10 E-value=0.23 Score=49.38 Aligned_cols=36 Identities=17% Similarity=0.120 Sum_probs=26.8
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHhhHhHhhh
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYARHLYRTKQ 676 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~~~~~~~~ 676 (694)
+.||+|+||.||+|+..+ +..||+|..........+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~ 53 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE 53 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHH
Confidence 689999999999999975 347888876544444333
No 172
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=80.99 E-value=0.26 Score=50.63 Aligned_cols=30 Identities=17% Similarity=0.025 Sum_probs=24.5
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+++-. .|..||+|+....
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~ 41 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLE 41 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecc
Confidence 57999999999999976 4668888876544
No 173
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=80.98 E-value=0.31 Score=48.37 Aligned_cols=32 Identities=16% Similarity=0.149 Sum_probs=24.8
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~~~~ 672 (694)
..||.|+||.||+|+... ...||||......-
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~ 48 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD 48 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc
Confidence 569999999999999753 34789988765443
No 174
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=80.97 E-value=0.34 Score=50.79 Aligned_cols=30 Identities=13% Similarity=0.252 Sum_probs=24.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+-. .|..||||+....
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~ 37 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKA 37 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHH
Confidence 46999999999999854 4679999987543
No 175
>KOG0667|consensus
Probab=80.88 E-value=0.32 Score=51.97 Aligned_cols=40 Identities=18% Similarity=0.177 Sum_probs=34.1
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHhHhhhhhhh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLYRTKQQRIR 680 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~~~~~~~~~ 680 (694)
.+||+|.||.|.|+.=.. |..||+|+-......-+|+.++
T Consensus 192 e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~E 232 (586)
T KOG0667|consen 192 EVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIE 232 (586)
T ss_pred EEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHH
Confidence 799999999999998655 6799999999888877777754
No 176
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=80.84 E-value=0.27 Score=49.05 Aligned_cols=31 Identities=19% Similarity=0.173 Sum_probs=23.8
Q ss_pred cceeecccceeeehhhhhh------hhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIILS------AMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g------~~vaV~~~~~~~ 671 (694)
..||+|+||.||+|..... ..||||......
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~ 47 (283)
T cd05048 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA 47 (283)
T ss_pred hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC
Confidence 5799999999999987443 368888775443
No 177
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=80.81 E-value=0.19 Score=50.44 Aligned_cols=29 Identities=10% Similarity=-0.044 Sum_probs=23.4
Q ss_pred cceeecccceeeehhh--hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI--ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l--~~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|+- .+|..||||+...
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~ 37 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV 37 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEec
Confidence 4699999999999975 3467899987654
No 178
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=80.62 E-value=0.28 Score=49.06 Aligned_cols=30 Identities=17% Similarity=0.115 Sum_probs=24.0
Q ss_pred cceeecccceeeehhhh------hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII------LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~------~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+.. ++..||+|+....
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~ 46 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE 46 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCC
Confidence 67899999999999864 3568999887543
No 179
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=80.61 E-value=0.3 Score=48.77 Aligned_cols=30 Identities=20% Similarity=0.179 Sum_probs=24.4
Q ss_pred cceeecccceeeehhhh-----hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-----LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-----~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+.. +|..||||.....
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~ 44 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS 44 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC
Confidence 57999999999999753 5678999987644
No 180
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=80.54 E-value=0.27 Score=48.39 Aligned_cols=29 Identities=21% Similarity=0.126 Sum_probs=25.2
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+..++..||||+...
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~valK~~~~ 40 (262)
T cd05071 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP 40 (262)
T ss_pred eecCCCCCCcEEEEEecCCceEEEEeccc
Confidence 46899999999999988877899998764
No 181
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=80.41 E-value=0.32 Score=47.62 Aligned_cols=32 Identities=16% Similarity=0.145 Sum_probs=27.1
Q ss_pred ccceeecccceeeehhhhhhhhHHHHHHHhhHh
Q psy3329 640 KSFLTLGNFGLISVGVIILSAMVYFSFYARHLY 672 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~ 672 (694)
.+.||.|+||.||+|+.. |..||||.......
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~ 42 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST 42 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh
Confidence 368999999999999985 67899998877655
No 182
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=80.38 E-value=0.23 Score=49.80 Aligned_cols=31 Identities=13% Similarity=0.060 Sum_probs=25.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~ 671 (694)
..||.|+||.||+|+-. +|++||||......
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~ 42 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEH 42 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEeccc
Confidence 68999999999999976 67899999876443
No 183
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=80.34 E-value=0.27 Score=48.54 Aligned_cols=32 Identities=16% Similarity=0.299 Sum_probs=24.6
Q ss_pred cccceeecccceeeehhhhh-hh---hHHHHHHHhh
Q psy3329 639 SKSFLTLGNFGLISVGVIIL-SA---MVYFSFYARH 670 (694)
Q Consensus 639 ~~~~iG~G~fG~VYkg~l~~-g~---~vaV~~~~~~ 670 (694)
..+.||+|+||.||+|+... |. +||||.....
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~ 44 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG 44 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEecccc
Confidence 34789999999999999863 32 6888876543
No 184
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=80.31 E-value=0.36 Score=48.77 Aligned_cols=29 Identities=17% Similarity=0.148 Sum_probs=23.2
Q ss_pred cceeecccceeeehhh--------hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI--------ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l--------~~g~~vaV~~~~~ 669 (694)
..||.|+||.||+|+. .++..||+|....
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~ 57 (304)
T cd05101 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57 (304)
T ss_pred ceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccc
Confidence 7899999999999974 2345789988764
No 185
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=80.27 E-value=0.27 Score=50.52 Aligned_cols=30 Identities=17% Similarity=-0.017 Sum_probs=24.2
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+.. +|.+||+|+....
T Consensus 11 ~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~ 41 (333)
T cd06650 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLE 41 (333)
T ss_pred ccccCCCCEEEEEEEECCCCcEEEEEEeecc
Confidence 57999999999999886 4668888865543
No 186
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=80.24 E-value=0.34 Score=49.62 Aligned_cols=30 Identities=13% Similarity=0.200 Sum_probs=25.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+.. +|..||||+....
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~ 54 (329)
T PTZ00263 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR 54 (329)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHH
Confidence 68999999999999985 4678999987654
No 187
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=80.17 E-value=0.29 Score=48.65 Aligned_cols=30 Identities=20% Similarity=0.259 Sum_probs=23.1
Q ss_pred ccceeecccceeeehhhh------hhhhHHHHHHHh
Q psy3329 640 KSFLTLGNFGLISVGVII------LSAMVYFSFYAR 669 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~------~g~~vaV~~~~~ 669 (694)
.+.||+|+||.||+|+.. .+..||||+...
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~ 46 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE 46 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc
Confidence 368999999999998753 345799987654
No 188
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=80.10 E-value=0.32 Score=48.54 Aligned_cols=30 Identities=27% Similarity=0.239 Sum_probs=23.4
Q ss_pred cceeecccceeeehh-----hhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGV-----IILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-----l~~g~~vaV~~~~~~ 670 (694)
..||+|+||.||.++ ..+|.+||||+....
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~ 44 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE 44 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccc
Confidence 579999999997754 346778999987654
No 189
>KOG0659|consensus
Probab=80.08 E-value=0.3 Score=46.36 Aligned_cols=31 Identities=13% Similarity=0.019 Sum_probs=23.1
Q ss_pred ccceeecccceeeehh-hhhhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGV-IILSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~ 670 (694)
...+|+|.||.||||+ ..-|+.||+|--+..
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~ 38 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLG 38 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeecc
Confidence 3579999999999997 334558888754443
No 190
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=79.86 E-value=0.33 Score=48.81 Aligned_cols=31 Identities=16% Similarity=0.175 Sum_probs=23.2
Q ss_pred cceeecccceeeehhhh-----------------hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII-----------------LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-----------------~g~~vaV~~~~~~~ 671 (694)
+.||+|+||.||++... ++..||||+.....
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~ 58 (296)
T cd05095 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA 58 (296)
T ss_pred eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC
Confidence 57999999999998543 23368888887543
No 191
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=79.85 E-value=0.25 Score=48.34 Aligned_cols=30 Identities=20% Similarity=0.246 Sum_probs=25.7
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|...++..+|||.....
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~ 39 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREG 39 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCC
Confidence 579999999999999887888999876643
No 192
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=79.79 E-value=0.31 Score=47.92 Aligned_cols=29 Identities=21% Similarity=0.138 Sum_probs=25.6
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+..++..||+|....
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~k~~~~ 40 (260)
T cd05070 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKP 40 (260)
T ss_pred heeccccCceEEEEEecCCceeEEEEecC
Confidence 57999999999999999888899987764
No 193
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=79.76 E-value=0.27 Score=48.88 Aligned_cols=29 Identities=14% Similarity=0.220 Sum_probs=24.5
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+. .+|..||||+...
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~ 36 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINL 36 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecC
Confidence 5799999999999996 5778999997643
No 194
>KOG0577|consensus
Probab=79.66 E-value=0.37 Score=50.88 Aligned_cols=35 Identities=20% Similarity=0.266 Sum_probs=25.8
Q ss_pred cceeecccceeeehhhhhh-hhHHHHHHHhhHhHhhhhh
Q psy3329 641 SFLTLGNFGLISVGVIILS-AMVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-~~vaV~~~~~~~~~~~~~~ 678 (694)
+-||.|+||.||.|.=.-. .+||+|--+ |-|+|..
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMs---ySGKQs~ 67 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSN 67 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeecc---ccccccH
Confidence 7899999999999975433 499996554 4555544
No 195
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=79.64 E-value=0.28 Score=49.00 Aligned_cols=29 Identities=14% Similarity=0.038 Sum_probs=24.2
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|... .|..||+|....
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~ 36 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRL 36 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeec
Confidence 46899999999999886 677899986654
No 196
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=79.60 E-value=0.42 Score=47.27 Aligned_cols=29 Identities=10% Similarity=0.257 Sum_probs=24.3
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
.+.||.|+||.||+|+-. +|..||||...
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~ 35 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVE 35 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeee
Confidence 457999999999999754 68899999764
No 197
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=79.59 E-value=0.27 Score=49.47 Aligned_cols=31 Identities=10% Similarity=-0.020 Sum_probs=26.8
Q ss_pred ccceeecccceeeehhhhh-hhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVIIL-SAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~ 670 (694)
.+.||.|+||.||+|+..+ |..||||.....
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~ 51 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT 51 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEecc
Confidence 4789999999999999976 889999987644
No 198
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=79.51 E-value=0.31 Score=49.25 Aligned_cols=29 Identities=17% Similarity=0.110 Sum_probs=21.6
Q ss_pred cceeecccceeeehhhh-hhh--hHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSA--MVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~--~vaV~~~~~ 669 (694)
+.||+|+||.||+|+.. +|. .||+|....
T Consensus 13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~ 44 (303)
T cd05088 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 44 (303)
T ss_pred eeecCCCCceEEEEEEccCCceeeEEEEEecc
Confidence 67999999999999864 454 456665443
No 199
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=79.41 E-value=0.33 Score=49.02 Aligned_cols=31 Identities=16% Similarity=0.104 Sum_probs=23.5
Q ss_pred ccceeecccceeeehhh------hhhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVI------ILSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l------~~g~~vaV~~~~~~ 670 (694)
.+.||+|+||.||+|+. .++..||||+....
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~ 76 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT 76 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc
Confidence 47899999999999874 23347899877644
No 200
>KOG0201|consensus
Probab=79.27 E-value=0.35 Score=49.22 Aligned_cols=30 Identities=13% Similarity=0.197 Sum_probs=23.1
Q ss_pred cceeecccceeeehhhhhh-hhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIILS-AMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-~~vaV~~~~~~ 670 (694)
..||+|.||.||||.-..- .+||.|+--..
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le 49 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE 49 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechh
Confidence 7899999999999986433 38888775443
No 201
>KOG0032|consensus
Probab=79.11 E-value=0.3 Score=50.67 Aligned_cols=36 Identities=19% Similarity=0.181 Sum_probs=33.3
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHhHhhh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLYRTKQ 676 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~~~~~ 676 (694)
..||+|.||.||+++-.. |..+|+|+-.....++.+
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~ 77 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE 77 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc
Confidence 789999999999999988 889999999998888877
No 202
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=79.04 E-value=0.33 Score=48.41 Aligned_cols=31 Identities=10% Similarity=0.158 Sum_probs=25.8
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~ 671 (694)
+.||.|+||.||+|...+ |.+||+|+.....
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~ 38 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESE 38 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhcc
Confidence 579999999999999864 6799999876543
No 203
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=79.04 E-value=0.31 Score=48.01 Aligned_cols=29 Identities=7% Similarity=0.108 Sum_probs=23.8
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|... +|..||||+...
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~ 36 (267)
T cd06610 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDL 36 (267)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEecc
Confidence 46899999999999954 566889998753
No 204
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=78.82 E-value=0.33 Score=48.73 Aligned_cols=31 Identities=16% Similarity=0.076 Sum_probs=23.9
Q ss_pred cceeecccceeeehhhhhh-----------------hhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIILS-----------------AMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-----------------~~vaV~~~~~~~ 671 (694)
..||+|+||.||+|+..+. .+||+|+.....
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~ 58 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA 58 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc
Confidence 6799999999999887642 357888876543
No 205
>KOG1166|consensus
Probab=78.79 E-value=0.4 Score=54.92 Aligned_cols=33 Identities=12% Similarity=0.040 Sum_probs=29.1
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhhHhH
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARHLYR 673 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~~ 673 (694)
..||+|++|+||+|+=.+|..||+|+-+-..++
T Consensus 704 ~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W 736 (974)
T KOG1166|consen 704 KEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW 736 (974)
T ss_pred eeeccccceEEEEeecCCCcEEEEEeecCCCce
Confidence 889999999999999999999999987655543
No 206
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=78.42 E-value=0.41 Score=47.48 Aligned_cols=29 Identities=7% Similarity=0.116 Sum_probs=24.8
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+.. +|..||+|+...
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~ 36 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDK 36 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEech
Confidence 46899999999999986 678999998765
No 207
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=78.31 E-value=0.36 Score=48.74 Aligned_cols=32 Identities=19% Similarity=0.242 Sum_probs=23.4
Q ss_pred cceeecccceeeehhhh-hhh----hHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSA----MVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~----~vaV~~~~~~~~ 672 (694)
+.||.|+||.||+|+.. +|. .||+|+......
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~ 49 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG 49 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCC
Confidence 68999999999999863 444 357776655443
No 208
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=78.26 E-value=0.36 Score=48.31 Aligned_cols=34 Identities=9% Similarity=0.043 Sum_probs=26.0
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHHhhHhH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYARHLYR 673 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~~~ 673 (694)
...||.|+||.||+++-. .|..||||........
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~ 43 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE 43 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh
Confidence 367999999999998864 4678999877654433
No 209
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=78.25 E-value=0.38 Score=48.05 Aligned_cols=29 Identities=17% Similarity=0.091 Sum_probs=23.4
Q ss_pred cceeecccceeeehhh-----hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI-----ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-----~~g~~vaV~~~~~ 669 (694)
..||+|+||.||.++. .+|..||||....
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~ 43 (284)
T cd05079 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 43 (284)
T ss_pred eecCCCCceeEEEEEEccCCCCccceEEEEEcCc
Confidence 4699999999999874 3567899998653
No 210
>KOG1035|consensus
Probab=78.20 E-value=0.85 Score=52.67 Aligned_cols=26 Identities=15% Similarity=0.065 Sum_probs=22.0
Q ss_pred cceeecccceeeehhh-hhhhhHHHHH
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSF 666 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~ 666 (694)
.+||+||||.|||.+= -||+.-|||-
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKK 511 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKK 511 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhh
Confidence 7999999999999852 3899888874
No 211
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=78.18 E-value=0.31 Score=48.85 Aligned_cols=31 Identities=13% Similarity=0.165 Sum_probs=25.3
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~ 671 (694)
..||.|+||.||+|+-. +|..||||+.....
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~ 42 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKT 42 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccC
Confidence 57999999999999764 67899999876543
No 212
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=78.15 E-value=0.33 Score=48.72 Aligned_cols=31 Identities=10% Similarity=-0.001 Sum_probs=25.6
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
.+.||.|+||.||+|+.. +|.+||||+....
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~ 37 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLE 37 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhh
Confidence 357999999999999975 6789999976554
No 213
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=78.13 E-value=0.41 Score=51.89 Aligned_cols=31 Identities=6% Similarity=-0.046 Sum_probs=27.7
Q ss_pred ccceeecccceeeehhhhh-hhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVIIL-SAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~ 670 (694)
..-||.|++|.||+|++.+ |+.||||+....
T Consensus 124 ~~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~ 155 (537)
T PRK04750 124 IKPLASASIAQVHFARLKDNGREVVVKVLRPD 155 (537)
T ss_pred hhhhcCCCccEEEEEEECCCCCEEEEEEeCcc
Confidence 3689999999999999999 999999988644
No 214
>KOG0194|consensus
Probab=78.05 E-value=0.39 Score=50.63 Aligned_cols=29 Identities=24% Similarity=0.226 Sum_probs=24.6
Q ss_pred cceeecccceeeehhhhhhh----h-HHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSA----M-VYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~----~-vaV~~~~~ 669 (694)
..||+|.||.||+|+|..+. + ||||....
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~ 196 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG 196 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecc
Confidence 78999999999999998862 3 88888774
No 215
>KOG0600|consensus
Probab=77.98 E-value=0.39 Score=49.78 Aligned_cols=25 Identities=12% Similarity=0.210 Sum_probs=21.5
Q ss_pred cceeecccceeeehh-hhhhhhHHHH
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFS 665 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~ 665 (694)
..||+|.||.||||+ +..|.+||.|
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALK 148 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALK 148 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEE
Confidence 579999999999996 6677788885
No 216
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=77.98 E-value=0.27 Score=49.19 Aligned_cols=29 Identities=10% Similarity=0.162 Sum_probs=24.2
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|+.. +|..||||+...
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~ 36 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKD 36 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEec
Confidence 46899999999999986 466899997754
No 217
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=77.87 E-value=0.35 Score=47.75 Aligned_cols=29 Identities=7% Similarity=0.015 Sum_probs=24.7
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+. .+|..||||+...
T Consensus 15 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~ 44 (267)
T cd06646 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKL 44 (267)
T ss_pred heeecCCCeEEEEEEECCCCeEEEEEEEec
Confidence 6799999999999996 5778899988753
No 218
>KOG0598|consensus
Probab=77.87 E-value=0.85 Score=45.45 Aligned_cols=35 Identities=11% Similarity=0.062 Sum_probs=26.9
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHhHhh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLYRTK 675 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~~~~ 675 (694)
++||+|+||.||..+-.| |+.-|+|+.....--.+
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~ 66 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK 66 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh
Confidence 799999999999887665 44888888876654443
No 219
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=77.65 E-value=0.37 Score=48.98 Aligned_cols=29 Identities=7% Similarity=-0.061 Sum_probs=23.2
Q ss_pred cceeecccceeeehhhhhh---hhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILS---AMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g---~~vaV~~~~~ 669 (694)
..||+|+||.||+|+..++ ..||||....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~ 38 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEG 38 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecC
Confidence 4699999999999997654 4788886543
No 220
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily.
Probab=77.51 E-value=2 Score=24.92 Aligned_cols=15 Identities=47% Similarity=0.592 Sum_probs=7.4
Q ss_pred CCccEEEccCCcCCc
Q psy3329 443 SRLRSLDLSRCKIDY 457 (694)
Q Consensus 443 ~~L~~L~Ls~n~l~~ 457 (694)
.+|+.|+|++|+|+.
T Consensus 2 ~~L~~L~L~~NkI~~ 16 (26)
T smart00365 2 TNLEELDLSQNKIKK 16 (26)
T ss_pred CccCEEECCCCccce
Confidence 345555555555543
No 221
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=77.25 E-value=0.42 Score=49.40 Aligned_cols=30 Identities=17% Similarity=0.112 Sum_probs=25.1
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|.. .+|..||||...+.
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~ 53 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 53 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCc
Confidence 6799999999999974 57889999977543
No 222
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=77.24 E-value=0.43 Score=48.52 Aligned_cols=29 Identities=7% Similarity=-0.073 Sum_probs=23.4
Q ss_pred cceeecccceeeehhhhh---hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL---SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~---g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+..+ +..||||....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~ 38 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEG 38 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECC
Confidence 579999999999998764 45788887654
No 223
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=77.18 E-value=0.36 Score=47.68 Aligned_cols=31 Identities=16% Similarity=0.219 Sum_probs=23.3
Q ss_pred ccceeecccceeeehhhh----hhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII----LSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~----~g~~vaV~~~~~~ 670 (694)
.+.||+|+||.||+|+.. .+..||||.....
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~ 43 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG 43 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCC
Confidence 368999999999999864 2337888876543
No 224
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=77.00 E-value=0.5 Score=49.16 Aligned_cols=30 Identities=10% Similarity=0.158 Sum_probs=24.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+++-. .|..||||+....
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~ 37 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKA 37 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHH
Confidence 57999999999999875 4779999987543
No 225
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=76.97 E-value=0.32 Score=50.56 Aligned_cols=30 Identities=17% Similarity=0.184 Sum_probs=25.0
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+- ..|..||||+..+.
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~ 57 (359)
T cd07876 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRP 57 (359)
T ss_pred EEeecCCCEEEEEEEEcCCCceeEEEEeccc
Confidence 6899999999999975 35779999987654
No 226
>PHA02988 hypothetical protein; Provisional
Probab=76.71 E-value=0.43 Score=47.65 Aligned_cols=29 Identities=10% Similarity=0.170 Sum_probs=25.8
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
..||+|++|.||+|++ +|..||||+....
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~ 54 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKF 54 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccc
Confidence 6899999999999999 7889999987654
No 227
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=76.62 E-value=0.34 Score=48.90 Aligned_cols=30 Identities=13% Similarity=0.079 Sum_probs=24.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. .|..||+|.....
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~ 42 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLE 42 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecc
Confidence 57999999999999865 4568899876543
No 228
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=76.34 E-value=0.47 Score=46.76 Aligned_cols=30 Identities=10% Similarity=0.016 Sum_probs=24.8
Q ss_pred ccceeecccceeeehhh-hhhhhHHHHHHHh
Q psy3329 640 KSFLTLGNFGLISVGVI-ILSAMVYFSFYAR 669 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~ 669 (694)
.+.||.|+||.||+|+. .+|..||||....
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~ 37 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQI 37 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeee
Confidence 35799999999999995 5888999986543
No 229
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=76.32 E-value=0.37 Score=49.49 Aligned_cols=30 Identities=13% Similarity=0.097 Sum_probs=25.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
++||.|+||.||+|+-. +|..||||+....
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~ 45 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKII 45 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeecc
Confidence 67999999999999854 6789999987543
No 230
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=76.32 E-value=0.42 Score=47.60 Aligned_cols=30 Identities=10% Similarity=0.146 Sum_probs=24.5
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+. .+|..||+|+....
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~ 52 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 52 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecC
Confidence 6899999999999997 45678999876543
No 231
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=76.03 E-value=0.5 Score=47.02 Aligned_cols=28 Identities=25% Similarity=0.332 Sum_probs=21.1
Q ss_pred cceeecccceeeehhhh-hhhh----HHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAM----VYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~----vaV~~~~ 668 (694)
+.||+|+||.||+|+.. +|.. ||+|...
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~ 45 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ 45 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecc
Confidence 68999999999999864 4543 5666654
No 232
>KOG1025|consensus
Probab=76.00 E-value=0.44 Score=52.54 Aligned_cols=36 Identities=19% Similarity=0.226 Sum_probs=26.5
Q ss_pred ccceeecccceeeehhhh-hhh----hHHHHHHHhhHhHhh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSA----MVYFSFYARHLYRTK 675 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~----~vaV~~~~~~~~~~~ 675 (694)
..+||.|.||+||||.+. .|. +||+||.-....+.+
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~ 741 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA 741 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh
Confidence 389999999999999874 444 788887655444433
No 233
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=75.80 E-value=0.42 Score=47.98 Aligned_cols=28 Identities=11% Similarity=0.179 Sum_probs=23.8
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~ 668 (694)
..||+|+||.||+|+. .+|..||||...
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~ 54 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMD 54 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEec
Confidence 5799999999999988 477899998754
No 234
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=75.70 E-value=0.44 Score=47.76 Aligned_cols=30 Identities=17% Similarity=0.183 Sum_probs=23.7
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|...+ +..||||+....
T Consensus 18 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~ 53 (293)
T cd05053 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD 53 (293)
T ss_pred eEecccccccEEEEEEecCCCCCCceeEEEEEccCC
Confidence 689999999999998753 247888877643
No 235
>KOG0198|consensus
Probab=75.67 E-value=0.65 Score=46.43 Aligned_cols=31 Identities=13% Similarity=0.156 Sum_probs=27.4
Q ss_pred ccceeecccceeeehhhhh-hhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVIIL-SAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~ 670 (694)
-+.||+|.||+||++...+ |...|||.....
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~ 53 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELE 53 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecc
Confidence 3789999999999999987 888999887776
No 236
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=75.60 E-value=0.56 Score=46.82 Aligned_cols=29 Identities=7% Similarity=0.020 Sum_probs=24.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+.. .|+.||+|+...
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~ 53 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDP 53 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeecc
Confidence 68999999999999774 467889987654
No 237
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=75.60 E-value=0.43 Score=49.76 Aligned_cols=30 Identities=20% Similarity=0.191 Sum_probs=24.4
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+- ..|..||||+....
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~ 60 (364)
T cd07875 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60 (364)
T ss_pred EEeecCCCeEEEEEEECCCCcEEEEEEeCcc
Confidence 6899999999999974 35668999987653
No 238
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=75.56 E-value=0.53 Score=48.50 Aligned_cols=31 Identities=16% Similarity=0.202 Sum_probs=24.6
Q ss_pred cceeecccceeeehhhhhh--hhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIILS--AMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g--~~vaV~~~~~~~ 671 (694)
..||+|+||.||+|+..+. ..||||+.....
T Consensus 36 ~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~ 68 (340)
T PTZ00426 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK 68 (340)
T ss_pred EEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH
Confidence 6799999999999986543 489999876543
No 239
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=75.50 E-value=0.38 Score=47.31 Aligned_cols=34 Identities=15% Similarity=0.096 Sum_probs=26.7
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhHhHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHLYRT 674 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~~~~ 674 (694)
+.||.|+||.||+|... +|..||+|.........
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~ 41 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA 41 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChH
Confidence 46999999999999987 57789998766554433
No 240
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=75.46 E-value=0.4 Score=47.64 Aligned_cols=30 Identities=17% Similarity=0.195 Sum_probs=24.8
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. .|.+||||+....
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~ 40 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE 40 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEecc
Confidence 56999999999999875 4779999987643
No 241
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=75.23 E-value=0.57 Score=48.94 Aligned_cols=30 Identities=10% Similarity=0.177 Sum_probs=24.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+-. .|..||||+....
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~ 79 (370)
T cd05596 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79 (370)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHH
Confidence 68999999999999875 4679999987543
No 242
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=75.19 E-value=0.45 Score=49.70 Aligned_cols=29 Identities=10% Similarity=0.183 Sum_probs=24.4
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+... |..||+|+...
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~ 78 (370)
T cd05621 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSK 78 (370)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEH
Confidence 689999999999999764 56899988754
No 243
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=74.99 E-value=0.6 Score=45.73 Aligned_cols=29 Identities=21% Similarity=0.198 Sum_probs=24.9
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
..||+|+||.||+|...++..||||....
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~ 38 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE 38 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCC
Confidence 46999999999999988877899996654
No 244
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=74.91 E-value=0.4 Score=47.49 Aligned_cols=31 Identities=13% Similarity=0.134 Sum_probs=25.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~ 671 (694)
..||.|+||.||+|+.. +|..||+|+.....
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~ 38 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE 38 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccc
Confidence 46899999999999975 57799999876543
No 245
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=74.81 E-value=0.46 Score=46.50 Aligned_cols=30 Identities=20% Similarity=0.201 Sum_probs=25.6
Q ss_pred ccceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 640 KSFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
.+.||+|+||.||+|...++..+|||+...
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~ 38 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIRE 38 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEecc
Confidence 367999999999999988777899998754
No 246
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=74.48 E-value=0.57 Score=47.43 Aligned_cols=30 Identities=20% Similarity=0.196 Sum_probs=22.9
Q ss_pred cceeecccceeeehhhh--------hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII--------LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~--------~g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|+.. .+..||||+....
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~ 61 (307)
T cd05098 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD 61 (307)
T ss_pred eeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC
Confidence 57899999999998742 3346888887643
No 247
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=74.27 E-value=0.54 Score=46.16 Aligned_cols=31 Identities=10% Similarity=-0.076 Sum_probs=26.2
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~ 671 (694)
+.||.|++|.||+|+..+ |..||||+.....
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~ 38 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG 38 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCc
Confidence 679999999999999985 7889998766554
No 248
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=74.25 E-value=0.56 Score=46.51 Aligned_cols=31 Identities=19% Similarity=0.214 Sum_probs=24.5
Q ss_pred cceeecccceeeehhhhh------hhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIIL------SAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~------g~~vaV~~~~~~~ 671 (694)
+.||.|+||.||+|...+ +..||+|......
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~ 48 (277)
T cd05032 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA 48 (277)
T ss_pred eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc
Confidence 679999999999998754 2478888876443
No 249
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=73.69 E-value=0.57 Score=53.89 Aligned_cols=29 Identities=14% Similarity=0.086 Sum_probs=24.2
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|+-. .|..||||+...
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~ 37 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIRE 37 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECc
Confidence 57999999999999864 477999997654
No 250
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=73.68 E-value=0.55 Score=47.57 Aligned_cols=30 Identities=13% Similarity=0.038 Sum_probs=23.5
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+.. .|.+||+|.....
T Consensus 7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~ 37 (308)
T cd06615 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLE 37 (308)
T ss_pred eeccCCCCeEEEEEEEcCCCeEEEEEEeccc
Confidence 57999999999999865 4668888776543
No 251
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=73.66 E-value=0.62 Score=46.85 Aligned_cols=28 Identities=18% Similarity=0.245 Sum_probs=21.0
Q ss_pred cceeecccceeeehhhhhh-h--hHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILS-A--MVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-~--~vaV~~~~ 668 (694)
.+||.|+||.||+|+..+. . .||+|...
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~ 38 (297)
T cd05089 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK 38 (297)
T ss_pred eeecCCCcceEEEEEecCCCCcceeEEEEcc
Confidence 5799999999999998653 3 35665554
No 252
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=73.51 E-value=0.66 Score=46.43 Aligned_cols=29 Identities=7% Similarity=0.046 Sum_probs=24.3
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+.. +|..||||+...
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~ 57 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDP 57 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecc
Confidence 68999999999999884 577888887754
No 253
>KOG1163|consensus
Probab=73.50 E-value=0.47 Score=44.37 Aligned_cols=30 Identities=23% Similarity=0.330 Sum_probs=25.7
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~ 670 (694)
+-||.|+||.+|.|. +.+|..||+|+-+..
T Consensus 21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~ 51 (341)
T KOG1163|consen 21 RKIGSGSFGDIYLGISITSGEEVAIKLESSK 51 (341)
T ss_pred EeecCCchhheeeeeeccCCceEEEEeeccc
Confidence 579999999999996 678899999986654
No 254
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=73.37 E-value=0.52 Score=47.46 Aligned_cols=30 Identities=10% Similarity=0.015 Sum_probs=25.4
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+- .+|..||||.....
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~ 55 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQ 55 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecC
Confidence 6799999999999984 57889999987643
No 255
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type.
Probab=73.27 E-value=2.4 Score=24.45 Aligned_cols=16 Identities=31% Similarity=0.613 Sum_probs=9.0
Q ss_pred CccEEEccCCcCCccC
Q psy3329 444 RLRSLDLSRCKIDYLP 459 (694)
Q Consensus 444 ~L~~L~Ls~n~l~~~~ 459 (694)
+|+.|++++|+|+.+|
T Consensus 3 ~L~~L~vs~N~Lt~LP 18 (26)
T smart00364 3 SLKELNVSNNQLTSLP 18 (26)
T ss_pred ccceeecCCCccccCc
Confidence 4555566666555554
No 256
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=73.14 E-value=0.57 Score=48.58 Aligned_cols=30 Identities=17% Similarity=0.141 Sum_probs=24.1
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+-. .|..||||...+.
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~ 53 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCc
Confidence 67999999999999743 4668999977643
No 257
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=73.09 E-value=0.6 Score=45.95 Aligned_cols=31 Identities=26% Similarity=0.192 Sum_probs=25.7
Q ss_pred ccceeecccceeeehhhhh-hhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVIIL-SAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~ 670 (694)
.+.||+|+||.||+|+..+ ++.||||+....
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~ 42 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 42 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCC
Confidence 3679999999999999764 678999987654
No 258
>KOG3763|consensus
Probab=72.63 E-value=1.8 Score=45.75 Aligned_cols=66 Identities=29% Similarity=0.284 Sum_probs=45.0
Q ss_pred CCCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCC--cCCccCCCCCCCCCCCCEEEccCCccCC
Q psy3329 416 YPDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRC--KIDYLPPNVFNNTRNITSLNLANNNLSM 481 (694)
Q Consensus 416 ~~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n--~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 481 (694)
.+.+..+.|++|++..+....-+....++|..|+|++| .+.....-.=-+...|++|-+.+|.+..
T Consensus 217 ~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~l~Leel~l~GNPlc~ 284 (585)
T KOG3763|consen 217 FPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKGLPLEELVLEGNPLCT 284 (585)
T ss_pred CcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcCCCHHHeeecCCcccc
Confidence 78888999999988776544333356688999999999 4443221111123467899999998864
No 259
>KOG4242|consensus
Probab=72.52 E-value=28 Score=36.38 Aligned_cols=114 Identities=20% Similarity=0.062 Sum_probs=62.6
Q ss_pred CCCceEEcCCCCCcccCCCCCCCcCCCCccEEEccCCcC---CccC----CCCC--CCCCCCCEEEccCCccCCCcchhh
Q psy3329 417 PDLEELRLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKI---DYLP----PNVF--NNTRNITSLNLANNNLSMTSELSF 487 (694)
Q Consensus 417 ~~L~~L~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l---~~~~----~~~~--~~l~~L~~L~L~~N~l~~~~~~~~ 487 (694)
..+++|.++.|.+.+.......-..-+..+.+++.+-.- .+.. +-.. ....-+..+.++.|.+..-.....
T Consensus 354 ~R~q~l~~rdnnldgeg~~vgk~~~s~s~r~l~agrs~~kqvm~s~~~a~~v~k~~~~~g~l~el~ls~~~lka~l~s~i 433 (553)
T KOG4242|consen 354 QRVQVLLQRDNNLDGEGGAVGKRKQSKSGRILKAGRSGDKQVMDSSTEAPPVSKKSRTHGVLAELSLSPGPLKAGLESAI 433 (553)
T ss_pred eeeeEeeccccccccccccccceeeccccccccccccCCceeccccccchhhhhhhcccccccCcccCCCcccccHHHHH
Confidence 357888888888776554433213445666676654322 1100 0000 111246677888887765554444
Q ss_pred hhhcccCCCcEEECCCCcccc----cChhhhcCCCcccEEEccCCcc
Q psy3329 488 QFLDVLLELESLDLSNNNLTH----ISPTVLRHNRAITSIKLVGNPW 530 (694)
Q Consensus 488 ~~l~~l~~L~~L~ls~N~l~~----~~~~~~~~~~~l~~l~l~~N~~ 530 (694)
..+..-+.+..|++++|.-.. ++|..++.-.+++.+..+.|-.
T Consensus 434 n~l~stqtl~kldisgn~mgd~gap~lpkalq~n~rlr~ipds~n~p 480 (553)
T KOG4242|consen 434 NKLLSTQTLAKLDISGNGMGDGGAPPLPKALQSNCRLRPIPDSLNLP 480 (553)
T ss_pred HhhccCcccccccccCCCcccCCCCcCccccCCCCccCCCCCCCCCc
Confidence 455666788888888887543 3344444444455555554433
No 260
>KOG0583|consensus
Probab=72.44 E-value=0.63 Score=48.24 Aligned_cols=30 Identities=20% Similarity=0.300 Sum_probs=25.1
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~ 670 (694)
..||+|+||+||.|+ ...|..||||+.-+.
T Consensus 23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~ 53 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRK 53 (370)
T ss_pred eeecCCCCeeEEEeeeccCCCeEEEEEechh
Confidence 689999999999995 446789999976664
No 261
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=72.03 E-value=0.6 Score=46.01 Aligned_cols=29 Identities=10% Similarity=0.031 Sum_probs=23.8
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
...||.|+||.||+|+.. +|..||||...
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~ 36 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQ 36 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEee
Confidence 357999999999999864 67799998654
No 262
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=72.03 E-value=0.88 Score=44.42 Aligned_cols=29 Identities=17% Similarity=0.173 Sum_probs=23.8
Q ss_pred ccceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 640 KSFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
.+.||+|+||.||+|.. .|..||||....
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~ 39 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKC 39 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecC
Confidence 37899999999999986 667888887643
No 263
>KOG0197|consensus
Probab=71.51 E-value=0.94 Score=47.31 Aligned_cols=30 Identities=23% Similarity=0.122 Sum_probs=26.2
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
+-||+|.||.|+.|.+..-+.||||..+..
T Consensus 212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~ 241 (468)
T KOG0197|consen 212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEG 241 (468)
T ss_pred HHhcCCccceEEEEEEcCCCcccceEEecc
Confidence 789999999999999977779999877663
No 264
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=71.39 E-value=0.84 Score=45.51 Aligned_cols=29 Identities=10% Similarity=0.167 Sum_probs=24.4
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+..+ |..||||++..
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~ 36 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKE 36 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhh
Confidence 468999999999998864 66899998764
No 265
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=70.81 E-value=0.67 Score=47.79 Aligned_cols=28 Identities=14% Similarity=0.114 Sum_probs=23.9
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~ 668 (694)
..||.|+||.||+|+ ..+|..||||+..
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~ 49 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLY 49 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEec
Confidence 579999999999997 4578899999764
No 266
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=70.70 E-value=0.61 Score=46.80 Aligned_cols=30 Identities=7% Similarity=0.045 Sum_probs=25.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||+|+||.||+|+.. +|.+||||.....
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~ 38 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLE 38 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhc
Confidence 57899999999999875 6788999877543
No 267
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=70.49 E-value=1 Score=51.16 Aligned_cols=30 Identities=17% Similarity=0.208 Sum_probs=25.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. +|..||||+....
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~ 40 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKA 40 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehh
Confidence 57999999999999987 5779999987543
No 268
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=70.14 E-value=0.68 Score=47.04 Aligned_cols=31 Identities=10% Similarity=0.135 Sum_probs=26.1
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~ 671 (694)
+.||.|+||.||+|+..+ |..||+|......
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~ 38 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE 38 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccc
Confidence 469999999999999876 7799999887543
No 269
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=70.09 E-value=0.83 Score=45.76 Aligned_cols=30 Identities=17% Similarity=0.057 Sum_probs=24.9
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+..+ |..||+|+....
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~ 48 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAKVIETK 48 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEEEeccC
Confidence 569999999999998865 778888887644
No 270
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=70.08 E-value=0.76 Score=47.37 Aligned_cols=29 Identities=14% Similarity=0.164 Sum_probs=24.9
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+. .+|..||||+..+
T Consensus 21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~ 50 (342)
T cd07879 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSR 50 (342)
T ss_pred EEeeecCCeEEEEEEeCCCCcEEEEEEecC
Confidence 7899999999999985 4688999997654
No 271
>KOG1235|consensus
Probab=69.96 E-value=0.69 Score=49.72 Aligned_cols=36 Identities=6% Similarity=-0.046 Sum_probs=30.1
Q ss_pred CcccceeecccceeeehhhhhhhhHHHHHHHhhHhH
Q psy3329 638 NSKSFLTLGNFGLISVGVIILSAMVYFSFYARHLYR 673 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~~ 673 (694)
.+..-||.-+.|-||+|+|++|..|||||-.-....
T Consensus 164 f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~ 199 (538)
T KOG1235|consen 164 FDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEK 199 (538)
T ss_pred cCcchhhhcchhheEEEEecCCCEEEEEecCcChHH
Confidence 455789999999999999999999999986554443
No 272
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=69.87 E-value=0.54 Score=46.87 Aligned_cols=30 Identities=13% Similarity=0.158 Sum_probs=25.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. +|..||+|+....
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~ 37 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVES 37 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeec
Confidence 46899999999999987 5789999977543
No 273
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=69.83 E-value=0.64 Score=45.63 Aligned_cols=28 Identities=21% Similarity=0.145 Sum_probs=23.9
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~ 668 (694)
..||.|+||.||+|+..++..||+|...
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~ 39 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLK 39 (260)
T ss_pred eeecCcCCCeEEEEEEcCCceEEEEEcc
Confidence 4699999999999999887788888654
No 274
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=69.78 E-value=0.89 Score=45.23 Aligned_cols=31 Identities=19% Similarity=0.086 Sum_probs=23.2
Q ss_pred ccceeecccceeeehhhh------hhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII------LSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~------~g~~vaV~~~~~~ 670 (694)
.+.||+||||.||++... ++..||||.....
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~ 46 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA 46 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC
Confidence 468999999999999642 3557888776543
No 275
>KOG0605|consensus
Probab=69.31 E-value=1.3 Score=46.56 Aligned_cols=32 Identities=9% Similarity=0.141 Sum_probs=26.2
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~ 672 (694)
.+||+|+||.||.++=.| |.+.|.|++...--
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M 179 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM 179 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHH
Confidence 789999999999998766 45889988765543
No 276
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=68.67 E-value=0.74 Score=46.58 Aligned_cols=29 Identities=14% Similarity=0.163 Sum_probs=24.7
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+.. +|..||+|+...
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~ 50 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSY 50 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEec
Confidence 67999999999999875 577999987754
No 277
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=68.54 E-value=0.65 Score=50.01 Aligned_cols=34 Identities=6% Similarity=-0.027 Sum_probs=29.2
Q ss_pred CcccceeecccceeeehhhhhhhhHHHHHHHhhH
Q psy3329 638 NSKSFLTLGNFGLISVGVIILSAMVYFSFYARHL 671 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~ 671 (694)
.+.+-|+.++-|-||+|+|.+|..|||||---..
T Consensus 128 F~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi 161 (517)
T COG0661 128 FEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGI 161 (517)
T ss_pred cCCCchhhhhHhhheeEEecCCCEEEEEecCCCh
Confidence 5558899999999999999999999999865433
No 278
>KOG1006|consensus
Probab=68.48 E-value=0.65 Score=44.13 Aligned_cols=42 Identities=12% Similarity=0.106 Sum_probs=34.0
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhhHhHhhhhhhhcc
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARHLYRTKQQRIRRN 682 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~~~~~~~~~~~ 682 (694)
..||.|.||+|||-+- +.|.+.|||.-....--..|+|...|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e 112 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLME 112 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHH
Confidence 6799999999999765 46779999988877777777776554
No 279
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=67.63 E-value=0.93 Score=46.03 Aligned_cols=31 Identities=16% Similarity=0.133 Sum_probs=22.8
Q ss_pred ccceeecccceeeehhhh--------hhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII--------LSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~--------~g~~vaV~~~~~~ 670 (694)
.+.||+|+||.||+|+-. .+..||||.....
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~ 55 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN 55 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC
Confidence 378999999999998642 2346888876543
No 280
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=67.37 E-value=1.1 Score=44.77 Aligned_cols=30 Identities=20% Similarity=0.141 Sum_probs=22.7
Q ss_pred ccceeecccceeeehhhh------hhhhHHHHHHHh
Q psy3329 640 KSFLTLGNFGLISVGVII------LSAMVYFSFYAR 669 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~------~g~~vaV~~~~~ 669 (694)
.+.||.|+||.||+++.. ++..||||....
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~ 45 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD 45 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC
Confidence 468999999999999852 334678877654
No 281
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=67.30 E-value=0.91 Score=44.30 Aligned_cols=32 Identities=13% Similarity=0.075 Sum_probs=26.4
Q ss_pred ccceeecccceeeehhhhh-hhhHHHHHHHhhH
Q psy3329 640 KSFLTLGNFGLISVGVIIL-SAMVYFSFYARHL 671 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~ 671 (694)
...||.|+||.||+|+..+ |..||||......
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~ 40 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE 40 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH
Confidence 3579999999999999987 6788998876553
No 282
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=67.28 E-value=0.82 Score=45.69 Aligned_cols=31 Identities=13% Similarity=0.013 Sum_probs=25.4
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
.+.||.|++|.||+|... .+..||+|+....
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~ 37 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTD 37 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecC
Confidence 357899999999999985 4678999987654
No 283
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=67.20 E-value=1 Score=45.15 Aligned_cols=29 Identities=10% Similarity=0.001 Sum_probs=23.5
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+- .+|..||+|....
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~ 54 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNL 54 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEecc
Confidence 5699999999999974 4667888887643
No 284
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=67.00 E-value=1.1 Score=43.99 Aligned_cols=28 Identities=14% Similarity=0.064 Sum_probs=23.5
Q ss_pred ccceeecccceeeehhhhh-hhhHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVIIL-SAMVYFSFY 667 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~-g~~vaV~~~ 667 (694)
.++||+|+||.||+|+..+ |..||||..
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~ 35 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQV 35 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEe
Confidence 4689999999999998754 779999865
No 285
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=66.96 E-value=0.91 Score=47.43 Aligned_cols=29 Identities=10% Similarity=0.179 Sum_probs=24.0
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~ 669 (694)
..||+|+||.||+++... |.+||+|+...
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~ 78 (371)
T cd05622 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 78 (371)
T ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEEEH
Confidence 789999999999998764 45889987654
No 286
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=66.47 E-value=1.2 Score=43.65 Aligned_cols=28 Identities=18% Similarity=0.208 Sum_probs=23.4
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|... |..||+|....
T Consensus 12 ~~lg~g~~~~v~~~~~~-~~~~~~k~~~~ 39 (256)
T cd05082 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN 39 (256)
T ss_pred eeecccCCCeEEEEEEc-CCcEEEEEeCC
Confidence 67999999999999875 67788887653
No 287
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=66.42 E-value=1.1 Score=49.48 Aligned_cols=21 Identities=14% Similarity=0.083 Sum_probs=18.3
Q ss_pred ccceeecccceeeehhhhhhh
Q psy3329 640 KSFLTLGNFGLISVGVIILSA 660 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~ 660 (694)
.+.||+|+||.||+|.+.+..
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~ 358 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD 358 (535)
T ss_pred cceeccCCcEEEEEEeecCcc
Confidence 589999999999999986664
No 288
>KOG0593|consensus
Probab=66.15 E-value=1.1 Score=43.49 Aligned_cols=29 Identities=10% Similarity=0.122 Sum_probs=23.1
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~ 669 (694)
..+|+|++|+|||-+=.+ |.+||||.+-.
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~E 37 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVE 37 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeecc
Confidence 368999999999988755 56899887643
No 289
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=66.09 E-value=0.72 Score=46.44 Aligned_cols=31 Identities=10% Similarity=0.027 Sum_probs=25.5
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
.+.||.|+||.||+|+.. +|..||||+....
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~ 43 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLD 43 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeec
Confidence 368999999999999986 4778999887543
No 290
>KOG0594|consensus
Probab=66.03 E-value=1.1 Score=44.47 Aligned_cols=27 Identities=15% Similarity=0.138 Sum_probs=21.4
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFY 667 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~ 667 (694)
+.||+|.||+||||+- ..|..||+|.-
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKki 44 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKI 44 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEE
Confidence 4599999999999975 45668888643
No 291
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=65.68 E-value=1.1 Score=44.24 Aligned_cols=29 Identities=10% Similarity=0.236 Sum_probs=23.8
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|... ++.+||||+...
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~ 41 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDV 41 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEc
Confidence 57999999999999875 456889988643
No 292
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=65.66 E-value=0.79 Score=47.49 Aligned_cols=29 Identities=14% Similarity=0.103 Sum_probs=24.6
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
..||+|+||.||+|+-. +|..||||....
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~ 51 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSR 51 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCc
Confidence 67999999999999854 678999998754
No 293
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=65.13 E-value=0.92 Score=45.65 Aligned_cols=29 Identities=10% Similarity=0.065 Sum_probs=24.1
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
..||.|+||.||+|+.. +|..||||+...
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~ 56 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDL 56 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEe
Confidence 46999999999999864 678999998643
No 294
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=65.12 E-value=0.73 Score=46.66 Aligned_cols=30 Identities=10% Similarity=0.105 Sum_probs=25.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+.. +|..||+|+....
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~ 43 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMD 43 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEec
Confidence 67999999999999975 4789999977543
No 295
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=64.93 E-value=0.96 Score=46.00 Aligned_cols=31 Identities=13% Similarity=0.128 Sum_probs=25.4
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
.+.||.|+||.||+|+.. +|..||||+....
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~ 61 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYS 61 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecC
Confidence 467999999999999964 5779999887643
No 296
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=64.58 E-value=1 Score=45.29 Aligned_cols=30 Identities=10% Similarity=-0.005 Sum_probs=24.4
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+- .+|..||||.....
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~ 56 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 56 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecC
Confidence 5799999999999984 56778998876543
No 297
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=64.54 E-value=1.2 Score=44.57 Aligned_cols=29 Identities=10% Similarity=0.029 Sum_probs=23.9
Q ss_pred ccceeecccceeeehhh-hhhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVI-ILSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l-~~g~~vaV~~~~ 668 (694)
-+.||.|++|.||+|+- .+|..||+|+..
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~ 53 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMD 53 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEe
Confidence 36899999999999985 467788888654
No 298
>KOG0615|consensus
Probab=64.45 E-value=1.3 Score=45.03 Aligned_cols=37 Identities=16% Similarity=0.174 Sum_probs=30.5
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhhHhHhhhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARHLYRTKQQ 677 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~~~~~~ 677 (694)
+.+|.|+||.|-+|.= ..|.+||||+.+.+..-+..+
T Consensus 178 ~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~ 215 (475)
T KOG0615|consen 178 KTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR 215 (475)
T ss_pred eeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc
Confidence 6899999999998864 467799999999888777443
No 299
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=63.86 E-value=1.4 Score=44.02 Aligned_cols=30 Identities=13% Similarity=0.144 Sum_probs=24.8
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. +|..||||+....
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~ 37 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKA 37 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHH
Confidence 57999999999999876 4679999887543
No 300
>PHA03211 serine/threonine kinase US3; Provisional
Probab=63.61 E-value=1.6 Score=46.94 Aligned_cols=27 Identities=19% Similarity=-0.070 Sum_probs=22.6
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFY 667 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~ 667 (694)
..||+|+||.||+|+... +..||||..
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~ 202 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAG 202 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEecc
Confidence 679999999999999865 457899853
No 301
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=63.07 E-value=0.72 Score=45.44 Aligned_cols=29 Identities=14% Similarity=0.108 Sum_probs=23.7
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
.+.||+|+||.||+|.-. .|..||+|...
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~ 36 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQ 36 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEee
Confidence 468999999999999875 47788888654
No 302
>KOG0574|consensus
Probab=62.61 E-value=1.5 Score=42.27 Aligned_cols=26 Identities=12% Similarity=0.139 Sum_probs=20.9
Q ss_pred cceeecccceeeehhh-hhhhhHHHHH
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSF 666 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~ 666 (694)
.-+|+|++|+||||.- +.|.+||+|.
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~ 65 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKK 65 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEe
Confidence 5699999999999975 4566888763
No 303
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=62.51 E-value=6.3 Score=23.21 Aligned_cols=13 Identities=38% Similarity=0.713 Sum_probs=6.4
Q ss_pred CCCEEEccCCccC
Q psy3329 468 NITSLNLANNNLS 480 (694)
Q Consensus 468 ~L~~L~L~~N~l~ 480 (694)
+|++|+|++|.+.
T Consensus 3 ~L~~LdL~~N~i~ 15 (28)
T smart00368 3 SLRELDLSNNKLG 15 (28)
T ss_pred ccCEEECCCCCCC
Confidence 3445555555543
No 304
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=62.44 E-value=1.1 Score=46.14 Aligned_cols=29 Identities=21% Similarity=0.028 Sum_probs=23.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||.|+||.||+|+-. .|..||||....
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~ 40 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVL 40 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEec
Confidence 57999999999999864 467888886543
No 305
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=62.28 E-value=1.2 Score=44.66 Aligned_cols=30 Identities=10% Similarity=0.076 Sum_probs=24.5
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+ ..+|..||||.....
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~ 55 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQ 55 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecc
Confidence 569999999999997 457789999877543
No 306
>PHA03212 serine/threonine kinase US3; Provisional
Probab=62.17 E-value=2.1 Score=45.07 Aligned_cols=29 Identities=17% Similarity=0.017 Sum_probs=23.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
..||+|+||.||++.-. .|..||+|...+
T Consensus 98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~ 127 (391)
T PHA03212 98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQR 127 (391)
T ss_pred EEEcCCCCeEEEEEEECCCCCEEEEechhh
Confidence 67999999999999753 456899986543
No 307
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=61.68 E-value=1.6 Score=44.83 Aligned_cols=29 Identities=21% Similarity=0.192 Sum_probs=21.5
Q ss_pred cceeecccceeeehhhhh--------hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL--------SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~--------g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|+-.. +..||+|+...
T Consensus 18 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~ 54 (334)
T cd05100 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD 54 (334)
T ss_pred ceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc
Confidence 679999999999996422 23678887653
No 308
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=61.45 E-value=1.5 Score=43.99 Aligned_cols=29 Identities=10% Similarity=0.044 Sum_probs=23.6
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
..||.|+||.||+|... +|..||||....
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~ 57 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDL 57 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEec
Confidence 56999999999999864 577899987643
No 309
>PHA03209 serine/threonine kinase US3; Provisional
Probab=60.99 E-value=1.6 Score=45.39 Aligned_cols=27 Identities=22% Similarity=0.055 Sum_probs=22.3
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFY 667 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~ 667 (694)
..||.|+||.||+|+... +..||+|+.
T Consensus 72 ~~lg~G~~g~Vy~~~~~~~~~~valK~~ 99 (357)
T PHA03209 72 KTLTPGSEGRVFVATKPGQPDPVVLKIG 99 (357)
T ss_pred EEecCCCCeEEEEEEECCCCceEEEEeC
Confidence 689999999999999754 348888863
No 310
>KOG0694|consensus
Probab=60.85 E-value=1.3 Score=47.87 Aligned_cols=31 Identities=13% Similarity=0.157 Sum_probs=25.0
Q ss_pred cceeecccceeeehhhhhhh-hHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIILSA-MVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~-~vaV~~~~~~~ 671 (694)
.+||+|+||.||.+.+..-. .-|||++....
T Consensus 374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~ 405 (694)
T KOG0694|consen 374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGD 405 (694)
T ss_pred EEeccCcCceEEEEEEcCCCcEEEEEEeeccc
Confidence 79999999999999986543 77888776543
No 311
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=60.76 E-value=1.5 Score=45.28 Aligned_cols=29 Identities=17% Similarity=0.159 Sum_probs=24.6
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
..||.|+||.||+|+.. +|..||||+...
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~ 50 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSR 50 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEeccc
Confidence 68999999999999986 466899998754
No 312
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=60.10 E-value=1.9 Score=43.11 Aligned_cols=31 Identities=16% Similarity=0.076 Sum_probs=23.5
Q ss_pred cceeecccceeeehhhh------hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII------LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~------~g~~vaV~~~~~~~ 671 (694)
+.||+|+||.||+|+.. ++..||+|......
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~ 47 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT 47 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc
Confidence 68999999999999743 34468888766443
No 313
>KOG3763|consensus
Probab=59.77 E-value=5.7 Score=42.16 Aligned_cols=16 Identities=25% Similarity=0.169 Sum_probs=9.8
Q ss_pred CCCcccEEeCCCCCCC
Q psy3329 186 NLVHLDSLDLSNCHLK 201 (694)
Q Consensus 186 ~~~~L~~L~l~~n~~~ 201 (694)
....|++|.+.+|.+.
T Consensus 268 k~l~Leel~l~GNPlc 283 (585)
T KOG3763|consen 268 KGLPLEELVLEGNPLC 283 (585)
T ss_pred cCCCHHHeeecCCccc
Confidence 3445666777777664
No 314
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=59.43 E-value=1.3 Score=43.55 Aligned_cols=29 Identities=7% Similarity=0.087 Sum_probs=23.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
..||.|+||.||+|+.. +|..||||+...
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~ 44 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKL 44 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEec
Confidence 67999999999999864 577899987643
No 315
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=59.17 E-value=1.4 Score=43.81 Aligned_cols=30 Identities=13% Similarity=0.010 Sum_probs=24.4
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. +|..||+|+....
T Consensus 11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~ 41 (280)
T cd06611 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIE 41 (280)
T ss_pred HHhcCCCCceEEEEEEcCCCcEEEEEEEeeC
Confidence 45899999999999985 5778999887543
No 316
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=58.87 E-value=1.5 Score=43.51 Aligned_cols=29 Identities=14% Similarity=0.024 Sum_probs=22.9
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~ 669 (694)
..||.|+||.||+|.... |.+||+|....
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~ 40 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDT 40 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCC
Confidence 459999999999999865 55778877643
No 317
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=58.79 E-value=1 Score=45.49 Aligned_cols=30 Identities=13% Similarity=0.042 Sum_probs=24.7
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
...||.|+||.||+|+-. +|..||||....
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~ 47 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLM 47 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEec
Confidence 367999999999999875 577999987643
No 318
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=58.39 E-value=1.2 Score=44.68 Aligned_cols=30 Identities=10% Similarity=0.084 Sum_probs=24.8
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
.+.||.|+||.||+|+.. +|++||||....
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~ 40 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKM 40 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEee
Confidence 368999999999999986 477888887653
No 319
>PHA03207 serine/threonine kinase US3; Provisional
Probab=58.29 E-value=2 Score=45.24 Aligned_cols=30 Identities=23% Similarity=-0.001 Sum_probs=23.0
Q ss_pred cceeecccceeeehhhhh---hhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIIL---SAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~---g~~vaV~~~~~~ 670 (694)
..||.|+||.||+++..+ +..||||.....
T Consensus 98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~ 130 (392)
T PHA03207 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG 130 (392)
T ss_pred EeecCCCCeEEEEEEEcCCccceeEEEEecccc
Confidence 579999999999987543 457888876544
No 320
>KOG0662|consensus
Probab=58.24 E-value=2 Score=38.09 Aligned_cols=25 Identities=12% Similarity=0.109 Sum_probs=19.5
Q ss_pred cceeecccceeeehhhhh-hhhHHHH
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFS 665 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~ 665 (694)
+.||+|.+|+|+||+=.+ +.+||.|
T Consensus 8 ekigegtygtvfkarn~~t~eivalk 33 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALK 33 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEE
Confidence 579999999999998544 3467665
No 321
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=58.23 E-value=1.6 Score=44.92 Aligned_cols=29 Identities=14% Similarity=0.132 Sum_probs=23.6
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~ 669 (694)
..||.|+||.||+|+- ..|..||||....
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~ 40 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIAN 40 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecc
Confidence 5799999999999985 3577899987543
No 322
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=58.06 E-value=1.5 Score=43.78 Aligned_cols=31 Identities=10% Similarity=-0.125 Sum_probs=26.0
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~~ 671 (694)
+.||.|+||.||+|... ++..||+|+.....
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~ 56 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK 56 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCc
Confidence 68999999999999997 57788998876443
No 323
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=57.58 E-value=1.5 Score=45.10 Aligned_cols=28 Identities=14% Similarity=0.138 Sum_probs=23.5
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
+.||.|+||.||+|+.. +|..||||...
T Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~ 41 (337)
T cd07852 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIF 41 (337)
T ss_pred HhhcCCCCeeEEEEEEcCCCeEEEEEeec
Confidence 67999999999999875 57789998653
No 324
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=57.48 E-value=1.6 Score=44.35 Aligned_cols=29 Identities=14% Similarity=0.131 Sum_probs=23.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~ 669 (694)
+.||+|+||.||+|+.. .|..||+|....
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~ 56 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSY 56 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEec
Confidence 56999999999999864 567899887754
No 325
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=55.95 E-value=1.6 Score=44.60 Aligned_cols=28 Identities=18% Similarity=0.236 Sum_probs=23.8
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~ 668 (694)
+.||.|+||.||+|+ ..+|..||||...
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~ 44 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIM 44 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEec
Confidence 689999999999997 4478899998654
No 326
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=55.35 E-value=2.7 Score=41.15 Aligned_cols=29 Identities=14% Similarity=0.141 Sum_probs=23.7
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
.+.||.|+||.||+|.-. +|..||||+..
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~ 36 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVP 36 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEe
Confidence 468999999999999864 57788888653
No 327
>KOG0663|consensus
Probab=55.05 E-value=2.7 Score=41.54 Aligned_cols=26 Identities=12% Similarity=0.147 Sum_probs=20.7
Q ss_pred cceeecccceeeehhhhh-hhhHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSF 666 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~ 666 (694)
|.|++|.||.||+|+=.- .++||.|-
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr 108 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKR 108 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeee
Confidence 899999999999998543 23888753
No 328
>KOG0696|consensus
Probab=54.95 E-value=11 Score=38.37 Aligned_cols=44 Identities=14% Similarity=0.105 Sum_probs=31.2
Q ss_pred CCccccccccCcc---cceeecccceeeehhhhhhh-hHHHHHHHhhH
Q psy3329 628 APSYINMEKLNSK---SFLTLGNFGLISVGVIILSA-MVYFSFYARHL 671 (694)
Q Consensus 628 ~~s~~~l~~~~~~---~~iG~G~fG~VYkg~l~~g~-~vaV~~~~~~~ 671 (694)
..+-.+...|++= .+||+|+||.|..|.=.... .-|||++...+
T Consensus 339 ~~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV 386 (683)
T KOG0696|consen 339 NSSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV 386 (683)
T ss_pred CCCcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccce
Confidence 3344455555544 69999999999999874433 78999887654
No 329
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=54.81 E-value=1.7 Score=39.10 Aligned_cols=34 Identities=18% Similarity=0.099 Sum_probs=26.8
Q ss_pred ccceeecccceeeehhhhhhhhHHHHHHHhhHhHh
Q psy3329 640 KSFLTLGNFGLISVGVIILSAMVYFSFYARHLYRT 674 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~~~ 674 (694)
...||+|++|.||+|.+.++ .||+|+..+...|+
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~r~ 60 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-EVALKVRRRDSPRR 60 (201)
T ss_pred hhhhhcccccEEEEeeccCc-eEEEEEecCCcchh
Confidence 37899999999999999777 67777765555544
No 330
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=54.71 E-value=2.3 Score=41.78 Aligned_cols=28 Identities=14% Similarity=0.082 Sum_probs=23.2
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFY 667 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~ 667 (694)
.++||+|+||.||+|+.. +|..||+|+.
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~ 35 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQV 35 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEE
Confidence 368999999999999864 4778999865
No 331
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=54.06 E-value=1.9 Score=44.25 Aligned_cols=30 Identities=10% Similarity=0.144 Sum_probs=24.9
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
+.||.|+||.||+|+-. .|..||||..+..
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~ 41 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA 41 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccc
Confidence 57999999999999865 5789999977653
No 332
>PHA03210 serine/threonine kinase US3; Provisional
Probab=53.97 E-value=6.2 Score=43.12 Aligned_cols=18 Identities=28% Similarity=0.340 Sum_probs=15.2
Q ss_pred cceeecccceeeehhhhh
Q psy3329 641 SFLTLGNFGLISVGVIIL 658 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~ 658 (694)
..||+|+||.||++++..
T Consensus 154 ~~LG~G~fG~Vyl~~~~~ 171 (501)
T PHA03210 154 DDLPAGAFGKIFICALRA 171 (501)
T ss_pred eEecCCCCcceEEEEEec
Confidence 689999999999986543
No 333
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=52.76 E-value=2.4 Score=41.82 Aligned_cols=30 Identities=20% Similarity=0.179 Sum_probs=23.9
Q ss_pred eeecccceeeehhh-hhhhhHHHHHHHhhHh
Q psy3329 643 LTLGNFGLISVGVI-ILSAMVYFSFYARHLY 672 (694)
Q Consensus 643 iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~ 672 (694)
+|.|+||.||+++- .+|.++|+|+......
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~ 54 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF 54 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhc
Confidence 79999999999986 4566888888766543
No 334
>KOG1151|consensus
Probab=52.67 E-value=2.1 Score=43.71 Aligned_cols=30 Identities=13% Similarity=0.062 Sum_probs=23.9
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~ 670 (694)
+++|+|||..||||.= ...+-||||+--..
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlN 499 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLN 499 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhc
Confidence 8999999999999974 34458999886544
No 335
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=51.74 E-value=2.5 Score=40.36 Aligned_cols=30 Identities=7% Similarity=-0.101 Sum_probs=24.7
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~ 671 (694)
+++|.||||.||...- ++..+|||++....
T Consensus 37 ~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~ 66 (232)
T PRK10359 37 KVFRNIDDTKVSLIDT-DYGKYILKVFAPKV 66 (232)
T ss_pred EEecCCCceEEEEEec-CCCcEEEEEechhc
Confidence 8999999999999766 45589999996443
No 336
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=50.26 E-value=2.5 Score=41.62 Aligned_cols=30 Identities=10% Similarity=0.108 Sum_probs=24.7
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. +|..||+|+....
T Consensus 12 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~ 42 (275)
T cd06608 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDII 42 (275)
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEEecC
Confidence 67999999999999985 5668888887644
No 337
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=49.62 E-value=2.7 Score=42.47 Aligned_cols=29 Identities=17% Similarity=0.155 Sum_probs=23.4
Q ss_pred ccceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
-+.||.|+||.||+|+.. +|..||||...
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~ 49 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMS 49 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEe
Confidence 367999999999999964 56688888654
No 338
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=49.18 E-value=3.1 Score=41.93 Aligned_cols=28 Identities=21% Similarity=0.161 Sum_probs=23.2
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~ 668 (694)
..||.|+||.||+|+.. +|..||||+..
T Consensus 14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~ 42 (311)
T cd07866 14 GKLGEGTFGEVYKARQIKTGRVVALKKIL 42 (311)
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEE
Confidence 67999999999999864 57788888653
No 339
>KOG0199|consensus
Probab=48.29 E-value=3.4 Score=45.10 Aligned_cols=29 Identities=21% Similarity=0.306 Sum_probs=23.6
Q ss_pred cceeecccceeeehhhhh--hh--hHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIIL--SA--MVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~--g~--~vaV~~~~~ 669 (694)
++||.|.||+|..|.|.. |+ .||||....
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~ 148 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRD 148 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccC
Confidence 789999999999999854 44 788887643
No 340
>KOG1164|consensus
Probab=47.46 E-value=3.5 Score=42.06 Aligned_cols=29 Identities=10% Similarity=-0.012 Sum_probs=21.9
Q ss_pred cceeecccceeeehhhhhh--hhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILS--AMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g--~~vaV~~~~~ 669 (694)
..||+|+||.||++.=... ..+|+|+-..
T Consensus 24 ~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~ 54 (322)
T KOG1164|consen 24 KKIGEGGFGAVYLVSDKSEKNKEYAKKLEKK 54 (322)
T ss_pred eeccccCCceEEEEEecCCCCeeEEEEEEEe
Confidence 6899999999999996554 2566665544
No 341
>KOG0666|consensus
Probab=47.00 E-value=8.5 Score=37.81 Aligned_cols=28 Identities=11% Similarity=0.093 Sum_probs=20.7
Q ss_pred cceeecccceeeehhhhhhh-----hHHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILSA-----MVYFSFYA 668 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~-----~vaV~~~~ 668 (694)
..||+|.+|.||||+=.++. ..|+|.+.
T Consensus 30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk 62 (438)
T KOG0666|consen 30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFK 62 (438)
T ss_pred ceecccccceeeEeeeccCCcccchhhHHHHHh
Confidence 56999999999999776664 44555443
No 342
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=46.64 E-value=3.1 Score=40.60 Aligned_cols=30 Identities=13% Similarity=0.124 Sum_probs=24.1
Q ss_pred cceeecccceeeehhhh-hhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVII-LSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~-~g~~vaV~~~~~~ 670 (694)
..||.|+||.||+|+.. ++..+|||+....
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~ 39 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLE 39 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcC
Confidence 56899999999999875 4568888877644
No 343
>KOG0196|consensus
Probab=45.83 E-value=4.4 Score=44.88 Aligned_cols=37 Identities=27% Similarity=0.434 Sum_probs=28.4
Q ss_pred cceeecccceeeehhhhhhh----hHHHHHHHhhHhHhhhhh
Q psy3329 641 SFLTLGNFGLISVGVIILSA----MVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~----~vaV~~~~~~~~~~~~~~ 678 (694)
.+||.|-||.||+|.|.--. .||+|-+... |-.+|+|
T Consensus 635 ~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrr 675 (996)
T KOG0196|consen 635 KVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRR 675 (996)
T ss_pred EEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHh
Confidence 89999999999999996532 8899887654 4444443
No 344
>KOG1989|consensus
Probab=44.73 E-value=5.3 Score=44.58 Aligned_cols=29 Identities=10% Similarity=0.084 Sum_probs=24.6
Q ss_pred ccceeecccceeeehhhhhh-hhHHHHHHH
Q psy3329 640 KSFLTLGNFGLISVGVIILS-AMVYFSFYA 668 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g-~~vaV~~~~ 668 (694)
+++|.+|||+.||.|....| ..+|+|..-
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~ 71 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMY 71 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeee
Confidence 47899999999999999999 788876543
No 345
>KOG0581|consensus
Probab=44.30 E-value=4 Score=40.92 Aligned_cols=42 Identities=17% Similarity=0.071 Sum_probs=30.0
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHhHhhhhhhhcc
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLYRTKQQRIRRN 682 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~~~~~~~~~~~ 682 (694)
++||+|..|+|||+.-.- |...|.|+--...-...|.|+-||
T Consensus 85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rE 127 (364)
T KOG0581|consen 85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRE 127 (364)
T ss_pred hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHH
Confidence 789999999999998864 447777776444455555554443
No 346
>KOG2345|consensus
Probab=44.21 E-value=7.8 Score=36.82 Aligned_cols=31 Identities=13% Similarity=0.175 Sum_probs=25.2
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~~ 671 (694)
..+|.|||..||.++ +.++..-|.|.-..+.
T Consensus 27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~ 58 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHS 58 (302)
T ss_pred eeecCCCceeeeeecccCcccchhhheeeccc
Confidence 579999999999998 6666678887766666
No 347
>KOG0592|consensus
Probab=43.43 E-value=9.4 Score=40.49 Aligned_cols=32 Identities=6% Similarity=0.080 Sum_probs=26.6
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~ 672 (694)
.+||.|.|.+||+|+=.+ ++..||||+....-
T Consensus 79 ~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I 111 (604)
T KOG0592|consen 79 KILGEGSYSTVVLAREKATGKEYAIKVLDKRYI 111 (604)
T ss_pred heeccccceeEEEeeecCCCceeeHhhhhHHHH
Confidence 689999999999998655 45999999987643
No 348
>KOG0986|consensus
Probab=42.78 E-value=16 Score=37.90 Aligned_cols=32 Identities=16% Similarity=0.157 Sum_probs=22.6
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLY 672 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~ 672 (694)
++||+||||-||--+..+ |..-|-|-+-..+-
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi 223 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRI 223 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHH
Confidence 899999999999877755 44556554444333
No 349
>KOG0585|consensus
Probab=41.60 E-value=4.9 Score=41.75 Aligned_cols=37 Identities=8% Similarity=0.167 Sum_probs=30.0
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhhHhHhhhh
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARHLYRTKQQ 677 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~~~~~~~~ 677 (694)
..||+|.||.|-+|. ..+|+.||+|+..+.-.+.++.
T Consensus 103 ~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~ 140 (576)
T KOG0585|consen 103 KEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYG 140 (576)
T ss_pred hhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcc
Confidence 679999999999886 4467799999998876665543
No 350
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=40.18 E-value=6.2 Score=39.70 Aligned_cols=30 Identities=7% Similarity=0.090 Sum_probs=23.5
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~ 670 (694)
+.||+|+||.||+|+-.. +..||||.....
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~ 37 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQ 37 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehh
Confidence 579999999999998654 457888876544
No 351
>PRK10345 hypothetical protein; Provisional
Probab=39.85 E-value=15 Score=34.68 Aligned_cols=24 Identities=17% Similarity=-0.002 Sum_probs=19.2
Q ss_pred ccCcccceeecccceeeehhhhhhh
Q psy3329 636 KLNSKSFLTLGNFGLISVGVIILSA 660 (694)
Q Consensus 636 ~~~~~~~iG~G~fG~VYkg~l~~g~ 660 (694)
+++++.+||+|+||.||. .-.++.
T Consensus 3 ~L~~~~~LG~G~~~~Vy~-hp~~~~ 26 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYA-HPEDAQ 26 (210)
T ss_pred ecCCcceecCCCceEEEE-CCCCcC
Confidence 356778999999999998 555665
No 352
>KOG1165|consensus
Probab=39.43 E-value=6 Score=39.21 Aligned_cols=31 Identities=23% Similarity=0.356 Sum_probs=25.6
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~~ 671 (694)
.-||+|.||..+.|+ |-++..||+|+-.+.+
T Consensus 34 kKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS 65 (449)
T KOG1165|consen 34 KKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS 65 (449)
T ss_pred cccccCcceeeecccccccCceEEEEeccccC
Confidence 469999999999997 6678899999866544
No 353
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=37.73 E-value=4.8 Score=35.06 Aligned_cols=30 Identities=7% Similarity=-0.170 Sum_probs=23.9
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhhH
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARHL 671 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~ 671 (694)
+.||.|+++.||+++..+ ..++||+.....
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~ 33 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSRE 33 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCC
Confidence 568999999999999865 567888765543
No 354
>KOG0579|consensus
Probab=36.25 E-value=11 Score=40.71 Aligned_cols=19 Identities=26% Similarity=0.170 Sum_probs=15.6
Q ss_pred ceeecccceeeehhhhhhh
Q psy3329 642 FLTLGNFGLISVGVIILSA 660 (694)
Q Consensus 642 ~iG~G~fG~VYkg~l~~g~ 660 (694)
-+|.|.||.||||+=.+-.
T Consensus 39 ELGDGAFGKVyKA~nket~ 57 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETK 57 (1187)
T ss_pred hhcCccchhhhhhhcccch
Confidence 4678999999999987554
No 355
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=35.75 E-value=6.1 Score=46.20 Aligned_cols=29 Identities=10% Similarity=0.077 Sum_probs=22.6
Q ss_pred cceeecccceeeehhhhhh-hhHHHHHHHh
Q psy3329 641 SFLTLGNFGLISVGVIILS-AMVYFSFYAR 669 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-~~vaV~~~~~ 669 (694)
..||.|+||.||+|.-... ..||+|+...
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~ 48 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISY 48 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEec
Confidence 6799999999999987544 4777776543
No 356
>KOG0200|consensus
Probab=35.51 E-value=6.3 Score=44.16 Aligned_cols=37 Identities=14% Similarity=0.267 Sum_probs=28.1
Q ss_pred ceeecccceeeehhhhh--------hhhHHHHHHHhhHhHhhhhh
Q psy3329 642 FLTLGNFGLISVGVIIL--------SAMVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 642 ~iG~G~fG~VYkg~l~~--------g~~vaV~~~~~~~~~~~~~~ 678 (694)
.+|.|.||.|++|.+.. ...||||+.+.......++.
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~ 347 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKD 347 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHH
Confidence 89999999999998642 33799999887666633333
No 357
>KOG0611|consensus
Probab=35.41 E-value=13 Score=37.76 Aligned_cols=38 Identities=13% Similarity=0.130 Sum_probs=31.0
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhhHhHhhhhh
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~~~~~~~ 678 (694)
..+|+|.+|.|-+|.= ..|++||||.-......-+|.-
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDl 97 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDL 97 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHH
Confidence 5799999999999987 7889999998776666555554
No 358
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=35.40 E-value=22 Score=45.81 Aligned_cols=32 Identities=25% Similarity=0.405 Sum_probs=17.5
Q ss_pred EcCCCCCcccCCCCCCCcCCCCccEEEccCCcCC
Q psy3329 423 RLSGNPLHVLPTGNLLPPQLSRLRSLDLSRCKID 456 (694)
Q Consensus 423 ~Ls~n~l~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 456 (694)
||++|+|+.+++..| ..+++|+.|+|++|.+.
T Consensus 1 DLSnN~LstLp~g~F--~~L~sL~~LdLsgNPw~ 32 (2740)
T TIGR00864 1 DISNNKISTIEEGIC--ANLCNLSEIDLSGNPFE 32 (2740)
T ss_pred CCCCCcCCccChHHh--ccCCCceEEEeeCCccc
Confidence 345555555555555 55555555555555443
No 359
>KOG0669|consensus
Probab=35.35 E-value=10 Score=36.05 Aligned_cols=25 Identities=16% Similarity=0.134 Sum_probs=21.1
Q ss_pred cceeecccceeeehhhhhhh-hHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILSA-MVYFS 665 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~-~vaV~ 665 (694)
..||.|.||.|+||+=.++. .||||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalk 48 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALK 48 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHH
Confidence 68999999999999987765 66765
No 360
>PF09919 DUF2149: Uncharacterized conserved protein (DUF2149); InterPro: IPR018676 This family of conserved hypothetical proteins has no known function.
Probab=34.28 E-value=9.3 Score=30.30 Aligned_cols=21 Identities=14% Similarity=0.153 Sum_probs=16.5
Q ss_pred ceeec-ccceeeehhhhhhhhHHH
Q psy3329 642 FLTLG-NFGLISVGVIILSAMVYF 664 (694)
Q Consensus 642 ~iG~G-~fG~VYkg~l~~g~~vaV 664 (694)
-=|+| .-|+||+ ++||++|.|
T Consensus 69 ~~G~G~~~G~aYr--l~~Gk~I~V 90 (92)
T PF09919_consen 69 GSGSGERLGTAYR--LKDGKLIYV 90 (92)
T ss_pred CCCCCeECeEEEE--cCCceEEEe
Confidence 34556 7899999 999997765
No 361
>KOG1167|consensus
Probab=32.02 E-value=15 Score=37.71 Aligned_cols=19 Identities=16% Similarity=0.090 Sum_probs=17.3
Q ss_pred ccceeecccceeeehhhhh
Q psy3329 640 KSFLTLGNFGLISVGVIIL 658 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~ 658 (694)
.+.||.|.|++||+|++..
T Consensus 41 v~kigeGsFssv~~a~~~~ 59 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIE 59 (418)
T ss_pred hccccccchhhhhhhhHhh
Confidence 3899999999999999976
No 362
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=30.57 E-value=9.8 Score=41.28 Aligned_cols=27 Identities=11% Similarity=-0.084 Sum_probs=20.2
Q ss_pred cceeecccceeeehhhhh--hhhHHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIIL--SAMVYFSFY 667 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~--g~~vaV~~~ 667 (694)
+.||+|+||.||+|.-.. +..||+|..
T Consensus 73 ~~lg~G~~g~vy~a~~~~~~~~~vv~K~~ 101 (478)
T PTZ00267 73 TLVGRNPTTAAFVATRGSDPKEKVVAKFV 101 (478)
T ss_pred EEEEeCCCcEEEEEEEcCCCCeEEEEEEc
Confidence 689999999999997543 345666643
No 363
>KOG4278|consensus
Probab=29.50 E-value=17 Score=39.35 Aligned_cols=32 Identities=22% Similarity=0.154 Sum_probs=26.3
Q ss_pred Ccccceeecccceeeehhhhhhh-hHHHHHHHh
Q psy3329 638 NSKSFLTLGNFGLISVGVIILSA-MVYFSFYAR 669 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g~-~vaV~~~~~ 669 (694)
+=.+-||.|.+|.||-|+|.--. .||||-+..
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE 302 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 302 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhh
Confidence 44588999999999999997665 899987653
No 364
>KOG4279|consensus
Probab=28.95 E-value=11 Score=41.25 Aligned_cols=26 Identities=12% Similarity=0.125 Sum_probs=20.4
Q ss_pred cceeecccceeeehhhhhhh-hHHHHH
Q psy3329 641 SFLTLGNFGLISVGVIILSA-MVYFSF 666 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~-~vaV~~ 666 (694)
-++|+|.+|+||-|+=.+-. -+|||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKE 607 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKE 607 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeee
Confidence 69999999999999876654 455544
No 365
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily.
Probab=28.22 E-value=40 Score=19.23 Aligned_cols=11 Identities=27% Similarity=0.474 Sum_probs=5.7
Q ss_pred CCCCEEEccCC
Q psy3329 467 RNITSLNLANN 477 (694)
Q Consensus 467 ~~L~~L~L~~N 477 (694)
++|+.|+|++|
T Consensus 2 ~~L~~L~l~~C 12 (26)
T smart00367 2 PNLRELDLSGC 12 (26)
T ss_pred CCCCEeCCCCC
Confidence 44555555554
No 366
>KOG1024|consensus
Probab=28.13 E-value=31 Score=35.20 Aligned_cols=33 Identities=24% Similarity=0.235 Sum_probs=24.8
Q ss_pred cccceeecccceeeeh------hhhhhhhHHHHHHHhhH
Q psy3329 639 SKSFLTLGNFGLISVG------VIILSAMVYFSFYARHL 671 (694)
Q Consensus 639 ~~~~iG~G~fG~VYkg------~l~~g~~vaV~~~~~~~ 671 (694)
..-++-+|.||.||+| +..|-..|.||-.+-+-
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A 326 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA 326 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc
Confidence 3467889999999999 66666688887655443
No 367
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=27.99 E-value=9.9 Score=38.35 Aligned_cols=27 Identities=4% Similarity=-0.220 Sum_probs=22.0
Q ss_pred eeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 643 LTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 643 iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
+|.|+++.||+++- +|..||||+....
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~ 36 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLD 36 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEecc
Confidence 46788899999988 7889999986543
No 368
>KOG0587|consensus
Probab=27.84 E-value=12 Score=42.03 Aligned_cols=44 Identities=9% Similarity=0.180 Sum_probs=32.8
Q ss_pred cceeecccceeeehh-hhhhhhHHHHHHHhhHhHhhhhhhhcccc
Q psy3329 641 SFLTLGNFGLISVGV-IILSAMVYFSFYARHLYRTKQQRIRRNTF 684 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~-l~~g~~vaV~~~~~~~~~~~~~~~~~~~~ 684 (694)
.+||.|.+|.|||++ ..+|+.+|||+.--..--....+.++|.-
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil 69 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNML 69 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHH
Confidence 689999999999986 56788999988766655555555555543
No 369
>KOG4721|consensus
Probab=25.11 E-value=24 Score=37.84 Aligned_cols=27 Identities=19% Similarity=0.224 Sum_probs=22.2
Q ss_pred CcccceeecccceeeehhhhhhhhHHHH
Q psy3329 638 NSKSFLTLGNFGLISVGVIILSAMVYFS 665 (694)
Q Consensus 638 ~~~~~iG~G~fG~VYkg~l~~g~~vaV~ 665 (694)
++=..+|.|.=|.||.|+|.+. .||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~ne-tVAVK 153 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLHNE-TVAVK 153 (904)
T ss_pred hhhhhhccCcccceeeeeccCc-eehhH
Confidence 4447899999999999999877 46774
No 370
>KOG0983|consensus
Probab=24.61 E-value=20 Score=34.72 Aligned_cols=38 Identities=13% Similarity=0.057 Sum_probs=30.9
Q ss_pred cceeecccceeeehhhhh-hhhHHHHHHHhhHhHhhhhh
Q psy3329 641 SFLTLGNFGLISVGVIIL-SAMVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~-g~~vaV~~~~~~~~~~~~~~ 678 (694)
..||.|..|.|.|.+... |.++|||.--|.+....-.|
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kR 136 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKR 136 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHH
Confidence 679999999999999876 67999988777766655555
No 371
>KOG0610|consensus
Probab=24.43 E-value=8.5 Score=39.36 Aligned_cols=38 Identities=8% Similarity=0.148 Sum_probs=27.9
Q ss_pred cceeecccceeeehhhhhh-hhHHHHHHHhhHhHhhhhh
Q psy3329 641 SFLTLGNFGLISVGVIILS-AMVYFSFYARHLYRTKQQR 678 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g-~~vaV~~~~~~~~~~~~~~ 678 (694)
..||+|--|+||.+.+.+- ..-|+||--+..-..++.-
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl 121 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKL 121 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHH
Confidence 6899999999999999765 4777777655554444433
No 372
>KOG1033|consensus
Probab=23.50 E-value=37 Score=36.12 Aligned_cols=43 Identities=14% Similarity=0.104 Sum_probs=36.2
Q ss_pred ccceeecccceeeehhhhhhh-hHHHHHHHhhHhHhhhhhhhcc
Q psy3329 640 KSFLTLGNFGLISVGVIILSA-MVYFSFYARHLYRTKQQRIRRN 682 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~-~vaV~~~~~~~~~~~~~~~~~~ 682 (694)
...+|+||||+|+-+....+. --||+..+...+.+.+.|+=+|
T Consensus 54 ~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~ 97 (516)
T KOG1033|consen 54 GQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLRE 97 (516)
T ss_pred cccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhcc
Confidence 379999999999999887665 8889999888888888886554
No 373
>KOG0584|consensus
Probab=23.50 E-value=32 Score=37.32 Aligned_cols=45 Identities=9% Similarity=0.008 Sum_probs=25.4
Q ss_pred ccceeecccceeeehhhhhhhhHHHHHHHhhHhHhhhhhhhccccC
Q psy3329 640 KSFLTLGNFGLISVGVIILSAMVYFSFYARHLYRTKQQRIRRNTFK 685 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~~~~~~~~~~~~~~~~ 685 (694)
+.+||+|.|-+||||.=.+ +-|.|=-+-..-+...|.....++|+
T Consensus 45 ~evLGrGafKtVYka~De~-~giEVAWnqvk~~d~~q~~~~leR~~ 89 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEE-EGIEVAWNQVKIRDVTQSPEELERLY 89 (632)
T ss_pred hhhcccccceeeeeccccc-cchhhHHHHHhHHHhhcChHHHHHHH
Confidence 3689999999999997633 33333223333333334444444443
No 374
>KOG0984|consensus
Probab=23.41 E-value=12 Score=34.51 Aligned_cols=41 Identities=12% Similarity=0.113 Sum_probs=32.4
Q ss_pred cceeecccceeeehhh-hhhhhHHHHHHHhhHhHhhhhhhhc
Q psy3329 641 SFLTLGNFGLISVGVI-ILSAMVYFSFYARHLYRTKQQRIRR 681 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l-~~g~~vaV~~~~~~~~~~~~~~~~~ 681 (694)
..||+|++|.|-|=+. .+|++.|||.-+.+..-+.|+|.-+
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~ 93 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLM 93 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHH
Confidence 6799999999866554 4788999998888888777777433
No 375
>PRK12274 serine/threonine protein kinase; Provisional
Probab=21.17 E-value=29 Score=32.64 Aligned_cols=21 Identities=19% Similarity=-0.042 Sum_probs=16.3
Q ss_pred ccceeecccceeeehhhhhhh
Q psy3329 640 KSFLTLGNFGLISVGVIILSA 660 (694)
Q Consensus 640 ~~~iG~G~fG~VYkg~l~~g~ 660 (694)
..+||+|+||+||.+.=++..
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k 27 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERK 27 (218)
T ss_pred ceeecCCCcceEEEeecCCce
Confidence 468999999999977664443
No 376
>KOG1094|consensus
Probab=21.14 E-value=18 Score=38.98 Aligned_cols=30 Identities=13% Similarity=0.111 Sum_probs=26.8
Q ss_pred cceeecccceeeehhhhhhhhHHHHHHHhh
Q psy3329 641 SFLTLGNFGLISVGVIILSAMVYFSFYARH 670 (694)
Q Consensus 641 ~~iG~G~fG~VYkg~l~~g~~vaV~~~~~~ 670 (694)
+.||+|.||.|-.-.+..+..||||...-.
T Consensus 544 ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~ 573 (807)
T KOG1094|consen 544 EKIGEGQFGEVHLCEVEGPLKVAVKILRPD 573 (807)
T ss_pred hhhcCcccceeEEEEecCceEEEEeecCcc
Confidence 789999999999999988899999987543
Done!